{ "instance": { "mpw-20221231.htm": { "axisCustom": 0, "axisStandard": 43, "baseTaxonomies": { "http://fasb.org/srt/2022": 764, "http://fasb.org/us-gaap/2022": 4024, "http://xbrl.sec.gov/dei/2022": 68 }, "contextCount": 1257, "dts": { "calculationLink": { "local": [ "mpw-20221231_cal.xml" ] }, "definitionLink": { "local": [ "mpw-20221231_def.xml" ] }, "inline": { "local": [ "mpw-20221231.htm" ] }, "labelLink": { "local": [ "mpw-20221231_lab.xml" ] }, "presentationLink": { "local": [ "mpw-20221231_pre.xml" ] }, "schema": { "local": [ "mpw-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 1380, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 32, "http://xbrl.sec.gov/dei/2022": 8, "total": 40 }, "keyCustom": 184, "keyStandard": 399, "memberCustom": 496, "memberStandard": 56, "nsprefix": "mpw", "nsuri": "http://medicalpropertiestrust.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "menuCat": "Cover", "order": "1", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "dei:DocumentPeriodEndDate", "span", "p", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "lang": "en-US", "name": "dei:DocumentPeriodEndDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100090 - Disclosure - Organization", "menuCat": "Notes", "order": "10", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureOrganization", "shortName": "Organization", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R100": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "mpw:ScheduleOfFutureMinimumRentalPaymentsForLeasesSubleaseReceivableAndNetPaymentsTableTextBlock", "div", "mpw:LesseeOperatingLeaseAndFinanceLeaseTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101020 - Disclosure - Leases (Lessee) - Schedule of Fixed Minimum Rental Payments Due under Leases with Non-Cancelable Terms (Detail)", "menuCat": "Details", "order": "100", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail", "shortName": "Leases (Lessee) - Schedule of Fixed Minimum Rental Payments Due under Leases with Non-Cancelable Terms (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "mpw:ScheduleOfFutureMinimumRentalPaymentsForLeasesSubleaseReceivableAndNetPaymentsTableTextBlock", "div", "mpw:LesseeOperatingLeaseAndFinanceLeaseTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R101": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "mpw:ScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock", "div", "mpw:LesseeOperatingLeaseAndFinanceLeaseTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FinanceLeaseRightOfUseAsset", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101030 - Disclosure - Leases (Lessee) - Summary of Supplemental Balance Sheet Information (Detail)", "menuCat": "Details", "order": "101", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail", "shortName": "Leases (Lessee) - Summary of Supplemental Balance Sheet Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "mpw:ScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock", "div", "mpw:LesseeOperatingLeaseAndFinanceLeaseTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FinanceLeaseRightOfUseAsset", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R102": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "mpw:ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock", "div", "mpw:LesseeOperatingLeaseAndFinanceLeaseTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101040 - Disclosure - Leases (Lessee) - Summary of Supplemental Cash Flow Information (Detail)", "menuCat": "Details", "order": "102", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalCashFlowInformationDetail", "shortName": "Leases (Lessee) - Summary of Supplemental Cash Flow Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "mpw:ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock", "div", "mpw:LesseeOperatingLeaseAndFinanceLeaseTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R103": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfOtherAssetsTableTextBlock", "div", "us-gaap:OtherAssetsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "first": true, "lang": null, "name": "mpw:DebtIssueCostsNet", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101050 - Disclosure - Other Assets - Summary of Other Assets on our Condensed Consolidated Balance Sheets (Detail)", "menuCat": "Details", "order": "103", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureOtherAssetsSummaryOfOtherAssetsOnOurCondensedConsolidatedBalanceSheetsDetail", "shortName": "Other Assets - Summary of Other Assets on our Condensed Consolidated Balance Sheets (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfOtherAssetsTableTextBlock", "div", "us-gaap:OtherAssetsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "first": true, "lang": null, "name": "mpw:DebtIssueCostsNet", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R104": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:OtherAssetsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:IncreaseDecreaseInDerivativeAssets", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101060 - Disclosure - Other Assets - Additional Information (Detail)", "menuCat": "Details", "order": "104", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureOtherAssetsAdditionalInformationDetail", "shortName": "Other Assets - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:OtherAssetsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:IncreaseDecreaseInDerivativeAssets", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R105": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101070 - Disclosure - Subsequent Events - Additional Information (Detail)", "menuCat": "Details", "order": "105", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "shortName": "Subsequent Events - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:SubsequentEventsTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_353591c3-9163-4999-8c72-547196030ddc", "decimals": "3", "lang": null, "name": "mpw:PercentageOfLeasedAssets", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" } }, "R106": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_5bf63889-09c9-4277-a1db-c7ec13f4accf", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ValuationAllowancesAndReservesBalance", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101080 - Disclosure - Schedule II - Schedule of Valuation and Qualifying Accounts (Detail)", "menuCat": "Details", "order": "106", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsDetail", "shortName": "Schedule II - Schedule of Valuation and Qualifying Accounts (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_9a89eaeb-426c-4d7f-871c-fbcfe6f5c85e", "decimals": "-3", "lang": null, "name": "us-gaap:ValuationAllowancesAndReservesBalance", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R107": { "firstAnchor": { "ancestors": [ "span", "div", "div", "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "-5", "first": true, "lang": null, "name": "mpw:IncreaseDecreaseInRealEstateImpairmentReserve", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101090 - Disclosure - Schedule II - Schedule of Valuation and Qualifying Accounts (Parenthetical) (Detail)", "menuCat": "Details", "order": "107", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail", "shortName": "Schedule II - Schedule of Valuation and Qualifying Accounts (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "-5", "first": true, "lang": null, "name": "mpw:IncreaseDecreaseInRealEstateImpairmentReserve", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R108": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "srt:RealEstateAndAccumulatedDepreciationDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RealEstateAndAccumulatedDepreciationInitialCostOfLand", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101100 - Disclosure - Schedule III - Real Estate Investments and Accumulated Depreciation (Detail)", "menuCat": "Details", "order": "108", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail", "shortName": "Schedule III - Real Estate Investments and Accumulated Depreciation (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "srt:RealEstateAndAccumulatedDepreciationDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RealEstateAndAccumulatedDepreciationInitialCostOfLand", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R109": { "firstAnchor": { "ancestors": [ "span", "div", "div", "srt:RealEstateAndAccumulatedDepreciationDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-8", "first": true, "lang": null, "name": "srt:RealEstateFederalIncomeTaxBasis", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101110 - Disclosure - Schedule III - Real Estate Investments and Accumulated Depreciation (Parenthetical) (Detail)", "menuCat": "Details", "order": "109", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationParentheticalDetail", "shortName": "Schedule III - Real Estate Investments and Accumulated Depreciation (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "srt:RealEstateAndAccumulatedDepreciationDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-8", "first": true, "lang": null, "name": "srt:RealEstateFederalIncomeTaxBasis", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100100 - Disclosure - Summary of Significant Accounting Policies", "menuCat": "Notes", "order": "11", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R110": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "srt:RealEstateAndAccumulatedDepreciationDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_5bf63889-09c9-4277-a1db-c7ec13f4accf", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RealEstateGrossAtCarryingValue", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101120 - Disclosure - Schedule III - Changes in Total Real Estate Assets (Detail)", "menuCat": "Details", "order": "110", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIChangesInTotalRealEstateAssetsDetail", "shortName": "Schedule III - Changes in Total Real Estate Assets (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "srt:RealEstateAndAccumulatedDepreciationDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "-3", "lang": null, "name": "mpw:RealEstateAcquisitions", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R111": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "srt:RealEstateAndAccumulatedDepreciationDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_5bf63889-09c9-4277-a1db-c7ec13f4accf", "decimals": "-3", "first": true, "lang": null, "name": "mpw:RealEstateAssetsAccumulatedDepreciation", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101130 - Disclosure - Schedule III - Changes in Accumulated Depreciation (Detail)", "menuCat": "Details", "order": "111", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIChangesInAccumulatedDepreciationDetail", "shortName": "Schedule III - Changes in Accumulated Depreciation (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "srt:RealEstateAndAccumulatedDepreciationDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_9a89eaeb-426c-4d7f-871c-fbcfe6f5c85e", "decimals": "-3", "lang": null, "name": "mpw:RealEstateAssetsAccumulatedDepreciation", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R112": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "mpw:ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock", "div", "mpw:LesseeOperatingLeaseAndFinanceLeaseTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101140 - Disclosure - Schedule III - Changes in Accumulated Depreciation (Parenthetical) (Detail)", "menuCat": "Details", "order": "112", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIChangesInAccumulatedDepreciationParentheticalDetail", "shortName": "Schedule III - Changes in Accumulated Depreciation (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "link:footnote", "div", "div", "srt:RealEstateAndAccumulatedDepreciationDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_5bf63889-09c9-4277-a1db-c7ec13f4accf", "decimals": "-8", "lang": null, "name": "mpw:RealEstateHeldForSaleLandAndBuildingCost", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R113": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "srt:MortgageLoansOnRealEstateByLoanDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "first": true, "lang": null, "name": "srt:MortgageLoansOnRealEstateFaceAmountOfMortgages", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101150 - Disclosure - Schedule IV - Schedule of Mortgage Loans on Real Estate (Detail)", "menuCat": "Details", "order": "113", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail", "shortName": "Schedule IV - Schedule of Mortgage Loans on Real Estate (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "srt:MortgageLoansOnRealEstateByLoanDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "first": true, "lang": null, "name": "srt:MortgageLoansOnRealEstateFaceAmountOfMortgages", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R114": { "firstAnchor": { "ancestors": [ "span", "div", "div", "srt:MortgageLoansOnRealEstateByLoanDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "INF", "first": true, "lang": null, "name": "srt:MortgageLoansOnRealEstatePriorLiens1", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101160 - Disclosure - Schedule IV - Schedule of Mortgage Loans on Real Estate (Parenthetical) (Detail)", "menuCat": "Details", "order": "114", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateParentheticalDetail", "shortName": "Schedule IV - Schedule of Mortgage Loans on Real Estate (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "srt:MortgageLoansOnRealEstateByLoanDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "INF", "first": true, "lang": null, "name": "srt:MortgageLoansOnRealEstatePriorLiens1", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R115": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "srt:MortgageLoansOnRealEstateByLoanDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_5bf63889-09c9-4277-a1db-c7ec13f4accf", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:MortgageLoansOnRealEstate", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101170 - Disclosure - Schedule IV - Changes in Mortgage Loans Excluding Allowance for Credit Loss (Detail)", "menuCat": "Details", "order": "115", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossDetail", "shortName": "Schedule IV - Changes in Mortgage Loans Excluding Allowance for Credit Loss (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "srt:MortgageLoansOnRealEstateByLoanDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "-3", "lang": null, "name": "mpw:MortgageLoansOnRealEstateExchangeRateFluctuations", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R116": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_5bf63889-09c9-4277-a1db-c7ec13f4accf", "decimals": "-3", "first": true, "lang": null, "name": "mpw:BusinessCombinationLoansPaidDownOnAcquisitionLoans", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101180 - Disclosure - Schedule IV - Changes in Mortgage Loans Excluding Allowance for Credit Loss (Parenthetical) (Detail)", "menuCat": "Details", "order": "116", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossParentheticalDetail", "shortName": "Schedule IV - Changes in Mortgage Loans Excluding Allowance for Credit Loss (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "srt:MortgageLoansOnRealEstateByLoanDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_706b48f1-6f26-486d-b0e6-46e49608033b", "decimals": "-6", "lang": null, "name": "mpw:BusinessCombinationLoansPaidDownOnAcquisitionLoans", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RealEstateDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100110 - Disclosure - Real Estate and Other Activities", "menuCat": "Notes", "order": "12", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities", "shortName": "Real Estate and Other Activities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RealEstateDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100120 - Disclosure - Debt", "menuCat": "Notes", "order": "13", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebt", "shortName": "Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100130 - Disclosure - Income Taxes", "menuCat": "Notes", "order": "14", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100140 - Disclosure - Earnings Per Share/Unit", "menuCat": "Notes", "order": "15", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureEarningsPerShareUnit", "shortName": "Earnings Per Share/Unit", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100150 - Disclosure - Stock Awards", "menuCat": "Notes", "order": "16", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwards", "shortName": "Stock Awards", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100160 - Disclosure - Commitments and Contingencies", "menuCat": "Notes", "order": "17", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PartnersCapitalNotesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100170 - Disclosure - Common Stock/Partner's Capital", "menuCat": "Notes", "order": "18", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnerSCapital", "shortName": "Common Stock/Partner's Capital", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PartnersCapitalNotesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100180 - Disclosure - Fair Value of Financial Instruments", "menuCat": "Notes", "order": "19", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstruments", "shortName": "Fair Value of Financial Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Land", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100010 - Statement - Consolidated Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Land", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "mpw:LesseeOperatingLeaseAndFinanceLeaseTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100190 - Disclosure - Leases (Lessee)", "menuCat": "Notes", "order": "20", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLessee", "shortName": "Leases (Lessee)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "mpw:LesseeOperatingLeaseAndFinanceLeaseTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100200 - Disclosure - Other Assets", "menuCat": "Notes", "order": "21", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureOtherAssets", "shortName": "Other Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100210 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "22", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureSubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100220 - Disclosure - Schedule II: Valuation and Qualifying Accounts", "menuCat": "Notes", "order": "23", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIValuationAndQualifyingAccounts", "shortName": "Schedule II: Valuation and Qualifying Accounts", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "srt:RealEstateAndAccumulatedDepreciationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100230 - Disclosure - SCHEDULE III - REAL ESTATE INVESTMENTS AND ACCUMULATED DEPRECIATION", "menuCat": "Notes", "order": "24", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSCHEDULEIIIREALESTATEINVESTMENTSANDACCUMULATEDDEPRECIATION", "shortName": "SCHEDULE III - REAL ESTATE INVESTMENTS AND ACCUMULATED DEPRECIATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "srt:RealEstateAndAccumulatedDepreciationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "srt:MortgageLoansOnRealEstateByLoanDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100240 - Disclosure - SCHEDULE IV - MORTGAGE LOANS ON REAL ESTATE", "menuCat": "Notes", "order": "25", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSCHEDULEIVMORTGAGELOANSONREALESTATE", "shortName": "SCHEDULE IV - MORTGAGE LOANS ON REAL ESTATE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "srt:MortgageLoansOnRealEstateByLoanDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100250 - Disclosure - Summary of Significant Accounting Policies (Policies)", "menuCat": "Policies", "order": "26", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "mpw:RealEstateAndDepreciationPolicyTextBlock", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100260 - Disclosure - Summary of Significant Accounting Policies (Tables)", "menuCat": "Tables", "order": "27", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "mpw:RealEstateAndDepreciationPolicyTextBlock", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100270 - Disclosure - Real Estate and Other Activities (Tables)", "menuCat": "Tables", "order": "28", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables", "shortName": "Real Estate and Other Activities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100280 - Disclosure - Debt (Tables)", "menuCat": "Tables", "order": "29", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtTables", "shortName": "Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100020 - Statement - Consolidated Balance Sheets (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100290 - Disclosure - Income Taxes (Tables)", "menuCat": "Tables", "order": "30", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "div", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100300 - Disclosure - Earnings Per Share/Unit (Tables)", "menuCat": "Tables", "order": "31", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureEarningsPerShareUnitTables", "shortName": "Earnings Per Share/Unit (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100310 - Disclosure - Stock Awards (Tables)", "menuCat": "Tables", "order": "32", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsTables", "shortName": "Stock Awards (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100320 - Disclosure - Fair Value of Financial Instruments (Tables)", "menuCat": "Tables", "order": "33", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsTables", "shortName": "Fair Value of Financial Instruments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "div", "mpw:LesseeOperatingLeaseAndFinanceLeaseTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100330 - Disclosure - Leases (Lessee) (Tables)", "menuCat": "Tables", "order": "34", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeTables", "shortName": "Leases (Lessee) (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "mpw:LesseeOperatingLeaseAndFinanceLeaseTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "div", "us-gaap:OtherAssetsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100340 - Disclosure - Other Assets (Tables)", "menuCat": "Tables", "order": "35", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureOtherAssetsTables", "shortName": "Other Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:OtherAssetsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "INF", "first": true, "lang": null, "name": "mpw:NumberOfFacilities", "reportCount": 1, "unique": true, "unitRef": "U_Facility", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100350 - Disclosure - Organization - Additional Information (Detail)", "menuCat": "Details", "order": "36", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail", "shortName": "Organization - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "INF", "first": true, "lang": null, "name": "mpw:NumberOfFacilities", "reportCount": 1, "unique": true, "unitRef": "U_Facility", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:ConsolidationPolicyTextBlock", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "INF", "first": true, "lang": null, "name": "mpw:ThresholdOwnershipPercentageForInterCompanyBalancesAndTransactionsElimination", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100360 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)", "menuCat": "Details", "order": "37", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "shortName": "Summary of Significant Accounting Policies - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:ConsolidationPolicyTextBlock", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "INF", "first": true, "lang": null, "name": "mpw:ThresholdOwnershipPercentageForInterCompanyBalancesAndTransactionsElimination", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "div", "mpw:RealEstateAndDepreciationPolicyTextBlock", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_917aa0b5-4814-437c-8b03-4308e0e1a31e", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100370 - Disclosure - Summary of Significant Accounting Policies - Estimated Useful Lives of Related Real Estate and Other Assets (Detail)", "menuCat": "Details", "order": "38", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfRelatedRealEstateAndOtherAssetsDetail", "shortName": "Summary of Significant Accounting Policies - Estimated Useful Lives of Related Real Estate and Other Assets (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "div", "mpw:RealEstateAndDepreciationPolicyTextBlock", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_917aa0b5-4814-437c-8b03-4308e0e1a31e", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock", "div", "us-gaap:LoanCommitmentsPolicy", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_5bf63889-09c9-4277-a1db-c7ec13f4accf", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FinancingReceivableAllowanceForCreditLosses", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100380 - Disclosure - Summary of Significant Accounting Policies - Summary of Credit Loss Reserves (Detail)", "menuCat": "Details", "order": "39", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCreditLossReservesDetail", "shortName": "Summary of Significant Accounting Policies - Summary of Credit Loss Reserves (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock", "div", "us-gaap:LoanCommitmentsPolicy", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_ebd8ab96-510a-4dc8-aae8-4f838fa283ea", "decimals": "-3", "lang": null, "name": "us-gaap:FinancingReceivableAllowanceForCreditLosses", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "-3", "first": true, "lang": null, "name": "mpw:RentBilled", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100030 - Statement - Consolidated Statements of Net Income", "menuCat": "Statements", "order": "4", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome", "shortName": "Consolidated Statements of Net Income", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "-3", "first": true, "lang": null, "name": "mpw:RentBilled", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100390 - Disclosure - Real Estate and Other Activities - Net Assets Acquired (Detail)", "menuCat": "Details", "order": "40", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "shortName": "Real Estate and Other Activities - Net Assets Acquired (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100400 - Disclosure - Real Estate and Other Activities - Net Assets Acquired (Parenthetical) (Detail)", "menuCat": "Details", "order": "41", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail", "shortName": "Real Estate and Other Activities - Net Assets Acquired (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "link:footnote", "div", "div", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_2dfdee4b-a74f-4d79-b480-ba300eda1bed", "decimals": "-6", "lang": null, "name": "mpw:BusinessCombinationLoansPaidDownOnAcquisitionLoans", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_5bf63889-09c9-4277-a1db-c7ec13f4accf", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100410 - Disclosure - Real Estate and Other Activities - 2022 Activity - Additional Information) (Detail)", "menuCat": "Details", "order": "42", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "shortName": "Real Estate and Other Activities - 2022 Activity - Additional Information) (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_568ad9d5-a374-4902-94cf-5e492844e94f", "decimals": "-5", "lang": null, "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "reportCount": 1, "unique": true, "unitRef": "U_GBP", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_3bcab7e2-bd5a-451b-84a8-0e76536968f2", "decimals": "-6", "first": true, "lang": null, "name": "mpw:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesAndOtherLiabilities", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100420 - Disclosure - Real Estate and Other Activities - 2021 Activity - Additional Information (Detail)", "menuCat": "Details", "order": "43", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "shortName": "Real Estate and Other Activities - 2021 Activity - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_d97c36be-5bed-44fa-a14e-ff424a29e95d", "decimals": "-6", "lang": null, "name": "us-gaap:EquityMethodInvestmentAggregateCost", "reportCount": 1, "unique": true, "unitRef": "U_CHF", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LessorOperatingLeaseRenewalTerm", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100430 - Disclosure - Real Estate and Other Activities - 2020 Activity - Additional Information (Detail)", "menuCat": "Details", "order": "44", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail", "shortName": "Real Estate and Other Activities - 2020 Activity - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_4c10c859-d4b0-4f76-8bb5-eecaf896ca90", "decimals": "-6", "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "INF", "first": true, "lang": null, "name": "mpw:NumberOfDevelopmentOfNewProjects", "reportCount": 1, "unique": true, "unitRef": "U_NewProject", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100440 - Disclosure - Real Estate and Other Activities - Development Activities - Additional Information (Detail)", "menuCat": "Details", "order": "45", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail", "shortName": "Real Estate and Other Activities - Development Activities - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "INF", "first": true, "lang": null, "name": "mpw:NumberOfDevelopmentOfNewProjects", "reportCount": 1, "unique": true, "unitRef": "U_NewProject", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "mpw:ScheduleOfDevelopmentProjectsTableTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "first": true, "lang": null, "name": "mpw:DevelopmentProjectsOriginalCommitmentAmount", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100450 - Disclosure - Real Estate and Other Activities - Development Activities - Summary of Status on Current Development Projects (Detail)", "menuCat": "Details", "order": "46", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "shortName": "Real Estate and Other Activities - Development Activities - Summary of Status on Current Development Projects (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "mpw:ScheduleOfDevelopmentProjectsTableTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "-3", "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "INF", "first": true, "lang": null, "name": "mpw:NumberOfFacilitiesSold", "reportCount": 1, "unitRef": "U_Facility", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100460 - Disclosure - Real Estate and Other Activities - Disposals - Additional Information (Detail)", "menuCat": "Details", "order": "47", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDisposalsAdditionalInformationDetail", "shortName": "Real Estate and Other Activities - Disposals - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "INF", "lang": null, "name": "mpw:NumberOfAncillaryPropertiesSold", "reportCount": 1, "unique": true, "unitRef": "U_Facility", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100470 - Disclosure - Real Estate and Other Activities - Summary of Operating Results from Properties Sold (Details)", "menuCat": "Details", "order": "48", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails", "shortName": "Real Estate and Other Activities - Summary of Operating Results from Properties Sold (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "mpw:SummaryOfOperatingResultsFromPropertiesTableTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_971e78cb-8888-4da4-868e-96a414941012", "decimals": "-3", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "-3", "first": true, "lang": null, "name": "mpw:StraightLineRentWriteOffs", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100480 - Disclosure - Real Estate and Other Activities - Summary of Operating Results from Properties Sold (Parenthetical) (Details)", "menuCat": "Details", "order": "49", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails", "shortName": "Real Estate and Other Activities - Summary of Operating Results from Properties Sold (Parenthetical) (Details)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "mpw:SummaryOfOperatingResultsFromPropertiesTableTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_971e78cb-8888-4da4-868e-96a414941012", "decimals": "-6", "lang": null, "name": "mpw:StraightLineRentWriteOffs", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100040 - Statement - Consolidated Statements of Comprehensive Income", "menuCat": "Statements", "order": "5", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveIncome", "shortName": "Consolidated Statements of Comprehensive Income", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "-3", "lang": null, "name": "us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_5bf63889-09c9-4277-a1db-c7ec13f4accf", "decimals": "INF", "first": true, "lang": null, "name": "mpw:NumberOfOperationsSold", "reportCount": 1, "unitRef": "U_Operator", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100490 - Disclosure - Real Estate and Other Activities - Other Disposal Transactions - Additional Information (Detail)", "menuCat": "Details", "order": "50", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherDisposalTransactionsAdditionalInformationDetail", "shortName": "Real Estate and Other Activities - Other Disposal Transactions - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": null }, "R51": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "first": true, "lang": null, "name": "mpw:IntangibleLeaseAssets", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100500 - Disclosure - Real Estate and Other Activities - Intangible Assets - Additional Information (Detail)", "menuCat": "Details", "order": "51", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesIntangibleAssetsAdditionalInformationDetail", "shortName": "Real Estate and Other Activities - Intangible Assets - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-8", "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100510 - Disclosure - Real Estate and Other Activities - Amortization Expense from Existing Lease Intangible Assets (Detail)", "menuCat": "Details", "order": "52", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAmortizationExpenseFromExistingLeaseIntangibleAssetsDetail", "shortName": "Real Estate and Other Activities - Amortization Expense from Existing Lease Intangible Assets (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LessorOperatingLeaseRenewalTerm", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100520 - Disclosure - Real Estate and Other Activities - Leasing Operations (Lessor) - Additional Information (Detail)", "menuCat": "Details", "order": "53", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail", "shortName": "Real Estate and Other Activities - Leasing Operations (Lessor) - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "2", "lang": null, "name": "mpw:LeasesAnnualRentEscalationsPercentage", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100530 - Disclosure - Real Estate and Other Activities - Summary of Total Future Minimum Lease Payments to be Received (Detail)", "menuCat": "Details", "order": "54", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail", "shortName": "Real Estate and Other Activities - Summary of Total Future Minimum Lease Payments to be Received (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DirectFinancingLeaseLeaseReceivable", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100540 - Disclosure - Real Estate and Other Activities - Components of Total Investment in Financing Leases (Detail)", "menuCat": "Details", "order": "55", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail", "shortName": "Real Estate and Other Activities - Components of Total Investment in Financing Leases (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DirectFinancingLeaseLeaseReceivable", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-5", "first": true, "lang": null, "name": "mpw:RemainingOutstandingDeferredRentToBeReceived", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100550 - Disclosure - Real Estate and Other Activities - Rent Deferrals - Additional Information (Detail)", "menuCat": "Details", "order": "56", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesRentDeferralsAdditionalInformationDetail", "shortName": "Real Estate and Other Activities - Rent Deferrals - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-5", "first": true, "lang": null, "name": "mpw:RemainingOutstandingDeferredRentToBeReceived", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100560 - Disclosure - Real Estate and Other Activities - Prospect Medical Holdings Additional Information (Detail)", "menuCat": "Details", "order": "57", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "shortName": "Real Estate and Other Activities - Prospect Medical Holdings Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_1d1453e9-4873-48fb-b018-43c1c8989fd0", "decimals": "-8", "lang": null, "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_82dbe13c-13d7-442a-bad9-74e64c401559", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DeferredRentReceivablesNet", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100570 - Disclosure - Real Estate and Other Activities - Pipeline Health System - Additional Information (Detail)", "menuCat": "Details", "order": "58", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "shortName": "Real Estate and Other Activities - Pipeline Health System - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_82dbe13c-13d7-442a-bad9-74e64c401559", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DeferredRentReceivablesNet", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_5bf63889-09c9-4277-a1db-c7ec13f4accf", "decimals": "-3", "first": true, "lang": null, "name": "mpw:BusinessCombinationLoansPaidDownOnAcquisitionLoans", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100590 - Disclosure - Real Estate and Other Activities - Watsonville Community Hospital - Additional Information (Detail)", "menuCat": "Details", "order": "59", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "shortName": "Real Estate and Other Activities - Watsonville Community Hospital - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_70f0f327-bd94-4f56-8ad4-18f1706027bd", "decimals": "-6", "lang": null, "name": "us-gaap:LoansAndLeasesReceivableAllowance", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_9a89eaeb-426c-4d7f-871c-fbcfe6f5c85e", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100050 - Statement - Consolidated Statements of Equity / Capital", "menuCat": "Statements", "order": "6", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital", "shortName": "Consolidated Statements of Equity / Capital", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_9a89eaeb-426c-4d7f-871c-fbcfe6f5c85e", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_b4fb296c-5649-4700-a316-0d02b74bb189", "decimals": "2", "first": true, "lang": null, "name": "mpw:PercentageOfPropertiesOccupiedByTenants", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100600 - Disclosure - Real Estate and Other Activities - Other Leasing Activities - Additional Information (Detail)", "menuCat": "Details", "order": "60", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail", "shortName": "Real Estate and Other Activities - Other Leasing Activities - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_b4fb296c-5649-4700-a316-0d02b74bb189", "decimals": "2", "first": true, "lang": null, "name": "mpw:PercentageOfPropertiesOccupiedByTenants", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_262ad284-a8ac-4979-94e8-ffd56f72fefc", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100610 - Disclosure - Real Estate and Other Activities - Investments in Unconsolidated Real Estate Joint Ventures - Additional Information (Details)", "menuCat": "Details", "order": "61", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "shortName": "Real Estate and Other Activities - Investments in Unconsolidated Real Estate Joint Ventures - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_262ad284-a8ac-4979-94e8-ffd56f72fefc", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100620 - Disclosure - Real Estate and Other Activities - Summary of Investments in Unconsolidated Real Estate Joint Ventures by Operator (Details)", "menuCat": "Details", "order": "62", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails", "shortName": "Real Estate and Other Activities - Summary of Investments in Unconsolidated Real Estate Joint Ventures by Operator (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "mpw:SummaryOfInvestmentsInUnconsolidatedOperatingEntitiesTableTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7aefbc25-015f-4ab4-b0ae-43dff390a7aa", "decimals": "2", "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "first": true, "lang": null, "name": "mpw:InvestmentsInUnconsolidatedOperatingEntities", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100630 - Disclosure - Real Estate and Other Activities - Summary of Investments in Unconsolidated Operating Entities (Details)", "menuCat": "Details", "order": "63", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "shortName": "Real Estate and Other Activities - Summary of Investments in Unconsolidated Operating Entities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_34a5bf0a-cd48-45ba-803d-ca2e56501248", "decimals": "-3", "lang": null, "name": "mpw:InvestmentsInUnconsolidatedOperatingEntities", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_2834779e-626a-4f73-b915-27fe4dd34b06", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:InvestmentCompanyDividendDistribution", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100640 - Disclosure - Real Estate and Other Activities - Investments in Unconsolidated Operating Entities - Additional Information (Details)", "menuCat": "Details", "order": "64", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "shortName": "Real Estate and Other Activities - Investments in Unconsolidated Operating Entities - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_2834779e-626a-4f73-b915-27fe4dd34b06", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:InvestmentCompanyDividendDistribution", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_e7d3161f-f4de-42a3-9d57-abe8d12f456a", "decimals": "-6", "first": true, "lang": null, "name": "mpw:RealEstateSecuredLoan", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100660 - Disclosure - Real Estate and Other Activities - Other Investment Activities - Additional Information (Detail)", "menuCat": "Details", "order": "65", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail", "shortName": "Real Estate and Other Activities - Other Investment Activities - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_e7d3161f-f4de-42a3-9d57-abe8d12f456a", "decimals": "-6", "first": true, "lang": null, "name": "mpw:RealEstateSecuredLoan", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_5234d6bd-ac70-43cd-b2b3-c09fbfa484b1", "decimals": "-5", "first": true, "lang": null, "name": "mpw:LeaseAndInterestRevenueEarnedFromTenants", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100670 - Disclosure - Real Estate and Other Activities - Concentration of Credit Risks and Related Party Transactions - Additional Information (Detail)", "menuCat": "Details", "order": "66", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "shortName": "Real Estate and Other Activities - Concentration of Credit Risks and Related Party Transactions - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_5234d6bd-ac70-43cd-b2b3-c09fbfa484b1", "decimals": "-5", "first": true, "lang": null, "name": "mpw:LeaseAndInterestRevenueEarnedFromTenants", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100680 - Disclosure - Debt - Summary of Debt (Detail)", "menuCat": "Details", "order": "67", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "shortName": "Debt - Summary of Debt (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "lang": null, "name": "us-gaap:DeferredFinanceCostsNet", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100690 - Disclosure - Debt - Summary of Debt (Parenthetical) (Detail)", "menuCat": "Details", "order": "68", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail", "shortName": "Debt - Summary of Debt (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "link:footnote", "div", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_ee95060e-357e-4207-9b84-b77eafbe0f42", "decimals": "-6", "lang": null, "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unique": true, "unitRef": "U_GBP", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100700 - Disclosure - Debt - Principal Payments Due for Debt (Detail)", "menuCat": "Details", "order": "69", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail", "shortName": "Debt - Principal Payments Due for Debt (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockDividendsPerShareDeclared", "reportCount": 1, "unique": true, "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100060 - Statement - Consolidated Statements of Equity / Capital (Parenthetical)", "menuCat": "Statements", "order": "7", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapitalParenthetical", "shortName": "Consolidated Statements of Equity / Capital (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockDividendsPerShareDeclared", "reportCount": 1, "unique": true, "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "4", "first": true, "lang": null, "name": "mpw:CommitmentFeeAdjustmentPercentage", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100710 - Disclosure - Debt - Credit Facility - Additional Information (Detail)", "menuCat": "Details", "order": "70", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail", "shortName": "Debt - Credit Facility - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "4", "first": true, "lang": null, "name": "mpw:CommitmentFeeAdjustmentPercentage", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "us-gaap:DebtInstrumentInterestRateStatedPercentage", "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_4cf0c2b2-3d4c-4a7e-ae5c-d0ab2e2b38e4", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "reportCount": 1, "unitRef": "U_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100720 - Disclosure - Debt - Interim Credit Facility - Additional Information (Detail)", "menuCat": "Details", "order": "71", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtInterimCreditFacilityAdditionalInformationDetail", "shortName": "Debt - Interim Credit Facility - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": null }, "R72": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_115eb2fc-11d9-447f-a892-f8b86b5fd0dc", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100730 - Disclosure - Debt - July 2021 Interim Credit Facility - Additional Information (Detail)", "menuCat": "Details", "order": "72", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtJuly2021InterimCreditFacilityAdditionalInformationDetail", "shortName": "Debt - July 2021 Interim Credit Facility - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_0a1c3135-2071-40ba-bb76-5a38a601936a", "decimals": "INF", "lang": null, "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_5c273229-b1aa-43b3-b78d-c607ae088e09", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "U_GBP", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100740 - Disclosure - Debt - British Pound Sterling Term Loan - Additional Information (Detail)", "menuCat": "Details", "order": "73", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "shortName": "Debt - British Pound Sterling Term Loan - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_5c273229-b1aa-43b3-b78d-c607ae088e09", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "U_GBP", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_99dac463-30f7-4090-befc-43b390672d6a", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100750 - Disclosure - Debt - Australian Term Loan - Additional Information (Detail)", "menuCat": "Details", "order": "74", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "shortName": "Debt - Australian Term Loan - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_99dac463-30f7-4090-befc-43b390672d6a", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DerivativeAssets", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100760 - Disclosure - Debt - Interest Rate Swaps - Additional Information (Detail)", "menuCat": "Details", "order": "75", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "shortName": "Debt - Interest Rate Swaps - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DerivativeAssets", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6a4b4e3c-fd3e-4a6a-b894-0d80090b10cd", "decimals": null, "first": true, "lang": "en-US", "name": "mpw:DebtInstrumentOfferingCompletionDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100770 - Disclosure - Debt - Basic Terms of Senior Unsecured Notes (Details)", "menuCat": "Details", "order": "76", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails", "shortName": "Debt - Basic Terms of Senior Unsecured Notes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6a4b4e3c-fd3e-4a6a-b894-0d80090b10cd", "decimals": null, "first": true, "lang": "en-US", "name": "mpw:DebtInstrumentOfferingCompletionDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_503f6081-03a6-4496-8385-f10fbfae3c1d", "decimals": "2", "first": true, "lang": null, "name": "mpw:DebtInstrumentRepurchasePricePercentageOnPrincipalAmountPlusAccruedAndUnpaidInterest", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100780 - Disclosure - Debt - Senior Unsecured Notes - Additional Information (Detail)", "menuCat": "Details", "order": "77", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSeniorUnsecuredNotesAdditionalInformationDetail", "shortName": "Debt - Senior Unsecured Notes - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_503f6081-03a6-4496-8385-f10fbfae3c1d", "decimals": "2", "first": true, "lang": null, "name": "mpw:DebtInstrumentRepurchasePricePercentageOnPrincipalAmountPlusAccruedAndUnpaidInterest", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "us-gaap:DebtInstrumentInterestRateStatedPercentage", "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_fb32b51d-9254-48fc-9fd4-fa422ebf499e", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "reportCount": 1, "unitRef": "U_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100790 - Disclosure - Debt - Additional Information (Detail)", "menuCat": "Details", "order": "78", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "shortName": "Debt - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_cdfffecb-fb1c-47c4-996e-f859444535cd", "decimals": "-6", "lang": null, "name": "mpw:DebtInstrumentRedemptionAmount", "reportCount": 1, "unique": true, "unitRef": "U_EUR", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "INF", "first": true, "lang": null, "name": "mpw:PercentageOfDividendsPayableOnBasisOfAdjustedOperatingFunds", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100800 - Disclosure - Debt - Covenants - Additional Information (Detail)", "menuCat": "Details", "order": "79", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCovenantsAdditionalInformationDetail", "shortName": "Debt - Covenants - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "INF", "first": true, "lang": null, "name": "mpw:PercentageOfDividendsPayableOnBasisOfAdjustedOperatingFunds", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100070 - Statement - Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "8", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "-3", "lang": null, "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:IncomeTaxPolicyTextBlock", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "2", "first": true, "lang": null, "name": "mpw:PercentageOfOrdinaryTaxableIncomeToBeDistributedForRealEstateInvestmentTrustQualification", "reportCount": 1, "unitRef": "U_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100810 - Disclosure - Income Taxes - Additional Information (Detail)", "menuCat": "Details", "order": "80", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail", "shortName": "Income Taxes - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "INF", "lang": null, "name": "mpw:PercentageOfTaxableIncomeToBeDistributedForFederalIncomeTaxExemption", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100820 - Disclosure - Income Taxes - Schedule of Income Tax (Expense) Benefit (Detail)", "menuCat": "Details", "order": "81", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfIncomeTaxExpenseBenefitDetail", "shortName": "Income Taxes - Schedule of Income Tax (Expense) Benefit (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100830 - Disclosure - Income Taxes - Summary of Reconciliation of Income Tax (Expense) Benefit from the Statutory Income Tax Rate to the Effective Tax Rate Based on Income before Income Taxes (Detail)", "menuCat": "Details", "order": "82", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitFromStatutoryIncomeTaxRateToEffectiveTaxRateBasedOnIncomeBeforeIncomeTaxesDetail", "shortName": "Income Taxes - Summary of Reconciliation of Income Tax (Expense) Benefit from the Statutory Income Tax Rate to the Effective Tax Rate Based on Income before Income Taxes (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "-3", "lang": null, "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unitRef": "U_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100840 - Disclosure - Income Taxes - Summary of Reconciliation of Income Tax Benefit (Expense) from the Statutory Income Tax Rate to the Effective Tax Rate Based on Income before Income Taxes (Parenthetical) (Detail)", "menuCat": "Details", "order": "83", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseFromStatutoryIncomeTaxRateToEffectiveTaxRateBasedOnIncomeBeforeIncomeTaxesParentheticalDetail", "shortName": "Income Taxes - Summary of Reconciliation of Income Tax Benefit (Expense) from the Statutory Income Tax Rate to the Effective Tax Rate Based on Income before Income Taxes (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R84": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100850 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and liabilities (Detail)", "menuCat": "Details", "order": "84", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail", "shortName": "Income Taxes - Schedule of Deferred Tax Assets and liabilities (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_2786d990-18e5-4bc2-b532-c447b8eb5499", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100860 - Disclosure - Income Taxes - Schedule of Net NOL and Other Tax Attribute Carryforwards (Detail)", "menuCat": "Details", "order": "85", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfNetNOLAndOtherTaxAttributeCarryforwardsDetail", "shortName": "Income Taxes - Schedule of Net NOL and Other Tax Attribute Carryforwards (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_2786d990-18e5-4bc2-b532-c447b8eb5499", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R86": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "mpw:ScheduleOfPerShareDistributionsToStockholdersTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:CommonStockDividendsPerShareCashPaid", "reportCount": 1, "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100870 - Disclosure - Income Taxes - Schedule of Per Share Distributions to Stockholders (Detail)", "menuCat": "Details", "order": "86", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfPerShareDistributionsToStockholdersDetail", "shortName": "Income Taxes - Schedule of Per Share Distributions to Stockholders (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "mpw:ScheduleOfPerShareDistributionsToStockholdersTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "4", "lang": null, "name": "mpw:OrdinaryDividendPerShare", "reportCount": 1, "unique": true, "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false" } }, "R87": { "firstAnchor": { "ancestors": [ "span", "div", "div", "mpw:ScheduleOfPerShareDistributionsToStockholdersTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "INF", "first": true, "lang": null, "name": "mpw:QualifiedBusinessIncomeDeductionDividendsPerShare", "reportCount": 1, "unique": true, "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100880 - Disclosure - Income Taxes - Schedule of Per Share Distributions to Stockholders (Parenthetical) (Details)", "menuCat": "Details", "order": "87", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfPerShareDistributionsToStockholdersParentheticalDetails", "shortName": "Income Taxes - Schedule of Per Share Distributions to Stockholders (Parenthetical) (Details)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "mpw:ScheduleOfPerShareDistributionsToStockholdersTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "INF", "first": true, "lang": null, "name": "mpw:QualifiedBusinessIncomeDeductionDividendsPerShare", "reportCount": 1, "unique": true, "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false" } }, "R88": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100890 - Disclosure - Earnings Per Share/Unit - Calculation of Earnings Per Share (Detail)", "menuCat": "Details", "order": "88", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail", "shortName": "Earnings Per Share/Unit - Calculation of Earnings Per Share (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "div", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "-3", "lang": null, "name": "mpw:UndistributedEarningAllocatedToParticipatingSecurities", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R89": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensation", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100900 - Disclosure - Stock Awards - Additional Information (Detail)", "menuCat": "Details", "order": "89", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail", "shortName": "Stock Awards - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-5", "lang": null, "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InterestPaidCapitalized", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100080 - Statement - Consolidated Statements of Cash Flows (Parenthetical)", "menuCat": "Statements", "order": "9", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlowsParenthetical", "shortName": "Consolidated Statements of Cash Flows (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InterestPaidCapitalized", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R90": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_ef91905f-a880-42e0-8824-4d726827a79d", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "reportCount": 1, "unitRef": "U_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100910 - Disclosure - Stock Awards - Stock-based Award Activity (Detail)", "menuCat": "Details", "order": "90", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsStockBasedAwardActivityDetail", "shortName": "Stock Awards - Stock-based Award Activity (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_ff20a463-5cd0-40dc-b38b-283997b30ec9", "decimals": "INF", "lang": null, "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" } }, "R91": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "INF", "first": true, "lang": null, "name": "mpw:NumberOfFacilitiesSold", "reportCount": 1, "unitRef": "U_Facility", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100920 - Disclosure - Commitments and Contingencies - Additional Information (Detail)", "menuCat": "Details", "order": "91", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "shortName": "Commitments and Contingencies - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_cc31365e-c50e-48ed-9026-70d21a685c83", "decimals": "INF", "lang": null, "name": "mpw:NumberOfFacilitiesSold", "reportCount": 1, "unique": true, "unitRef": "U_Facility", "xsiNil": "false" } }, "R92": { "firstAnchor": { "ancestors": [ "us-gaap:CommonStockSharesOutstanding", "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesIssued", "reportCount": 1, "unitRef": "U_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100930 - Disclosure - Common Stock/Partners' Capital - Additional Information (Detail)", "menuCat": "Details", "order": "92", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "shortName": "Common Stock/Partners' Capital - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:PartnersCapitalNotesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_73307373-905a-462f-949c-30f21d8c010a", "decimals": "INF", "lang": null, "name": "us-gaap:SharesIssuedPricePerShare", "reportCount": 1, "unique": true, "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false" } }, "R93": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "first": true, "lang": null, "name": "mpw:InterestAndRentReceivable", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100940 - Disclosure - Fair Value of Financial Instruments - Summary of Fair Value Information of Financial Instruments (Detail)", "menuCat": "Details", "order": "93", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail", "shortName": "Fair Value of Financial Instruments - Summary of Fair Value Information of Financial Instruments (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "lang": null, "name": "mpw:Loans", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R94": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_7fcb0561-e736-4b84-8342-8c833980df21", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100950 - Disclosure - Fair Value of Financial Instruments - Summary of Fair Value Information of Financial Instruments (Parenthetical) (Detail)", "menuCat": "Details", "order": "94", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "shortName": "Fair Value of Financial Instruments - Summary of Fair Value Information of Financial Instruments (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_ea39f359-d963-4db5-b618-999b96e04b1a", "decimals": "-5", "lang": null, "name": "us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R95": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:ScheduleOfSensitivityAnalysisOfFairValueOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrServicingLiabilitiesTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_408232aa-5c8c-4403-9359-5342867833a1", "decimals": "INF", "first": true, "lang": null, "name": "mpw:DiscountForLackOfMarketabilityPercentage", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100960 - Disclosure - Fair Value of Financial Instruments - Additional Information (Detail)", "menuCat": "Details", "order": "95", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "shortName": "Fair Value of Financial Instruments - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:ScheduleOfSensitivityAnalysisOfFairValueOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrServicingLiabilitiesTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_408232aa-5c8c-4403-9359-5342867833a1", "decimals": "INF", "first": true, "lang": null, "name": "mpw:DiscountForLackOfMarketabilityPercentage", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" } }, "R96": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_9fcee4b9-681f-46e8-a679-9416d2e86d14", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtFairValue", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100980 - Disclosure - Fair Value of Financial Instruments - Equity Interest in Related Party and Related Loans Measured at Fair Value on Recurring Basis (Detail)", "menuCat": "Details", "order": "96", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "shortName": "Fair Value of Financial Instruments - Equity Interest in Related Party and Related Loans Measured at Fair Value on Recurring Basis (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_9fcee4b9-681f-46e8-a679-9416d2e86d14", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtFairValue", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R97": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfSensitivityAnalysisOfFairValueOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrServicingLiabilitiesTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_1af9db1b-d798-46cd-b996-e705e5eb4ae7", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100990 - Disclosure - Fair Value of Financial Instruments - Schedule of Effects of Movement in DLOM by Sensitivity Analysis by Using Basis Point Variations (Detail)", "menuCat": "Details", "order": "97", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDLOMBySensitivityAnalysisByUsingBasisPointVariationsDetail", "shortName": "Fair Value of Financial Instruments - Schedule of Effects of Movement in DLOM by Sensitivity Analysis by Using Basis Point Variations (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfSensitivityAnalysisOfFairValueOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrServicingLiabilitiesTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_1af9db1b-d798-46cd-b996-e705e5eb4ae7", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R98": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "div", "mpw:LesseeOperatingLeaseAndFinanceLeaseTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101000 - Disclosure - Leases (Lessee) - Summary of Lease Expense (Detail)", "menuCat": "Details", "order": "98", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail", "shortName": "Leases (Lessee) - Summary of Lease Expense (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "div", "mpw:LesseeOperatingLeaseAndFinanceLeaseTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "-3", "lang": null, "name": "us-gaap:LeaseCost", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R99": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "div", "mpw:LesseeOperatingLeaseAndFinanceLeaseTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_6e07aa90-60fc-4224-a591-affb9a3f24f6", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101010 - Disclosure - Leases (Lessee) - Summary of Lease Expense (Parenthetical) (Detail)", "menuCat": "Details", "order": "99", "role": "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseParentheticalDetail", "shortName": "Leases (Lessee) - Summary of Lease Expense (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "link:footnote", "div", "div", "us-gaap:LeaseCostTableTextBlock", "div", "mpw:LesseeOperatingLeaseAndFinanceLeaseTextBlock", "div", "body", "html" ], "baseRef": "mpw-20221231.htm", "contextRef": "C_c7b2898b-cd86-4201-832b-b301b51f1f62", "decimals": "-5", "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } } }, "segmentCount": 570, "tag": { "country_AU": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "AUSTRALIA", "terseLabel": "Australia [Member]" } } }, "localname": "AU", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "country_CO": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "COLOMBIA", "terseLabel": "Colombia [Member]" } } }, "localname": "CO", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateParentheticalDetail" ], "xbrltype": "domainItemType" }, "country_ES": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SPAIN", "terseLabel": "Spain [Member]" } } }, "localname": "ES", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "country_FI": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FINLAND", "terseLabel": "Finland [Member]" } } }, "localname": "FI", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "country_GB": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED KINGDOM", "terseLabel": "United Kingdom [Member]", "verboseLabel": "British Pound Sterling [Member]" } } }, "localname": "GB", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "country_IN": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INDIA", "terseLabel": "Indiana [Member]" } } }, "localname": "IN", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "country_PT": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PORTUGAL", "terseLabel": "Portugal [Member]" } } }, "localname": "PT", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "U.S. [Member]" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfNetNOLAndOtherTaxAttributeCarryforwardsDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "verboseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r799", "r800", "r801" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID", "terseLabel": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r799", "r800", "r801" ], "lang": { "en-us": { "role": { "label": "Auditor Location", "terseLabel": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r799", "r800", "r801" ], "lang": { "en-us": { "role": { "label": "Auditor Name", "terseLabel": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r799", "r800", "r801" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report", "terseLabel": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]", "terseLabel": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]", "terseLabel": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r802" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type", "verboseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r797" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]", "terseLabel": "Documents Incorporated by Reference" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r796" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "verboseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r796" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r796" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r803" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float", "terseLabel": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r796" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r796" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r796" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r796" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers", "terseLabel": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r804" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer", "terseLabel": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r799", "r800", "r801" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag", "terseLabel": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r795" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r798" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "mpw_AberdeenUnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aberdeen United Kingdom.", "label": "Aberdeen United Kingdom [Member]", "terseLabel": "Aberdeen, UK [Member]", "verboseLabel": "Aberdeen, UK [Member]" } } }, "localname": "AberdeenUnitedKingdomMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_AccumulatedAmortizationIncludedInRealEstateHeldForSale": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amortization included in real estate held for sale.", "label": "Accumulated Amortization Included In Real Estate Held For Sale", "terseLabel": "Accumulated amortization included in real estate held for sale" } } }, "localname": "AccumulatedAmortizationIncludedInRealEstateHeldForSale", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIChangesInAccumulatedDepreciationParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "mpw_AcquiredRealEstatePurchasePriceAllocationPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Acquired real estate purchase price allocation.", "label": "Acquired Real Estate Purchase Price Allocation Policy [Text Block]", "terseLabel": "Acquired Real Estate Purchase Price Allocation" } } }, "localname": "AcquiredRealEstatePurchasePriceAllocationPolicyTextBlock", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "mpw_AcquisitionLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Acquisition loan.", "label": "Acquisition Loan [Member]", "terseLabel": "Acquisition Loans [Member]", "verboseLabel": "Acquisition Loans [Member]" } } }, "localname": "AcquisitionLoanMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "xbrltype": "domainItemType" }, "mpw_AcquisitionLoans": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Acquisition loans.", "label": "Acquisition Loans", "terseLabel": "Acquisition loans" } } }, "localname": "AcquisitionLoans", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mpw_AcquisitionLoansAndOtherLoans": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Acquisition loans and other loans.", "label": "Acquisition Loans And Other Loans", "terseLabel": "Other loans" } } }, "localname": "AcquisitionLoansAndOtherLoans", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "mpw_AcuteCareCampusMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Acute care campus.", "label": "Acute Care Campus [Member]", "terseLabel": "Acute Care Campus [Member]" } } }, "localname": "AcuteCareCampusMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_AcuteCareHospitalAndOnCampusMedicalOfficeBuildingsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Acute care hospital and on campus medical office buildings.", "label": "Acute Care Hospital And On Campus Medical Office Buildings [Member]", "terseLabel": "Acute Care Hospital and On Campus Medical Office Buildings [Member]" } } }, "localname": "AcuteCareHospitalAndOnCampusMedicalOfficeBuildingsMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_AcuteCareHospitalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Acute care hospital.", "label": "Acute Care Hospital [Member]", "terseLabel": "Acute Care Hospital [Member]" } } }, "localname": "AcuteCareHospitalMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherDisposalTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_AdditionalCaptialFunding": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Additional captial funding.", "label": "Additional Captial Funding", "terseLabel": "Capital funding" } } }, "localname": "AdditionalCaptialFunding", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mpw_AevisVictoriaSAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aevis Victoria SA.", "label": "Aevis Victoria S A [Member]", "terseLabel": "Aevis Victoria SA [Member]" } } }, "localname": "AevisVictoriaSAMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_AffiliatesOfStewardHealthCareSystemLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Affiliates of Steward Health Care System LLC.", "label": "Affiliates of Steward Health Care System L L C [Member]" } } }, "localname": "AffiliatesOfStewardHealthCareSystemLLCMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "mpw_AlectoHealthcareServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Alecto healthcare services.", "label": "Alecto Healthcare Services [Member]", "terseLabel": "Alecto Healthcare Services [Member]" } } }, "localname": "AlectoHealthcareServicesMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_AlgecirasSpainMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Algeciras, Spain.", "label": "Algeciras, Spain [Member]" } } }, "localname": "AlgecirasSpainMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_AlternateBaseRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Alternate Base Rate [Member]", "label": "Alternate Base Rate [Member]", "terseLabel": "Alternate Base Rate [Member]" } } }, "localname": "AlternateBaseRateMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_AltoonaWIMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Altoona, WI.", "label": "Altoona W I [Member]", "terseLabel": "Altoona, WI [Member]" } } }, "localname": "AltoonaWIMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_AltrinchamUnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Altrincham, United Kingdom.", "label": "Altrincham, United Kingdom [Member]", "terseLabel": "Altrincham, UK [Member]" } } }, "localname": "AltrinchamUnitedKingdomMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_AlvinTexasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Alvin Texas.", "label": "Alvin Texas [Member]", "terseLabel": "Alvin, TX [Member]" } } }, "localname": "AlvinTexasMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_AnaheimCAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Anaheim, CA.", "label": "Anaheim C A [Member]", "terseLabel": "Anaheim, CA [Member]" } } }, "localname": "AnaheimCAMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_ApplicableMarginForRevolvingLoans": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Applicable margin for revolving loans.", "label": "Applicable Margin For Revolving Loans", "terseLabel": "Applicable margin for revolving loans" } } }, "localname": "ApplicableMarginForRevolvingLoans", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_ApplicableMarginForTermLoans": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Applicable margin for term loans.", "label": "Applicable Margin For Term Loans", "terseLabel": "Applicable margin for term loan" } } }, "localname": "ApplicableMarginForTermLoans", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_ArnoldUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arnold, UK.", "label": "Arnold U K [Member]", "terseLabel": "Arnold, UK [Member]" } } }, "localname": "ArnoldUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_AshteadUnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ashtead united kingdom.", "label": "Ashtead United Kingdom [Member]", "terseLabel": "Ashtead, UK [Member]" } } }, "localname": "AshteadUnitedKingdomMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_AsprisChildrensServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aspris children's services.", "label": "Aspris Children's Services [Member]", "terseLabel": "Aspris Children's Services [Member]" } } }, "localname": "AsprisChildrensServicesMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails" ], "xbrltype": "domainItemType" }, "mpw_AtTheMarketEquityOfferingProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "At-the-market equity offering program.", "label": "At The Market Equity Offering Program [Member]", "terseLabel": "At-the-Market Equity Offering Program [Member]" } } }, "localname": "AtTheMarketEquityOfferingProgramMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_AuroraCoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aurora, CO.", "label": "Aurora Co [Member]", "terseLabel": "Aurora, CO [Member]" } } }, "localname": "AuroraCoMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_AustinTXMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Austin, TX.", "label": "Austin T X [Member]", "terseLabel": "Austin, TX [Member]" } } }, "localname": "AustinTXMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_AvondaleAZMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Avondale, AZ.", "label": "Avondale A Z [Member]", "terseLabel": "Avondale, AZ [Member]" } } }, "localname": "AvondaleAZMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_AyerMAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ayer, MA.", "label": "Ayer M A [Member]", "terseLabel": "Ayer, MA [Member]" } } }, "localname": "AyerMAMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_AyrUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ayr, UK [Member]", "label": "Ayr U K [Member]", "terseLabel": "Ayr, UK [Member]" } } }, "localname": "AyrUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_BMIHealthcareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "BMI healthcare.", "label": "B M I Healthcare [Member]", "terseLabel": "BMI [Member]" } } }, "localname": "BMIHealthcareMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_BadOeynhausenGermanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bad Oeynhausen Germany.", "label": "Bad Oeynhausen Germany [Member]", "terseLabel": "Bad Oeynhausen, Germany [Member]" } } }, "localname": "BadOeynhausenGermanyMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_BadSalzuflenGermanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bad Salzuflen Germany.", "label": "Bad Salzuflen Germany [Member]", "terseLabel": "Bad Salzuflen, Germany [Member]" } } }, "localname": "BadSalzuflenGermanyMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_BakersfieldCaliforniaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bakersfield California.", "label": "Bakersfield California [Member]", "terseLabel": "Bakersfield, California [Member]", "verboseLabel": "Bakersfield, CA [Member]" } } }, "localname": "BakersfieldCaliforniaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_BankOfAmericaNAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bank of America, N.A.", "label": "Bank Of America N A [Member]", "terseLabel": "Bank of America, N.A" } } }, "localname": "BankOfAmericaNAMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_BarclaysBankPLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Barclays Bank PLC.", "label": "Barclays Bank P L C [Member]", "terseLabel": "Barclays Bank PLC [Member]" } } }, "localname": "BarclaysBankPLCMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtJuly2021InterimCreditFacilityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_BasingstokeUnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Basingstoke, United Kingdom.", "label": "Basingstoke United Kingdom [Member]", "terseLabel": "Basingstoke, UK [Member]" } } }, "localname": "BasingstokeUnitedKingdomMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_BassenheimGermanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bassenheim, Germany.", "label": "Bassenheim Germany [Member]", "terseLabel": "Bassenheim, Germany [Member]" } } }, "localname": "BassenheimGermanyMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_BathUnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bath United kingdom.", "label": "Bath United Kingdom [Member]", "terseLabel": "Bath, UK [Member]" } } }, "localname": "BathUnitedKingdomMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_BeckenhamUnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Beckenham, United Kingdom.", "label": "Beckenham United Kingdom [Member]", "terseLabel": "Beckenham, UK [Member]" } } }, "localname": "BeckenhamUnitedKingdomMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_BedfordUnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bedford United Kingdom.", "label": "Bedford United Kingdom [Member]", "terseLabel": "Bedford, UK [Member]" } } }, "localname": "BedfordUnitedKingdomMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_BehavioralHealthFacilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Behavioral health facilities.", "label": "Behavioral Health Facilities [Member]", "terseLabel": "Behavioral Health Facilities [Member]", "verboseLabel": "Behavioral health facilities" } } }, "localname": "BehavioralHealthFacilitiesMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_BehavioralHospitalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Behavioral hospital.", "label": "Behavioral Hospital [Member]", "terseLabel": "Behavioral Hospital [Member]" } } }, "localname": "BehavioralHospitalMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_BellflowerCaliforniaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bellflower, California.", "label": "Bellflower California [Member]", "terseLabel": "Bellflower, CA [Member]" } } }, "localname": "BellflowerCaliforniaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_BennettsvilleSouthCarolinaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bennettsville, South Carolina.", "label": "Bennettsville South Carolina [Member]", "terseLabel": "Bennettsville, SC [Member]" } } }, "localname": "BennettsvilleSouthCarolinaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_BigSpringTexasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Big Spring, Texas.", "label": "Big Spring Texas [Member]", "terseLabel": "Big Spring, TX [Member]" } } }, "localname": "BigSpringTexasMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_BirminghamUkMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Birmingham UK", "label": "Birmingham Uk [Member]", "terseLabel": "Birmingham, England [Member]" } } }, "localname": "BirminghamUkMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_BirminghamUnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Birmingham United Kingdom.", "label": "Birmingham United Kingdom [Member]", "terseLabel": "Birmingham, UK [Member]" } } }, "localname": "BirminghamUnitedKingdomMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_BlackburnUnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Blackburn United Kingdom.", "label": "Blackburn United Kingdom [Member]", "terseLabel": "Blackburn, UK [Member]" } } }, "localname": "BlackburnUnitedKingdomMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_BloomingtonIndianaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bloomington, Indiana.", "label": "Bloomington Indiana [Member]", "terseLabel": "Bloomington, IN [Member]" } } }, "localname": "BloomingtonIndianaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_BlueSpringsMOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Blue Springs, MO.", "label": "Blue Springs M O [Member]", "terseLabel": "Blue Springs, MO [Member]" } } }, "localname": "BlueSpringsMOMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_BoardmanOhioMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boardman, Ohio.", "label": "Boardman Ohio [Member]", "terseLabel": "Boardman, OH [Member]" } } }, "localname": "BoardmanOhioMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_BoiseIDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boise, ID.", "label": "Boise I D [Member]", "terseLabel": "Boise, ID [Member]" } } }, "localname": "BoiseIDMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_BoltonUnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bolton United Kingdom.", "label": "Bolton United Kingdom [Member]", "terseLabel": "Bolton, UK [Member]" } } }, "localname": "BoltonUnitedKingdomMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_BoontonTownshipNJMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boonton Township NJ.", "label": "Boonton Township N J [Member]", "terseLabel": "Boonton Township, NJ [Member]" } } }, "localname": "BoontonTownshipNJMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_BossierCityLosAngelesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bossier City, Los Angeles.", "label": "Bossier City Los Angeles [Member]", "terseLabel": "Bossier City, LA [Member]" } } }, "localname": "BossierCityLosAngelesMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_BowlingGreenKYMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bowling green, KY.", "label": "Bowling Green K Y [Member]", "terseLabel": "Bowling Green, KY [Member]" } } }, "localname": "BowlingGreenKYMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_BraunfelsGermanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Braunfels, Germany.", "label": "Braunfels, Germany [Member]", "terseLabel": "Braunfels Germany" } } }, "localname": "BraunfelsGermanyMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_BrightonMAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Brighton, MA.", "label": "Brighton M A [Member]", "terseLabel": "Brighton, MA [Member]" } } }, "localname": "BrightonMAMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_BristolUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bristol, UK.", "label": "Bristol U K [Member]", "terseLabel": "Bristol, UK [Member]" } } }, "localname": "BristolUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_BrocktonMAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Brockton, MA.", "label": "Brockton M A [Member]", "terseLabel": "Brockton, MA [Member]" } } }, "localname": "BrocktonMAMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_BromleyUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bromley, UK.", "label": "Bromley U K [Member]", "terseLabel": "Bromley, UK [Member]" } } }, "localname": "BromleyUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_BroomfieldCOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Broomfield, CO.", "label": "Broomfield C O [Member]", "terseLabel": "Broomfield, CO [Member]" } } }, "localname": "BroomfieldCOMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_BundooraAustraliaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bundoora, Australia.", "label": "Bundoora Australia [Member]", "terseLabel": "Bundoora, Australia [Member]" } } }, "localname": "BundooraAustraliaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_BuryUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bury, UK.", "label": "Bury U K [Member]", "terseLabel": "Bury, UK [Member]" } } }, "localname": "BuryUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_BusinessAcquisitionIncurredDeferredIncomeTaxLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business acquisition incurred deferred income tax liabilities.", "label": "Business Acquisition Incurred Deferred Income Tax Liabilities", "terseLabel": "Incurred deferred income tax liabilities" } } }, "localname": "BusinessAcquisitionIncurredDeferredIncomeTaxLiabilities", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mpw_BusinessCombinationConsiderationTransferredWithAdditionalAcquisitionLoan": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business combination consideration transferred with additional acquisition loan.", "label": "Business Combination Consideration Transferred With Additional Acquisition Loan", "terseLabel": "Purchase price of acquisition loan" } } }, "localname": "BusinessCombinationConsiderationTransferredWithAdditionalAcquisitionLoan", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mpw_BusinessCombinationLoansPaidDownOnAcquisitionLoans": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business combination loans paid down on acquisition loans.", "label": "Business Combination Loans Paid Down On Acquisition Loans", "negatedLabel": "Loans repaid", "terseLabel": "Loans repaid", "verboseLabel": "Advanced to the mortgage loan" } } }, "localname": "BusinessCombinationLoansPaidDownOnAcquisitionLoans", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "mpw_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesAndOtherLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed deferred tax liabilities and other liabilities.", "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Deferred Tax Liabilities and Other Liabilities", "terseLabel": "Deferred income tax liabilities and other liabilities, incurred" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesAndOtherLiabilities", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mpw_BussageUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bussage, UK.", "label": "Bussage U K [Member]", "terseLabel": "Bussage, UK [Member]" } } }, "localname": "BussageUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_COVID19PandemicMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "COVID - 19 pandemic.", "label": "C O V I D19 Pandemic [Member]", "terseLabel": "COVID-19 Pandemic [Member]" } } }, "localname": "COVID19PandemicMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_COVIDNineteenPandemicMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "COVID nineteen pandemic.", "label": "C O V I D Nineteen Pandemic [Member]", "terseLabel": "COVID-19 Pandemic [Member]" } } }, "localname": "COVIDNineteenPandemicMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesRentDeferralsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_CadizSpainMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cadiz, Spain.", "label": "Cadiz Spain [Member]", "terseLabel": "Cadiz, Spain [Member]" } } }, "localname": "CadizSpainMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_CampbelltownAustraliaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Campbelltown Australia.", "label": "Campbelltown Australia [Member]", "terseLabel": "Campbelltown, Australia [Member]" } } }, "localname": "CampbelltownAustraliaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_CanterburyUnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Canterbury United Kingdom.", "label": "Canterbury United Kingdom [Member]", "terseLabel": "Canterbury, UK [Member]" } } }, "localname": "CanterburyUnitedKingdomMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_CaremaxIncorporatedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CareMax Incorporated.", "label": "CareMax Incorporated [Member]", "terseLabel": "Caremax [Member]" } } }, "localname": "CaremaxIncorporatedMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails" ], "xbrltype": "domainItemType" }, "mpw_CarmarthenUnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Carmarthen, UK.", "label": "Carmarthen United Kingdom [Member]", "terseLabel": "Carmarthen, UK [Member]" } } }, "localname": "CarmarthenUnitedKingdomMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_CarrolltonTXMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Carrollton, TX.", "label": "Carrollton T X [Member]", "terseLabel": "Carrollton, TX [Member]" } } }, "localname": "CarrolltonTXMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cash paid for amounts included in the measurement of lease liabilities.", "label": "Cash Paid For Amounts Included In Measurement Of Lease Liabilities [Abstract]", "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:" } } }, "localname": "CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalCashFlowInformationDetail" ], "xbrltype": "stringItemType" }, "mpw_CasperWyomingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Casper, Wyoming.", "label": "Casper Wyoming [Member]", "terseLabel": "Casper, WY [Member]" } } }, "localname": "CasperWyomingMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_CaterhamUnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Caterham UK.", "label": "Caterham United Kingdom [Member]", "terseLabel": "Caterham, UK [Member]" } } }, "localname": "CaterhamUnitedKingdomMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_CatholicHealthInitiativesColoradoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Catholic health initiatives colorado.", "label": "Catholic Health Initiatives Colorado [Member]", "terseLabel": "Catholic Health Initiatives Colorado [Member]" } } }, "localname": "CatholicHealthInitiativesColoradoMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_ChandlerAZMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Chandler AZ.", "label": "Chandler A Z [Member]", "terseLabel": "Chandler, AZ [Member]" } } }, "localname": "ChandlerAZMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_CheadleUnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cheadle, UK.", "label": "Cheadle United Kingdom [Member]", "terseLabel": "Cheadle, UK [Member]" } } }, "localname": "CheadleUnitedKingdomMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_CherawSouthCarolinaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cheraw, South Carolina.", "label": "Cheraw South Carolina [Member]", "terseLabel": "Cheraw, SC [Member]" } } }, "localname": "CherawSouthCarolinaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_CircleHealthMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Circle Health Group.", "label": "Circle Health [Member]", "terseLabel": "Circle [Member]" } } }, "localname": "CircleHealthMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_ClarksvilleTexasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Clarksville, TX.", "label": "Clarksville Texas [Member]", "terseLabel": "Clarksville, TX [Member]" } } }, "localname": "ClarksvilleTexasMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_CologneGermanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cologne Germany.", "label": "Cologne Germany [Member]", "terseLabel": "Cologne Germany [Member]" } } }, "localname": "CologneGermanyMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_ColoradoSpringsCOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Colorado Springs, CO.", "label": "Colorado Springs C O [Member]", "terseLabel": "Colorado Springs CO [Member]" } } }, "localname": "ColoradoSpringsCOMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_ColumbusOHMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Columbus, OH.", "label": "Columbus O H [Member]", "terseLabel": "Columbus OH [Member]" } } }, "localname": "ColumbusOHMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_CommerceCityTXMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commerce City, TX.", "label": "Commerce City T X [Member]", "terseLabel": "Commerce City, TX [Member]" } } }, "localname": "CommerceCityTXMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_CommitmentAndContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commitment And Contingencies [Line Items]", "label": "Commitment And Contingencies [Line Items]", "terseLabel": "Commitment And Contingencies [Line Items]" } } }, "localname": "CommitmentAndContingenciesLineItems", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "mpw_CommitmentAndContingenciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commitment And Contingencies [Table]", "label": "Commitment And Contingencies [Table]", "terseLabel": "Commitment And Contingencies [Table]" } } }, "localname": "CommitmentAndContingenciesTable", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "mpw_CommitmentFeeAdjustmentPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commitment fee adjustment percentage.", "label": "Commitment Fee Adjustment Percentage", "terseLabel": "Commitment fee" } } }, "localname": "CommitmentFeeAdjustmentPercentage", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_CommonUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common units.", "label": "Common Units [Member]", "terseLabel": "Common Units" } } }, "localname": "CommonUnitsMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "domainItemType" }, "mpw_ConroeTXMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conroe, TX.", "label": "Conroe T X [Member]", "terseLabel": "Conroe, TX [Member]" } } }, "localname": "ConroeTXMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_ConstructionInProgressEquipmentAndOther": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Construction in progress equipment and other.", "label": "Construction In Progress Equipment And Other", "negatedLabel": "Construction in progress and other" } } }, "localname": "ConstructionInProgressEquipmentAndOther", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "mpw_ConverseTXMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Converse,TX.", "label": "Converse T X [Member]", "terseLabel": "Converse, TX [Member]" } } }, "localname": "ConverseTXMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_CoralGablesFLMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Coral Gables, FL.", "label": "Coral Gables F L [Member]", "terseLabel": "Coral Gables, FL [Member]" } } }, "localname": "CoralGablesFLMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_CostMethodInvestmentOwnershipPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cost method investment ownership percentage.", "label": "Cost Method Investment Ownership Percentage", "terseLabel": "Ownership interest in joint venture under the cost method" } } }, "localname": "CostMethodInvestmentOwnershipPercentage", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "mpw_CostsOfLeasedAndRentedPropertyOrEquipment": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "order": 2.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Costs of leased and rented property or equipment.", "label": "Costs Of Leased And Rented Property Or Equipment", "terseLabel": "Property-related" } } }, "localname": "CostsOfLeasedAndRentedPropertyOrEquipment", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "monetaryItemType" }, "mpw_CreditRatingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Credit rating.", "label": "Credit Rating [Member]", "terseLabel": "Credit Rating" } } }, "localname": "CreditRatingMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_CrownPointINMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Crown point IN.", "label": "Crown Point I N [Member]", "terseLabel": "Crown Point, IN [Member]" } } }, "localname": "CrownPointINMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_CroydonUnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Croydon, UK.", "label": "Croydon United Kingdom [Member]", "terseLabel": "Croydon, UK [Member]" } } }, "localname": "CroydonUnitedKingdomMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_DahlenGermanyDEMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dahlen, Germany.", "label": "Dahlen Germany D E [Member]", "terseLabel": "Dahlen, Germany [Member]" } } }, "localname": "DahlenGermanyDEMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_DahlenGermanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dahlen Germany.", "label": "Dahlen Germany [Member]", "terseLabel": "Dahlen, Germany [Member]" } } }, "localname": "DahlenGermanyMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_DallasTexasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dallas, Texas.", "label": "Dallas Texas [Member]", "terseLabel": "Dallas, TX [Member]" } } }, "localname": "DallasTexasMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_DarlingtonUnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Darlington, United Kingdom.", "label": "Darlington United Kingdom [Member]", "terseLabel": "Darlington, United Kingdom [Member]" } } }, "localname": "DarlingtonUnitedKingdomMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_DarlingtonUnitedKingdomOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Darlington United Kingdom.", "label": "Darlington United Kingdom One [Member]", "terseLabel": "Darlington UK [Member]" } } }, "localname": "DarlingtonUnitedKingdomOneMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_DarlingtonUnitedKingdomTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Darlington United Kingdom.", "label": "Darlington United Kingdom Two [Member]", "terseLabel": "Darlington UK [Member]" } } }, "localname": "DarlingtonUnitedKingdomTwoMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_DavisAndJordanValleyFacilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Davis and Jordan valley facilities.", "label": "Davis And Jordan Valley Facilities [Member]", "terseLabel": "Davis and Jordan Valley Facilities [Member]" } } }, "localname": "DavisAndJordanValleyFacilitiesMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_DebtInstrumentEffectiveDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt instrument effective date.", "label": "Debt Instrument Effective Date", "terseLabel": "Debt instrument effective date" } } }, "localname": "DebtInstrumentEffectiveDate", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail" ], "xbrltype": "dateItemType" }, "mpw_DebtInstrumentInterestRateAdjustableBasedOnPricingGridPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt instrument interest rate adjustable based on pricing grid percentage.", "label": "Debt Instrument Interest Rate Adjustable Based On Pricing Grid Percentage", "terseLabel": "Applicable margin adjustable based on pricing grid, percentage" } } }, "localname": "DebtInstrumentInterestRateAdjustableBasedOnPricingGridPercentage", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_DebtInstrumentMaturityYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt instrument maturity year.", "label": "Debt Instrument Maturity Year", "terseLabel": "Senior unsecured notes, maturity year" } } }, "localname": "DebtInstrumentMaturityYear", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "gYearItemType" }, "mpw_DebtInstrumentOfferingCompletionDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt instrument offering completion date.", "label": "Debt Instrument Offering Completion Date", "terseLabel": "Offering Completion Date" } } }, "localname": "DebtInstrumentOfferingCompletionDate", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails" ], "xbrltype": "dateItemType" }, "mpw_DebtInstrumentPercentageOfParValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt instrument percentage of par value.", "label": "Debt Instrument Percentage Of Par Value", "terseLabel": "% of Par Value" } } }, "localname": "DebtInstrumentPercentageOfParValue", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails" ], "xbrltype": "percentItemType" }, "mpw_DebtInstrumentPercentageOfReferenceRateForCalculationOfFixedInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt instrument percentage of reference rate for calculation of fixed interest rate.", "label": "Debt Instrument Percentage Of Reference Rate For Calculation Of Fixed Interest Rate", "terseLabel": "Reference rate" } } }, "localname": "DebtInstrumentPercentageOfReferenceRateForCalculationOfFixedInterestRate", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_DebtInstrumentRedemptionAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt instrument redemption amount.", "label": "Debt Instrument Redemption Amount", "terseLabel": "Senior unsecured notes redemption amount including accrued and unpaid interest" } } }, "localname": "DebtInstrumentRedemptionAmount", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mpw_DebtInstrumentRepurchasePricePercentageOnPrincipalAmountPlusAccruedAndUnpaidInterest": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt instrument repurchase price percentage on principal amount plus accrued and unpaid interest.", "label": "Debt Instrument Repurchase Price Percentage On Principal Amount Plus Accrued And Unpaid Interest", "terseLabel": "Senior notes, repurchased price percentage on principal amount plus accrued and unpaid interest" } } }, "localname": "DebtInstrumentRepurchasePricePercentageOnPrincipalAmountPlusAccruedAndUnpaidInterest", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSeniorUnsecuredNotesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_DebtInstrumentVariableInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument variable interest rate.", "label": "Debt Instrument Variable Interest Rate", "terseLabel": "Variable interest rate" } } }, "localname": "DebtInstrumentVariableInterestRate", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_DebtIssueCostsNet": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureOtherAssetsSummaryOfOtherAssetsOnOurCondensedConsolidatedBalanceSheetsDetail": { "order": 0.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt issue costs, net.", "label": "Debt Issue Costs Net", "terseLabel": "Debt issue costs, net" } } }, "localname": "DebtIssueCostsNet", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureOtherAssetsSummaryOfOtherAssetsOnOurCondensedConsolidatedBalanceSheetsDetail" ], "xbrltype": "monetaryItemType" }, "mpw_DebtRefinancingAndUnutilizedFinancingCosts": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "order": 6.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt refinancing and unutilized financing costs.", "label": "Debt Refinancing And Unutilized Financing Costs", "negatedLabel": "Debt refinancing and unutilized financing costs", "terseLabel": "Debt refinancing and unutilized financing costs" } } }, "localname": "DebtRefinancingAndUnutilizedFinancingCosts", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "monetaryItemType" }, "mpw_DebtRefinancingCharge": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt refinancing charge.", "label": "Debt Refinancing Charge", "terseLabel": "Debt refinancing costs" } } }, "localname": "DebtRefinancingCharge", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mpw_DecreaseInAccountsReceivableAndOtherReserves": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Decrease in accounts receivable and other reserves.", "label": "Decrease In Accounts Receivable And Other Reserves", "terseLabel": "Decrease in accounts receivable and other reserves" } } }, "localname": "DecreaseInAccountsReceivableAndOtherReserves", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "mpw_DeferredFinancingCostsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Deferred financing costs.", "label": "Deferred Financing Costs Policy [Text Block]", "terseLabel": "Deferred Financing Costs" } } }, "localname": "DeferredFinancingCostsPolicyTextBlock", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "mpw_DeferredTaxAssetsInterestRateSwap": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets interest rate swap.", "label": "Deferred Tax Assets Interest Rate Swap", "terseLabel": "Interest rate swap" } } }, "localname": "DeferredTaxAssetsInterestRateSwap", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "mpw_DeferredTaxAssetsValuationAllowancesExpectedNotRealized": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets valuation allowances expected not realized.", "label": "Deferred Tax Assets Valuation Allowances Expected Not Realized", "terseLabel": "Valuation allowance not expected to be realized" } } }, "localname": "DeferredTaxAssetsValuationAllowancesExpectedNotRealized", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mpw_DeferredTaxLiabilitiesOneTimeAdjustment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred tax liabilities one time adjustment.", "label": "Deferred Tax Liabilities One Time Adjustment", "terseLabel": "Deferred tax liabilities, one time adjustment" } } }, "localname": "DeferredTaxLiabilitiesOneTimeAdjustment", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mpw_DeferredTaxLiabilityNetUnbilledRevenue": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred tax liability net unbilled revenue", "label": "Deferred Tax Liability Net Unbilled Revenue", "negatedLabel": "Net unbilled revenue" } } }, "localname": "DeferredTaxLiabilityNetUnbilledRevenue", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "mpw_DenverCOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Denver, CO.", "label": "Denver C O [Member]", "terseLabel": "Denver, CO [Member]" } } }, "localname": "DenverCOMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_DenvilleNJMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Denville, NJ.", "label": "Denville N J [Member]", "terseLabel": "Denville, NJ [Member]" } } }, "localname": "DenvilleNJMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_DetroitMichiganMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detroit, Michigan.", "label": "Detroit Michigan [Member]", "terseLabel": "Detroit, MI [Member]" } } }, "localname": "DetroitMichiganMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_DevelopmentActivitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Development activities.", "label": "Development Activities [Member]", "terseLabel": "Development Activities [Member]" } } }, "localname": "DevelopmentActivitiesMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_DevelopmentProjectsEstimatedRentCommencementDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Development projects estimated rent commencement date.", "label": "Development Projects Estimated Rent Commencement Date", "terseLabel": "Estimated Rent Commencement Date" } } }, "localname": "DevelopmentProjectsEstimatedRentCommencementDate", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "xbrltype": "stringItemType" }, "mpw_DevelopmentProjectsOriginalCommitmentAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Development projects original commitment amount.", "label": "Total commitment", "terseLabel": "Expected commence rent", "verboseLabel": "Commitment" } } }, "localname": "DevelopmentProjectsOriginalCommitmentAmount", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mpw_DirectFinancingLeaseUnearnedIncomeAndAllowanceForCreditLoss": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail": { "order": 2.0, "parentTag": "us-gaap_DirectFinancingLeaseNetInvestmentInLease", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Direct financing lease, unearned income and allowance for credit loss.", "label": "Direct Financing Lease Unearned Income And Allowance For Credit Loss", "negatedLabel": "Less: Unearned income and allowance for credit loss" } } }, "localname": "DirectFinancingLeaseUnearnedIncomeAndAllowanceForCreditLoss", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail" ], "xbrltype": "monetaryItemType" }, "mpw_DiscountForLackOfMarketabilityPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Discount for Lack of Marketability Percentage", "label": "Discount for Lack of Marketability Percentage", "terseLabel": "Discount for lack of marketability percentage on Springstone equity investment" } } }, "localname": "DiscountForLackOfMarketabilityPercentage", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_DissUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Diss, UK.", "label": "Diss U K [Member]", "terseLabel": "Diss, UK [Member]" } } }, "localname": "DissUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_DistributionUnrecapturedSectionOneTwoFiveZeroGainPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Distribution, unrecaptured section one two five zero gain per share", "label": "Distribution Unrecaptured Section One Two Five Zero Gain Per Share", "terseLabel": "Unrecaptured Sec. 1250 gain" } } }, "localname": "DistributionUnrecapturedSectionOneTwoFiveZeroGainPerShare", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfPerShareDistributionsToStockholdersParentheticalDetails" ], "xbrltype": "perShareItemType" }, "mpw_DodgeCityKSMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dodge City Kansas.", "label": "Dodge City K S [Member]", "terseLabel": "Dodge City, KS [Member]" } } }, "localname": "DodgeCityKSMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_DorchesterMassachusettsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dorchester Massachusetts.", "label": "Dorchester Massachusetts [Member]", "terseLabel": "Dorchester, MA [Member]" } } }, "localname": "DorchesterMassachusettsMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_DorchesterUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dorchester, UK.", "label": "Dorchester U K [Member]", "terseLabel": "Dorchester, UK [Member]" } } }, "localname": "DorchesterUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_DormagenGermanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dormagen, Germany.", "label": "Dormagen Germany [Member]", "terseLabel": "Dormagen Germany [Member]" } } }, "localname": "DormagenGermanyMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_DoverNJMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dover, NJ.", "label": "Dover N J [Member]", "terseLabel": "Dover NJ [Member]" } } }, "localname": "DoverNJMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_DroitwichUnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Droitwich, UK.", "label": "Droitwich United Kingdom [Member]", "terseLabel": "Droitwich, UK [Member]" } } }, "localname": "DroitwichUnitedKingdomMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_DublinOHMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dublin, OH.", "label": "Dublin O H [Member]", "terseLabel": "Dublin, OH [Member]" } } }, "localname": "DublinOHMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_EighteenEightyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Eighteen eighty five.", "label": "Eighteen Eighty Five [Member]", "terseLabel": "1885 [Member]" } } }, "localname": "EighteenEightyFiveMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_EighteenEightySevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Eighteen eighty seven.", "label": "Eighteen Eighty Seven [Member]", "terseLabel": "1887 [Member}" } } }, "localname": "EighteenEightySevenMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_EighteenEightySixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Eighteen eighty six.", "label": "Eighteen Eighty Six [Member]", "terseLabel": "1886 [Member]" } } }, "localname": "EighteenEightySixMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_EighteenElevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Eighteen eleven.", "label": "Eighteen Eleven [Member]", "terseLabel": "1811 [Member]" } } }, "localname": "EighteenElevenMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_EighteenFiftyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Eighteen fifty.", "label": "Eighteen Fifty [Member]", "terseLabel": "1850 [Member]" } } }, "localname": "EighteenFiftyMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_EighteenFortyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Eighteen Forty.", "label": "Eighteen Forty [Member]", "terseLabel": "1840 [Member]" } } }, "localname": "EighteenFortyMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_EighteenFortyNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Eighteen forty nine.", "label": "Eighteen Forty Nine [Member]", "terseLabel": "1849 [Member]" } } }, "localname": "EighteenFortyNineMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_EighteenHundredMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Eighteen hundred.", "label": "Eighteen Hundred [Member]", "terseLabel": "1800 [Member]" } } }, "localname": "EighteenHundredMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_EighteenNinetyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Eighteen Ninety.", "label": "Eighteen Ninety [Member]", "terseLabel": "1890 [Member]" } } }, "localname": "EighteenNinetyMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_EighteenNinetyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Eighteen ninety two.", "label": "Eighteen Ninety Two [Member]", "terseLabel": "1892 [Member]" } } }, "localname": "EighteenNinetyTwoMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_EighteenThirtyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Eighteen thirty.", "label": "Eighteen Thirty [Member]", "terseLabel": "1830 [Member]" } } }, "localname": "EighteenThirtyMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_EighteenTwentyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Eighteen twenty.", "label": "Eighteen Twenty [Member]", "terseLabel": "1820 [Member]" } } }, "localname": "EighteenTwentyMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_ElPasoTexasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "El Paso, TX.", "label": "El Paso Texas [Member]", "terseLabel": "El Paso, TX [Member]" } } }, "localname": "ElPasoTexasMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_EmployeeRestrictedEquityAwardsVestingActivityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employee Restricted Equity Awards Vesting Activity [Line Items]", "label": "Employee Restricted Equity Awards Vesting Activity [Line Items]", "terseLabel": "Employee Restricted Equity Awards Vesting Activity [Line Items]" } } }, "localname": "EmployeeRestrictedEquityAwardsVestingActivityLineItems", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsStockBasedAwardActivityDetail" ], "xbrltype": "stringItemType" }, "mpw_EmployeeRestrictedEquityAwardsVestingActivityTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employee Restricted Equity Awards Vesting Activity [Table]", "label": "Employee Restricted Equity Awards Vesting Activity [Table]", "terseLabel": "Employee Restricted Equity Awards Vesting Activity [Table]" } } }, "localname": "EmployeeRestrictedEquityAwardsVestingActivityTable", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsStockBasedAwardActivityDetail" ], "xbrltype": "stringItemType" }, "mpw_EnglewoodCOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Englewood, CO.", "label": "Englewood C O [Member]", "terseLabel": "Englewood, CO [Member]" } } }, "localname": "EnglewoodCOMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_EquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity incentive plan member.", "label": "Equity Incentive Plan [Member]", "terseLabel": "Equity Incentive Plan [Member]" } } }, "localname": "EquityIncentivePlanMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_EquityInvestmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity investments.", "label": "Equity Investments [Member]", "terseLabel": "Equity Investments [Member]" } } }, "localname": "EquityInvestmentsMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "xbrltype": "domainItemType" }, "mpw_EquityMethodInvestmentAndOtherLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity method investment and other loans.", "label": "Equity Method Investment And Other Loans [Member]", "terseLabel": "Equity Method Investment and Other Loans [Member]" } } }, "localname": "EquityMethodInvestmentAndOtherLoansMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "mpw_ErnestHealthIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ernest Health, Inc.", "label": "Ernest Health Inc [Member]", "terseLabel": "Ernest [Member]", "verboseLabel": "Ernest Health Inc [Member]" } } }, "localname": "ErnestHealthIncMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "xbrltype": "domainItemType" }, "mpw_EssexUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Essex, UK.", "label": "Essex U K [Member]", "terseLabel": "Essex, UK [Member]" } } }, "localname": "EssexUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_EstimatedDevelopmentCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Estimated development costs.", "label": "Estimated Development Costs", "terseLabel": "Estimated total development cost" } } }, "localname": "EstimatedDevelopmentCosts", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mpw_EuroDenominatedBorrowingsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "EURO denominated borrowings.", "label": "EURO Denominated Borrowings [Member]", "terseLabel": "EURO-denominated Borrowings [Member]" } } }, "localname": "EuroDenominatedBorrowingsMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "xbrltype": "domainItemType" }, "mpw_EuxtonUnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Euxton United Kingdom.", "label": "Euxton United Kingdom [Member]", "terseLabel": "Euxton, UK [Member]" } } }, "localname": "EuxtonUnitedKingdomMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_ExpectedLeaseUpPeriodsForEstimatingLostRentals": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expected lease-up periods for estimating lost rentals.", "label": "Expected Lease Up Periods For Estimating Lost Rentals", "verboseLabel": "Expected lease-up periods for estimating lost rentals, in months" } } }, "localname": "ExpectedLeaseUpPeriodsForEstimatingLostRentals", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "mpw_ExpirationOfOperatingLossCarryforwardsDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expiration of operating loss carryforwards, description.", "label": "Expiration Of Operating Loss Carryforwards Description", "terseLabel": "Expiration periods" } } }, "localname": "ExpirationOfOperatingLossCarryforwardsDescription", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfNetNOLAndOtherTaxAttributeCarryforwardsDetail" ], "xbrltype": "stringItemType" }, "mpw_FallRiverMassachusettsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fall river Massachusetts.", "label": "Fall River Massachusetts [Member]", "terseLabel": "Fall River, MA [Member]" } } }, "localname": "FallRiverMassachusettsMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_FavorableNonCashFairValueAdjustmentOnInvestment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Favorable non-cash fair value adjustment on investment.", "label": "Favorable Non Cash Fair Value Adjustment On Investment", "terseLabel": "Favorable non-cash fair value adjustment on investment" } } }, "localname": "FavorableNonCashFairValueAdjustmentOnInvestment", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "mpw_FinancialInstrumentsMeasuredAtFairValueOnRecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instruments measured at fair value on recurring basis.", "label": "Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]", "terseLabel": "Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]" } } }, "localname": "FinancialInstrumentsMeasuredAtFairValueOnRecurringBasisLineItems", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDLOMBySensitivityAnalysisByUsingBasisPointVariationsDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "xbrltype": "stringItemType" }, "mpw_FinancialInstrumentsMeasuredAtFairValueOnRecurringBasisTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial Instruments Measured At Fair Value On Recurring Basis [Table]", "label": "Financial Instruments Measured At Fair Value On Recurring Basis [Table]", "terseLabel": "Financial Instruments Measured At Fair Value On Recurring Basis [Table]" } } }, "localname": "FinancialInstrumentsMeasuredAtFairValueOnRecurringBasisTable", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDLOMBySensitivityAnalysisByUsingBasisPointVariationsDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "xbrltype": "stringItemType" }, "mpw_FinancingLeasesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financing leases.", "label": "Financing Leases [Member]", "terseLabel": "Financing Leases [Member]" } } }, "localname": "FinancingLeasesMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail" ], "xbrltype": "domainItemType" }, "mpw_FinancingReceivableAllowanceForCreditLossesPeriodDecrease": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Financing receivable allowance for credit losses period decrease.", "label": "Financing Receivable Allowance for Credit Losses Period Decrease", "terseLabel": "Decrease in credit loss reserves on financing-type receivables" } } }, "localname": "FinancingReceivableAllowanceForCreditLossesPeriodDecrease", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "mpw_FinancingReceivableAllowancesOfCreditLossesRelatedToFinancialInstrumentSold": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Financing receivable allowances of credit losses related to financial instrument sold.", "label": "Financing Receivable Allowances Of Credit Losses Related To Financial Instrument Sold", "terseLabel": "Expected credit loss reserve related to financial instruments sold, repaid, or satisfied" } } }, "localname": "FinancingReceivableAllowancesOfCreditLossesRelatedToFinancialInstrumentSold", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCreditLossReservesDetail" ], "xbrltype": "monetaryItemType" }, "mpw_FiniteLivedIntangibleAssetsAmortizationExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Finite Lived Intangible Assets Amortization Expenses", "label": "Finite Lived Intangible Assets Amortization Expenses", "terseLabel": "Amortization expense related to intangible lease assets" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenses", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesIntangibleAssetsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mpw_FirestoneTexasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Firestone, Texas.", "label": "Firestone Texas [Member]", "terseLabel": "Firestone, TX [Member]" } } }, "localname": "FirestoneTexasMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_FivePointFiveZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Five point five zero zero percentage senior unsecured notes due two thousand twenty four.", "label": "Five Point Five Zero Zero Percentage Senior Unsecured Notes Due Two Thousand Twenty Four [Member]", "terseLabel": "5.500% Senior Unsecured Notes due 2024 [Member]" } } }, "localname": "FivePointFiveZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentyFourMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_FivePointTwoFiveZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Five point two five zero percentage senior unsecured notes due two thousand twenty six.", "label": "Five Point Two Five Zero Percentage Senior Unsecured Notes Due Two Thousand Twenty Six [Member]", "terseLabel": "5.250% Senior Unsecured Notes Due 2026 [Member]" } } }, "localname": "FivePointTwoFiveZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "xbrltype": "domainItemType" }, "mpw_FivePointZeroZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Five point zero zero zero percentage senior unsecured notes due two thousand twenty seven.", "label": "Five Point Zero Zero Zero Percentage Senior Unsecured Notes Due Two Thousand Twenty Seven [Member]", "terseLabel": "5.000% Senior Unsecured Notes Due 2027 [Member]" } } }, "localname": "FivePointZeroZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySevenMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "xbrltype": "domainItemType" }, "mpw_FlagstaffArizonaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Flagstaff Arizona.", "label": "Flagstaff Arizona [Member]", "terseLabel": "Flagstaff, AZ [Member]" } } }, "localname": "FlagstaffArizonaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_FlorenceAZMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Florence, AZ.", "label": "Florence A Z [Member]", "terseLabel": "Florence, AZ [Member]" } } }, "localname": "FlorenceAZMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_FloridablancaColombiaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Floridablanca, Colombia.", "label": "Floridablanca Colombia [Member]", "terseLabel": "Floridablanca, Colombia [Member]" } } }, "localname": "FloridablancaColombiaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_FolsomCaliforniaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Folsom California.", "label": "Folsom California [Member]", "terseLabel": "Folsom, CA [Member]" } } }, "localname": "FolsomCaliforniaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_FortWorthTXMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fort Worth, TX.", "label": "Fort Worth T X [Member]", "terseLabel": "Fort Worth, TX [Member]" } } }, "localname": "FortWorthTXMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_FountainCOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fountain, CO.", "label": "Fountain C O [Member]", "terseLabel": "Fountain, CO [Member]" } } }, "localname": "FountainCOMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_FourPointSixTwoFivePercentageSeniorUnsecuredNotesDueTwoThousandTwentyNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Four point six two five percentage senior unsecured notes due two thousand twenty nine.", "label": "Four Point Six Two Five Percentage Senior Unsecured Notes Due Two Thousand Twenty Nine [Member]", "terseLabel": "4.625% Senior Unsecured Notes Due 2029 [Member]" } } }, "localname": "FourPointSixTwoFivePercentageSeniorUnsecuredNotesDueTwoThousandTwentyNineMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "xbrltype": "domainItemType" }, "mpw_FourPointZeroZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Four point zero zero zero percentage senior unsecured notes due two thousand twenty two.", "label": "Four Point Zero Zero Zero Percentage Senior Unsecured Notes Due Two Thousand Twenty Two [Member]", "terseLabel": "4.000% Senior Unsecured Notes Due 2022 [Member]" } } }, "localname": "FourPointZeroZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentyTwoMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails" ], "xbrltype": "domainItemType" }, "mpw_FreestandingERUrgentCareFacilitiesAndBehavioralHealthFacilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Freestanding ER/urgent care facilities and behavioral health facilities.", "label": "Freestanding E R Urgent Care Facilities And Behavioral Health Facilities [Member]", "terseLabel": "Freestanding ER/Urgent Care Facilities and Behavioral Health Facilities [Member]" } } }, "localname": "FreestandingERUrgentCareFacilitiesAndBehavioralHealthFacilitiesMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_FreestandingErUrgentCareAndLongTermAcuteCareFacilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Freestanding ER urgent care and long term acute care facilities.", "label": "Freestanding ER Urgent Care and Long Term Acute Care Facilities [Member]", "terseLabel": "Freestanding ER/Urgent Care and Long-Term Acute Care Facilities [Member]" } } }, "localname": "FreestandingErUrgentCareAndLongTermAcuteCareFacilitiesMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_FresnoCaliforniaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fresno, California.", "label": "Fresno California [Member]", "terseLabel": "Fresno, CA [Member]" } } }, "localname": "FresnoCaliforniaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_FromeUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Frome, UK.", "label": "Frome U K [Member]", "terseLabel": "Frome, UK [Member]" } } }, "localname": "FromeUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_FromeUKOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Frome, UK.", "label": "Frome U K One [Member]", "terseLabel": "Frome, UK [Member]" } } }, "localname": "FromeUKOneMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_FurnitureEquipmentAndOtherMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Furniture, Equipment And Other [Member]", "label": "Furniture Equipment And Other [Member]", "terseLabel": "Furniture, equipment and other [Member]" } } }, "localname": "FurnitureEquipmentAndOtherMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfRelatedRealEstateAndOtherAssetsDetail" ], "xbrltype": "domainItemType" }, "mpw_FutureMinimumPaymentsReceivableCurrentNet": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "order": 0.0, "parentTag": "mpw_FutureMinimumPaymentsReceivableNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Future Minimum Payments Receivable, Current Net", "label": "Future Minimum Payments Receivable Current Net", "terseLabel": "Net Payments, 2023" } } }, "localname": "FutureMinimumPaymentsReceivableCurrentNet", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "xbrltype": "monetaryItemType" }, "mpw_FutureMinimumPaymentsReceivableInFiveYearsNet": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "order": 4.0, "parentTag": "mpw_FutureMinimumPaymentsReceivableNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Future Minimum Payments Receivable, in Five Years Net", "label": "Future Minimum Payments Receivable In Five Years Net", "terseLabel": "Net Payments, 2027" } } }, "localname": "FutureMinimumPaymentsReceivableInFiveYearsNet", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "xbrltype": "monetaryItemType" }, "mpw_FutureMinimumPaymentsReceivableInFourYearsNet": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "order": 3.0, "parentTag": "mpw_FutureMinimumPaymentsReceivableNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Future Minimum Payments Receivable, in Four Years Net", "label": "Future Minimum Payments Receivable In Four Years Net", "terseLabel": "Net Payments, 2026" } } }, "localname": "FutureMinimumPaymentsReceivableInFourYearsNet", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "xbrltype": "monetaryItemType" }, "mpw_FutureMinimumPaymentsReceivableInThreeYearsNet": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "order": 2.0, "parentTag": "mpw_FutureMinimumPaymentsReceivableNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Future Minimum Payments Receivable, in Three Years Net", "label": "Future Minimum Payments Receivable In Three Years Net", "terseLabel": "Net Payments, 2025" } } }, "localname": "FutureMinimumPaymentsReceivableInThreeYearsNet", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "xbrltype": "monetaryItemType" }, "mpw_FutureMinimumPaymentsReceivableInTwoYearsNet": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "order": 1.0, "parentTag": "mpw_FutureMinimumPaymentsReceivableNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Future Minimum Payments Receivable, In Two Years Net", "label": "Future Minimum Payments Receivable In Two Years Net", "terseLabel": "Net Payments, 2024" } } }, "localname": "FutureMinimumPaymentsReceivableInTwoYearsNet", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "xbrltype": "monetaryItemType" }, "mpw_FutureMinimumPaymentsReceivableNet": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Future Minimum Payments Receivable Net", "label": "Future Minimum Payments Receivable Net", "totalLabel": "Net Payments, Total undiscounted minimum lease payments" } } }, "localname": "FutureMinimumPaymentsReceivableNet", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "xbrltype": "monetaryItemType" }, "mpw_FutureMinimumPaymentsReceivableThereafterNet": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "order": 5.0, "parentTag": "mpw_FutureMinimumPaymentsReceivableNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Future Minimum Payments Receivable, Thereafter Net", "label": "Future Minimum Payments Receivable Thereafter Net", "terseLabel": "Net Payments, Thereafter" } } }, "localname": "FutureMinimumPaymentsReceivableThereafterNet", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "xbrltype": "monetaryItemType" }, "mpw_GBPDenominatedBorrowingsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "GBP-denominated Borrowings [Member]", "label": "G B P Denominated Borrowings [Member]", "terseLabel": "GBP-denominated Borrowings [Member]" } } }, "localname": "GBPDenominatedBorrowingsMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "xbrltype": "domainItemType" }, "mpw_GainLossOnDispositionOfRealEstate": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain loss on disposition of real estate.", "label": "Gain Loss on Disposition of Real Estate", "totalLabel": "Income from real estate dispositions, net" } } }, "localname": "GainLossOnDispositionOfRealEstate", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails" ], "xbrltype": "monetaryItemType" }, "mpw_GardenGroveCaliforniaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Garden Grove, California.", "label": "Garden Grove California [Member]", "terseLabel": "Garden Grove, CA [Member]" } } }, "localname": "GardenGroveCaliforniaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_GardenaCAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gardena, CA.", "label": "Gardena C A [Member]", "terseLabel": "Gardena, CA [Member]" } } }, "localname": "GardenaCAMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_GeneralAcuteCareHospitalAndHealthcareSystemMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "General Acute Care Hospital and Healthcare System.", "label": "General Acute Care Hospital and Healthcare System [Member]", "terseLabel": "General Acute Care Hospital And Healthcare System" } } }, "localname": "GeneralAcuteCareHospitalAndHealthcareSystemMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_GeneralAcuteCareHospitalsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "General acute care hospitals.", "label": "General Acute Care Hospitals [Member]", "terseLabel": "General Acute Care Hospitals [Member]", "verboseLabel": "General Acute Care Facilities [Member]" } } }, "localname": "GeneralAcuteCareHospitalsMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_GeneralAcuteHospitalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "General acute hospital.", "label": "General Acute Hospital [Member]", "terseLabel": "General Acute Hospital [Member]" } } }, "localname": "GeneralAcuteHospitalMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_GeorgetownTXMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Georgetown, TX.", "label": "Georgetown T X [Member]", "terseLabel": "Georgetown, TX [Member]" } } }, "localname": "GeorgetownTXMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_GilbertArizonaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gilbert, Arizona.", "label": "Gilbert Arizona [Member]", "terseLabel": "Gilbert, AZ [Member]" } } }, "localname": "GilbertArizonaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_GlasgowUnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Glasgow, UK.", "label": "Glasgow United Kingdom [Member]", "terseLabel": "Glasgow, UK [Member]" } } }, "localname": "GlasgowUnitedKingdomMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_GlenWaverlyAustraliaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Glen Waverly Australia.", "label": "Glen Waverly Australia [Member]", "terseLabel": "Glen Waverly, Australia [Member]" } } }, "localname": "GlenWaverlyAustraliaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_GlendaleAZMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Glendale, AZ.", "label": "Glendale A Z [Member]", "terseLabel": "Glendale,AZ [Member]" } } }, "localname": "GlendaleAZMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_GloucesterUnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gloucester United Kingdom.", "label": "Gloucester United Kingdom [Member]", "terseLabel": "Gloucester, UK [Member]" } } }, "localname": "GloucesterUnitedKingdomMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_GodalmingUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Godalming, UK.", "label": "Godalming U K [Member]", "terseLabel": "Godalming, UK [Member]" } } }, "localname": "GodalmingUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_GoodyearArizonaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Goodyear Arizona.", "label": "Goodyear Arizona [Member]", "terseLabel": "Goodyear, AZ [Member]" } } }, "localname": "GoodyearArizonaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_GreatMissendenUnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Great Missenden, UK.", "label": "Great Missenden United Kingdom [Member]", "terseLabel": "Great Missenden, UK [Member]" } } }, "localname": "GreatMissendenUnitedKingdomMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_GrefathGermanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Grefath, Germany.", "label": "Grefath Germany [Member]", "terseLabel": "Grefath, Germany [Member]" } } }, "localname": "GrefathGermanyMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_GrossInvestmentInRealEstateAssets": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 0.0, "parentTag": "mpw_NetInvestmentInRealEstateAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross investment in real estate assets", "label": "Gross Investment In Real Estate Assets", "totalLabel": "Gross investment in real estate assets" } } }, "localname": "GrossInvestmentInRealEstateAssets", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "mpw_GuildfordUnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Guildford, UK.", "label": "Guildford United Kingdom [Member]", "terseLabel": "Guildford, UK [Member]" } } }, "localname": "GuildfordUnitedKingdomMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_HCAHealthcareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "HCA healthcare.", "label": "H C A Healthcare [Member]", "terseLabel": "HCA Healthcare [Member]" } } }, "localname": "HCAHealthcareMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_HalsallUnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Halsall United Kingdom.", "label": "Halsall United Kingdom [Member]", "terseLabel": "Halsall, UK [Member]" } } }, "localname": "HalsallUnitedKingdomMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_HalsenHealthcareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Halsen healthcare.", "label": "Halsen Healthcare [Member]", "terseLabel": "Halsen Healthcare [Member]" } } }, "localname": "HalsenHealthcareMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_HarrowUnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Harrow, UK.", "label": "Harrow United Kingdom [Member]", "terseLabel": "Harrow, UK [Member]" } } }, "localname": "HarrowUnitedKingdomMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_HartsvilleSouthCarolinaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hartsville south Carolina.", "label": "Hartsville South Carolina [Member]", "terseLabel": "Hartsville, SC [Member]" } } }, "localname": "HartsvilleSouthCarolinaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_HassocksUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hassocks, UK.", "label": "Hassocks U K [Member]", "terseLabel": "Hassocks, UK [Member]" } } }, "localname": "HassocksUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_HastingsPAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hastings PA.", "label": "Hastings P A [Member]", "terseLabel": "Hastings, PA [Member]" } } }, "localname": "HastingsPAMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_HausmanTXMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hausman, TX.", "label": "Hausman T X [Member]", "terseLabel": "Hausman, TX [Member]" } } }, "localname": "HausmanTXMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_HaverhillMassachusettsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Haverhill, Massachusetts.", "label": "Haverhill Massachusetts [Member]", "terseLabel": "Haverhill, MA [Member]" } } }, "localname": "HaverhillMassachusettsMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_HeidelbergGermanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Heidelberg Germany.", "label": "Heidelberg Germany [Member]", "terseLabel": "Heidelberg, Germany [Member]" } } }, "localname": "HeidelbergGermanyMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_HelotesTexasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Helotes Texas.", "label": "Helotes Texas [Member]", "terseLabel": "Helotes, TX [Member]" } } }, "localname": "HelotesTexasMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_HelsinkiFinlandMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Helsinki, Finland.", "label": "Helsinki Finland [Member]", "terseLabel": "Helsinki, Finland [Member]" } } }, "localname": "HelsinkiFinlandMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_HemelHempsteadUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hemel Hempstead, UK.", "label": "Hemel Hempstead U K [Member]", "terseLabel": "Hemel Hempstead, UK [Member]" } } }, "localname": "HemelHempsteadUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_HialeahFLMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hialeah, FL.", "label": "Hialeah F L [Member]", "terseLabel": "Hialeah, FL [Member]" } } }, "localname": "HialeahFLMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_HighlandHillsOHMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Highland Hills, OH.", "label": "Highland Hills O H [Member]", "terseLabel": "Highland Hills, OH [Member]" } } }, "localname": "HighlandHillsOHMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_HighlandVillageTXMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Highland Village, TX.", "label": "Highland Village T X [Member]", "terseLabel": "Highland Village TX [Member]" } } }, "localname": "HighlandVillageTXMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_HighlandsRanchColoradoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Highlands Ranch Colorado.", "label": "Highlands Ranch Colorado [Member]", "terseLabel": "Highlands Ranch, CO [Member]" } } }, "localname": "HighlandsRanchColoradoMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_HillCountyTXMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hill County, TX.", "label": "Hill County T X [Member]", "terseLabel": "Hill County, TX [Member]" } } }, "localname": "HillCountyTXMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_HinckleyUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hinckley, UK.", "label": "Hinckley U K [Member]", "terseLabel": "Hinckley, UK [Member]" } } }, "localname": "HinckleyUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_HmHospitalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "HM Hospital.", "label": "HM Hospital [Member]", "terseLabel": "HM Hospital [Member]" } } }, "localname": "HmHospitalMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails" ], "xbrltype": "domainItemType" }, "mpw_HookUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hook, UK.", "label": "Hook U K [Member]", "terseLabel": "Hook, UK [Member]" } } }, "localname": "HookUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_HooverAlMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hoover, AL.", "label": "Hoover Al [Member]", "terseLabel": "Hoover, AL [Member]" } } }, "localname": "HooverAlMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_HopeARMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hope, AR.", "label": "Hope A R [Member]", "terseLabel": "Hope, AR [Member]" } } }, "localname": "HopeARMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_HotSpringsARMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hot Springs, AR.", "label": "Hot Springs A R [Member]", "terseLabel": "Hot Springs, AR [Member]" } } }, "localname": "HotSpringsARMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_HoustonTXMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Houston, TX.", "label": "Houston T X [Member]", "terseLabel": "Houston, TX [Member]" } } }, "localname": "HoustonTXMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_HoustonTexasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Houston, Texas.", "label": "Houston Texas [Member]", "terseLabel": "Houston, TX [Member]", "verboseLabel": "Houston, Texas [Member]" } } }, "localname": "HoustonTexasMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_HuntingtonParkCAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Huntington Park, CA.", "label": "Huntington Park C A [Member]", "terseLabel": "Huntington Park, CA [Member]" } } }, "localname": "HuntingtonParkCAMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_IdahoFallsIDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Idaho Falls, ID.", "label": "Idaho Falls I D [Member]", "terseLabel": "Idaho Falls, ID [Member]" } } }, "localname": "IdahoFallsIDMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_ImedHospitalesOneFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "IMED Hospitales One Facility.", "label": "IMED Hospitales One Facility [Member]", "terseLabel": "IMED [Member]" } } }, "localname": "ImedHospitalesOneFacilityMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "xbrltype": "domainItemType" }, "mpw_ImedHospitalesThreeFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "IMED hospitales Three facility.", "label": "IMED Hospitales Three Facility [Member]", "terseLabel": "IMED [Member]" } } }, "localname": "ImedHospitalesThreeFacilityMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "xbrltype": "domainItemType" }, "mpw_ImedHospitalesTwoFacilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "IMED Hospitales Two Facilities.", "label": "IMED Hospitales Two Facilities [Member]", "terseLabel": "IMED [Member]" } } }, "localname": "ImedHospitalesTwoFacilitiesMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "xbrltype": "domainItemType" }, "mpw_IncomeTaxBenefitRelatedToTheInitialLoanImpairment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Income tax benefit related to the initial loan impairment.", "label": "Income Tax Benefit Related To The Initial Loan Impairment", "terseLabel": "Income tax benefit related to the initial loan impairment" } } }, "localname": "IncomeTaxBenefitRelatedToTheInitialLoanImpairment", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mpw_IncomeTaxReconciliationIncreaseDecreaseInEquityInvestments": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitFromStatutoryIncomeTaxRateToEffectiveTaxRateBasedOnIncomeBeforeIncomeTaxesDetail": { "order": 4.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Income tax reconciliation increase (decrease) in equity investments.", "label": "Income Tax Reconciliation Increase Decrease In Equity Investments", "negatedLabel": "Equity investments" } } }, "localname": "IncomeTaxReconciliationIncreaseDecreaseInEquityInvestments", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitFromStatutoryIncomeTaxRateToEffectiveTaxRateBasedOnIncomeBeforeIncomeTaxesDetail" ], "xbrltype": "monetaryItemType" }, "mpw_IncomeTaxReconciliationInterestDisallowance": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitFromStatutoryIncomeTaxRateToEffectiveTaxRateBasedOnIncomeBeforeIncomeTaxesDetail": { "order": 7.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Income tax reconciliation interest disallowance.", "label": "Income Tax Reconciliation Interest Disallowance", "negatedLabel": "Interest disallowance" } } }, "localname": "IncomeTaxReconciliationInterestDisallowance", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitFromStatutoryIncomeTaxRateToEffectiveTaxRateBasedOnIncomeBeforeIncomeTaxesDetail" ], "xbrltype": "monetaryItemType" }, "mpw_IncomeTaxesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Income Taxes [Line Items]", "label": "Income Taxes [Line Items]", "terseLabel": "Income Taxes [Line Items]" } } }, "localname": "IncomeTaxesLineItems", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfNetNOLAndOtherTaxAttributeCarryforwardsDetail" ], "xbrltype": "stringItemType" }, "mpw_IncomeTaxesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Income Taxes [Table]", "label": "Income Taxes [Table]", "terseLabel": "Income Taxes [Table]" } } }, "localname": "IncomeTaxesTable", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfNetNOLAndOtherTaxAttributeCarryforwardsDetail" ], "xbrltype": "stringItemType" }, "mpw_IncreaseDecreaseInAccountsReceivableAndOtherReserves": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase (decrease) in accounts receivable and other reserves.", "label": "Increase Decrease In Accounts Receivable And Other Reserves", "terseLabel": "Increase in accounts receivable and other reserves" } } }, "localname": "IncreaseDecreaseInAccountsReceivableAndOtherReserves", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "mpw_IncreaseDecreaseInEquityInvestmentImpairmentsRelatedToDisposals": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in equity investment impairments related to disposals.", "label": "Increase Decrease In Equity Investment Impairments Related To Disposals", "terseLabel": "Equity investment impairments reserve related to disposals" } } }, "localname": "IncreaseDecreaseInEquityInvestmentImpairmentsRelatedToDisposals", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "mpw_IncreaseDecreaseInInterestAndRentReceivable": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in interest and rent receivable.", "label": "Increase Decrease In Interest And Rent Receivable", "negatedLabel": "Interest and rent receivables" } } }, "localname": "IncreaseDecreaseInInterestAndRentReceivable", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "mpw_IncreaseDecreaseInRealEstateImpairmentReserve": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in real estate impairment reserve.", "label": "Increase Decrease In Real Estate Impairment Reserve", "terseLabel": "Increase in real estate impairment reserves" } } }, "localname": "IncreaseDecreaseInRealEstateImpairmentReserve", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "mpw_IncreaseDecreaseInRealEstateImpairmentReserveRelatedToDisposals": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in real estate impairment reserve related to disposals.", "label": "Increase Decrease In Real Estate Impairment Reserve Related To Disposals", "terseLabel": "Increase (decrease) in real estate impairment reserves related to disposals" } } }, "localname": "IncreaseDecreaseInRealEstateImpairmentReserveRelatedToDisposals", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "mpw_InfracoreMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Infracore.", "label": "Infracore [Member]", "terseLabel": "Infracore [Member]" } } }, "localname": "InfracoreMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail" ], "xbrltype": "domainItemType" }, "mpw_InpatientRehabilitationHospitalAcuteCareHospitalAndPrivateAcuteCareHospitalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Inpatient rehabilitation hospital acute care hospital and private acute care hospital.", "label": "Inpatient Rehabilitation Hospital Acute Care Hospital And Private Acute Care Hospital [Member]", "terseLabel": "Inpatient Rehabilitation Hospital, Acute Care Hospital and Private Acute Care Hospital [Member]" } } }, "localname": "InpatientRehabilitationHospitalAcuteCareHospitalAndPrivateAcuteCareHospitalMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_InpatientRehabilitationHospitalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Inpatient Rehabilitation Hospital [Member]", "label": "Inpatient Rehabilitation Hospital [Member]", "terseLabel": "Inpatient Rehabilitation Hospital [Member]" } } }, "localname": "InpatientRehabilitationHospitalMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_IntangibleLeaseAssets": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "mpw_GrossInvestmentInRealEstateAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intangible lease assets.", "label": "Intangible Lease Assets", "terseLabel": "Intangible lease assets" } } }, "localname": "IntangibleLeaseAssets", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesIntangibleAssetsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "mpw_IntangibleLeaseAssetsIncludedInRealEstateHeldForSale": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intangible lease assets included in real estate held for sale.", "label": "Intangible Lease Assets Included In Real Estate Held For Sale", "terseLabel": "Intangible lease assets included in real estate held for sale" } } }, "localname": "IntangibleLeaseAssetsIncludedInRealEstateHeldForSale", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIChangesInAccumulatedDepreciationParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "mpw_IntangibleLeaseAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intangible Lease Assets", "label": "Intangible Lease Assets [Member]", "terseLabel": "Intangible Lease Assets [Member]" } } }, "localname": "IntangibleLeaseAssetsMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "xbrltype": "domainItemType" }, "mpw_InterestAndRentReceivable": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest and rent receivable.", "label": "Interest And Rent Receivable", "terseLabel": "Interest and rent receivables", "verboseLabel": "Interest and rent receivables, Book value" } } }, "localname": "InterestAndRentReceivable", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "mpw_InterestMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest.", "label": "Interest [Member]", "terseLabel": "Interest [Member]" } } }, "localname": "InterestMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail" ], "xbrltype": "domainItemType" }, "mpw_InterimCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interim credit facility.", "label": "Interim Credit Facility [Member]", "terseLabel": "Interim Credit Facility [Member]" } } }, "localname": "InterimCreditFacilityMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtInterimCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtJuly2021InterimCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail" ], "xbrltype": "domainItemType" }, "mpw_InternationalJointVentureMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "International joint venture.", "label": "International Joint Venture [Member]", "terseLabel": "International Joint Venture [Member]" } } }, "localname": "InternationalJointVentureMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails" ], "xbrltype": "domainItemType" }, "mpw_InvestmentsInFinancingLeasesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments in financing leases.", "label": "Investments In Financing Leases [Member]", "terseLabel": "Investments in Financing Leases [Member]" } } }, "localname": "InvestmentsInFinancingLeasesMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "xbrltype": "domainItemType" }, "mpw_InvestmentsInOtherLoans": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investments in other loans.", "label": "Investments in Other Loans", "terseLabel": "Other loans" } } }, "localname": "InvestmentsInOtherLoans", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "mpw_InvestmentsInUnconsolidatedEntitiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments In unconsolidated entities.", "label": "Investments In Unconsolidated Entities Policy [Text Block]", "terseLabel": "Investments in Unconsolidated Entities" } } }, "localname": "InvestmentsInUnconsolidatedEntitiesPolicyTextBlock", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "mpw_InvestmentsInUnconsolidatedOperatingEntities": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investments In Unconsolidated Operating Entities", "label": "Investments In Unconsolidated Operating Entities", "terseLabel": "Investments in unconsolidated operating entities" } } }, "localname": "InvestmentsInUnconsolidatedOperatingEntities", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "mpw_InvestmentsInUnconsolidatedOperatingEntitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments In Unconsolidated Operating Entities [Member]", "label": "Investments In Unconsolidated Operating Entities [Member]" } } }, "localname": "InvestmentsInUnconsolidatedOperatingEntitiesMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "xbrltype": "domainItemType" }, "mpw_JohnstownPAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Johnstown PA.", "label": "Johnstown P A [Member]", "terseLabel": "Johnstown, PA [Member]" } } }, "localname": "JohnstownPAMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_JointVenturePartnerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Joint Venture Partner [Member]", "label": "Joint Venture Partner [Member]", "terseLabel": "Joint Venture Partner [Member]" } } }, "localname": "JointVenturePartnerMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_KansasCityKSMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kansas City KS.", "label": "Kansas City K S [Member]", "terseLabel": "Kansas City, KS [Member]" } } }, "localname": "KansasCityKSMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_KansasCityMOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kansas City, MO.", "label": "Kansas City M O [Member]", "terseLabel": "Kansas City, MO [Member]" } } }, "localname": "KansasCityMOMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_KatyTXMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Katy, TX.", "label": "Katy T X [Member]", "terseLabel": "Katy, TX [Member]" } } }, "localname": "KatyTXMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_KingswoodAustraliaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kingswood Australia.", "label": "Kingswood Australia [Member]", "terseLabel": "Kingswood, Australia [Member]" } } }, "localname": "KingswoodAustraliaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_KuopioFinlandMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kuopio, finland.", "label": "Kuopio, Finland [Member]", "terseLabel": "Kuopio, Finland [Member]" } } }, "localname": "KuopioFinlandMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_LafayetteINMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lafayette IN.", "label": "Lafayette I N [Member]", "terseLabel": "Lafayette, IN [Member]" } } }, "localname": "LafayetteINMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_LanderWyomingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lander, Wyoming.", "label": "Lander Wyoming [Member]", "terseLabel": "Lander, WY [Member]" } } }, "localname": "LanderWyomingMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_LauderdaleLakesFLMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lauderdale Lakes, FL.", "label": "Lauderdale Lakes F L [Member]", "terseLabel": "Lauderdale Lakes, FL [Member]" } } }, "localname": "LauderdaleLakesFLMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_LawtonOklahomaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lawton, Oklahoma.", "label": "Lawton Oklahoma [Member]", "terseLabel": "Lawton, OK [Member]" } } }, "localname": "LawtonOklahomaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_LaytonUtahMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Layton, Utah.", "label": "Layton Utah [Member]", "terseLabel": "Layton, UT [Member]" } } }, "localname": "LaytonUtahMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_LeagueCityTXMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "League City TX.", "label": "League City T X [Member]", "terseLabel": "League City, TX [Member]" } } }, "localname": "LeagueCityTXMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_LeaseAndInterestRevenueEarnedFromTenants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Lease and interest revenue earned from tenants", "label": "Lease And Interest Revenue Earned From Tenants", "terseLabel": "Lease and interest revenue earned from tenants" } } }, "localname": "LeaseAndInterestRevenueEarnedFromTenants", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mpw_LeaseIntangiblesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lease intangibles.", "label": "Lease Intangibles [Member]", "terseLabel": "Lease Intangibles [Member]" } } }, "localname": "LeaseIntangiblesMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfRelatedRealEstateAndOtherAssetsDetail" ], "xbrltype": "domainItemType" }, "mpw_LeaseLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lease liabilities.", "label": "Lease Liabilities [Abstract]", "terseLabel": "Lease liabilities:" } } }, "localname": "LeaseLiabilitiesAbstract", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "xbrltype": "stringItemType" }, "mpw_LeaseOperatingLeaseAnnuallyPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lease operating lease annually percentage.", "label": "Lease Operating Lease Annually Percentage", "terseLabel": "Percentage of annually" } } }, "localname": "LeaseOperatingLeaseAnnuallyPercentage", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_LeasesAnnualRentEscalationsPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Leases annual rent escalations percentage.", "label": "Leases Annual Rent Escalations Percentage", "terseLabel": "Annual rent escalations" } } }, "localname": "LeasesAnnualRentEscalationsPercentage", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_LeawoodKansasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Leawood, Kansas.", "label": "Leawood Kansas [Member]", "terseLabel": "Leawood, KS [Member]" } } }, "localname": "LeawoodKansasMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_LeedsUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Leeds, UK.", "label": "Leeds U K [Member]", "terseLabel": "Leeds, UK [Member]" } } }, "localname": "LeedsUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_LehiUtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lehi UT [Member]", "label": "Lehi Ut [Member]", "terseLabel": "Lehi, UT [Member]" } } }, "localname": "LehiUtMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_LesseeOperatingLeaseAndFinanceLeaseRealEstateRightOfUseAssetNet": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail": { "order": 0.0, "parentTag": "mpw_LesseeOperatingLeaseAndFinanceLeaseRightOfUseAssetNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Lessee, operating lease and finance lease real estate right of use asset net.", "label": "Lessee Operating Lease And Finance Lease Real Estate Right Of Use Asset Net", "totalLabel": "Total real estate right of use assets", "verboseLabel": "Right-of-use-assets" } } }, "localname": "LesseeOperatingLeaseAndFinanceLeaseRealEstateRightOfUseAssetNet", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "xbrltype": "monetaryItemType" }, "mpw_LesseeOperatingLeaseAndFinanceLeaseRightOfUseAssetNet": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Lessee, operating lease and finance lease right of use asset net.", "label": "Lessee Operating Lease And Finance Lease Right Of Use Asset Net", "totalLabel": "Total right of use assets" } } }, "localname": "LesseeOperatingLeaseAndFinanceLeaseRightOfUseAssetNet", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "xbrltype": "monetaryItemType" }, "mpw_LesseeOperatingLeaseAndFinanceLeaseTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lessee, operating lease and financing lease.", "label": "Lessee Operating Lease And Finance Lease [Text Block]", "terseLabel": "Leases (Lessee)" } } }, "localname": "LesseeOperatingLeaseAndFinanceLeaseTextBlock", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLessee" ], "xbrltype": "textBlockItemType" }, "mpw_LesseeOperatingLeaseExtendedExpirationYearOfContract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lessee operating lease extended expiration year of contract.", "label": "Lessee Operating Lease Extended Expiration Year Of Contract", "terseLabel": "Lease extension expiration year" } } }, "localname": "LesseeOperatingLeaseExtendedExpirationYearOfContract", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "xbrltype": "gYearItemType" }, "mpw_LesseeOperatingLeaseInitialFixedTermOfContract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lessee operating lease initial fixed term of contract.", "label": "Lessee Operating Lease Initial Fixed Term Of Contract", "terseLabel": "Lease extension expiration term" } } }, "localname": "LesseeOperatingLeaseInitialFixedTermOfContract", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "mpw_LessorOperatingLeaseGroundLeaseTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lessor operating lease ground lease term.", "label": "Lessor Operating Lease Ground Lease Term", "terseLabel": "Lessor operating lease ground lease term" } } }, "localname": "LessorOperatingLeaseGroundLeaseTerm", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "mpw_LessorOperatingLeaseInitialFixedTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lessor operating lease initial fixed term.", "label": "Lessor Operating Lease Initial Fixed Term", "terseLabel": "Initial fixed term of lease" } } }, "localname": "LessorOperatingLeaseInitialFixedTerm", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail" ], "xbrltype": "gYearItemType" }, "mpw_LewistonIDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lewiston, ID.", "label": "Lewiston I D [Member]", "terseLabel": "Lewiston, ID [Member]" } } }, "localname": "LewistonIDMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_LifePointMasterLeaseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "LifePoint master lease.", "label": "Life Point Master Lease [Member]", "terseLabel": "LifePoint Master Lease [Member]" } } }, "localname": "LifePointMasterLeaseMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_LifepointTransactionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lifepoint Transaction.", "label": "Lifepoint Transaction [Member]" } } }, "localname": "LifepointTransactionMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_LittleElmTXMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Little Elm, TX.", "label": "Little Elm T X [Member]", "terseLabel": "Little Elm, TX [Member]" } } }, "localname": "LittleElmTXMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_LiverpoolAustraliaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Liverpool Australia.", "label": "Liverpool Australia [Member]", "terseLabel": "Liverpool, Australia [Member]" } } }, "localname": "LiverpoolAustraliaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_LoanTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loan term.", "label": "Loan Term", "terseLabel": "Loan term" } } }, "localname": "LoanTerm", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "mpw_Loans": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Loans.", "label": "Loans", "terseLabel": "Loans, Book value" } } }, "localname": "Loans", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail" ], "xbrltype": "monetaryItemType" }, "mpw_LoansAndOrEquityInvestmentsInVariableInterestEntities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Loans and/or equity investments in variable interest entities.", "label": "Loans And Or Equity Investments In Variable Interest Entities", "terseLabel": "Loans and/or equity investments in variable interest entities" } } }, "localname": "LoansAndOrEquityInvestmentsInVariableInterestEntities", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mpw_LoansLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loans.", "label": "Loans [Line Items]", "terseLabel": "Loans [Line Items]" } } }, "localname": "LoansLineItems", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "mpw_LoansTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loans [Table]", "label": "Loans [Table]", "terseLabel": "Loans [Table]" } } }, "localname": "LoansTable", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "mpw_LondonUnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "London, United Kingdom.", "label": "London United Kingdom [Member]", "terseLabel": "London, UK [Member]" } } }, "localname": "LondonUnitedKingdomMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_LondonUnitedKingdomOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "London, UK.", "label": "London United Kingdom One [Member]", "terseLabel": "London, UK [Member]" } } }, "localname": "LondonUnitedKingdomOneMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_LongTermAcuteCareHospitalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long-term acute care hospital.", "label": "Long-term Acute Care Hospital [Member]", "terseLabel": "Long Term Acute Care Hospital" } } }, "localname": "LongTermAcuteCareHospitalMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_LongTermCapitalGainLossPerShare": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfPerShareDistributionsToStockholdersDetail": { "order": 1.0, "parentTag": "us-gaap_CommonStockDividendsPerShareCashPaid", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Long-term capital gain (loss) per share.", "label": "Long-term Capital Gain (Loss) Per Share", "terseLabel": "Long-term capital gain" } } }, "localname": "LongTermCapitalGainLossPerShare", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfPerShareDistributionsToStockholdersDetail" ], "xbrltype": "perShareItemType" }, "mpw_LongTermIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long term incentive plan.", "label": "Long Term Incentive Plan [Member]", "terseLabel": "Long Term Incentive Plan [Member]" } } }, "localname": "LongTermIncentivePlanMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "xbrltype": "domainItemType" }, "mpw_LongmontColoradoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Longmont Colorado.", "label": "Longmont Colorado [Member]", "terseLabel": "Longmont, CO [Member]" } } }, "localname": "LongmontColoradoMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_LosAngelesCAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Los Angeles, CA.", "label": "Los Angeles C A [Member]", "terseLabel": "Los Angeles, CA [Member]" } } }, "localname": "LosAngelesCAMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_LosAngelesCaliforniaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Los Angeles, California.", "label": "Los Angeles California [Member]", "terseLabel": "Los Angeles, California [Member]" } } }, "localname": "LosAngelesCaliforniaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_LossesFromRentReceivablesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Losses from rent receivables.", "label": "Losses From Rent Receivables Policy [Text Block]", "terseLabel": "Losses from Rent Receivables" } } }, "localname": "LossesFromRentReceivablesPolicyTextBlock", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "mpw_LubbockTXMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lubbock TX.", "label": "Lubbock T X [Member]", "terseLabel": "Lubbock, TX [Member]" } } }, "localname": "LubbockTXMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_LynwoodCAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lynwood, CA.", "label": "Lynwood C A [Member]", "terseLabel": "Lynwood, CA [Member]" } } }, "localname": "LynwoodCAMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_MPTTRSIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "MPT TRS, Inc", "label": "M P T T R S Inc [Member]", "terseLabel": "MPT TRS, Inc [Member]" } } }, "localname": "MPTTRSIncMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_MacquarieAssetManagementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Macquarie Asset Management.", "label": "Macquarie Asset Management [Member]", "terseLabel": "Macquarie Asset Management [Member]" } } }, "localname": "MacquarieAssetManagementMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_MalagaSPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Malaga, SP.", "label": "Malaga S P [Member]", "terseLabel": "Malaga, SP [Member]" } } }, "localname": "MalagaSPMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_MandevilleLouisianaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mandeville Louisiana.", "label": "Mandeville Louisiana [Member]", "terseLabel": "Mandeville, LA [Member]" } } }, "localname": "MandevilleLouisianaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_MarketConditionsBasedAwardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Market Conditions Based Awards [Member]", "label": "Market Conditions Based Awards [Member]", "terseLabel": "Market Conditions Based Awards [Member]" } } }, "localname": "MarketConditionsBasedAwardsMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_MarreroLouisianaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Marrero Louisiana.", "label": "Marrero Louisiana [Member]", "terseLabel": "Marrero, LA [Member]" } } }, "localname": "MarreroLouisianaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_MassachusettsBasedGeneralAcuteCareHospitalsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Massachusetts based general acute care hospitals.", "label": "Massachusetts Based General Acute Care Hospitals [Member]", "terseLabel": "Massachusetts-based General Acute Care Hospitals [Member]" } } }, "localname": "MassachusettsBasedGeneralAcuteCareHospitalsMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDisposalsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_MaximumIncrementalCreditFacility": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum incremental credit facility", "label": "Maximum Incremental Credit Facility", "terseLabel": "Maximum incremental credit facility" } } }, "localname": "MaximumIncrementalCreditFacility", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mpw_MaximumPercentageOfDeferredRentOnAnnualRent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum percentage of deferred rent on annual rent.", "label": "Maximum Percentage Of Deferred Rent On Annual Rent", "terseLabel": "Maximum percentage of deferred rent on annual rent" } } }, "localname": "MaximumPercentageOfDeferredRentOnAnnualRent", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesRentDeferralsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_MaximumPercentageOfEntitysAssetsInvestedOnSingleProperty": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum percentage of entity's assets invested on single property.", "label": "Maximum Percentage Of Entitys Assets Invested On Single Property", "terseLabel": "Maximum percentage of entity's assets invested on single property" } } }, "localname": "MaximumPercentageOfEntitysAssetsInvestedOnSingleProperty", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_MaximumPercentageOfUnencumberedAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum percentage of unencumbered assets.", "label": "Maximum Percentage Of Unencumbered Assets", "terseLabel": "Maximum percentage of total unencumbered assets" } } }, "localname": "MaximumPercentageOfUnencumberedAssets", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCovenantsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_MaximumSecuredDebtPercentageOnAssetsValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum secured debt percentage on assets value.", "label": "Maximum Secured Debt Percentage On Assets Value", "terseLabel": "Maximum secured debt percentage of asset value" } } }, "localname": "MaximumSecuredDebtPercentageOnAssetsValue", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDisposalsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_McKinneyTXMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "McKinney, TX.", "label": "Mc Kinney T X [Member]", "terseLabel": "Mc Kinney T X", "verboseLabel": "McKinney, Texas [Member]" } } }, "localname": "McKinneyTXMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_McminnvilleOregonMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "McMinnville Oregon.", "label": "Mcminnville Oregon [Member]", "terseLabel": "Mcminnville, OR [Member]" } } }, "localname": "McminnvilleOregonMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_MedianKlinikenSARLMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Median Kliniken S A R L [Member]", "label": "Median Kliniken S A R L [Member]", "terseLabel": "Median [Member]" } } }, "localname": "MedianKlinikenSARLMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails" ], "xbrltype": "domainItemType" }, "mpw_MedicalPropertiesTrustLimitedLiabilityCompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Medical properties trust LLC.", "label": "Medical Properties Trust Limited Liability Company [Member]", "terseLabel": "Medical Properties Trust, LLC. [Member]" } } }, "localname": "MedicalPropertiesTrustLimitedLiabilityCompanyMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_MelbourneFLMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Melbourne, FL.", "label": "Melbourne F L [Member]", "terseLabel": "Melbourne, FL [Member]" } } }, "localname": "MelbourneFLMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_MeltonMowbrayUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Melton Mowbray, UK.", "label": "Melton Mowbray U K [Member]", "terseLabel": "Melton Mowbray, UK [Member]" } } }, "localname": "MeltonMowbrayUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_MesaArizonaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mesa - Arizona.", "label": "Mesa Arizona [Member]", "terseLabel": "Mesa, AZ [Member]" } } }, "localname": "MesaArizonaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_MethodistHealthcareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Methodist healthcare.", "label": "Methodist Healthcare [Member]", "terseLabel": "Methodist [Member]" } } }, "localname": "MethodistHealthcareMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_MethuenMassachusettsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Methuen Massachusetts.", "label": "Methuen Massachusetts [Member]", "terseLabel": "Methuen, MA [Member]" } } }, "localname": "MethuenMassachusettsMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_MeyersdalePennsylvaniaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Meyersdale, Pennsylvania.", "label": "Meyersdale Pennsylvania [Member]", "terseLabel": "Meyersdale, PA [Member]" } } }, "localname": "MeyersdalePennsylvaniaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_MiamiFLMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Miami, FL.", "label": "Miami F L [Member]", "terseLabel": "Miami, FL [Member]" } } }, "localname": "MiamiFLMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_MiltonKeynesUnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Milton Keynes United Kingdom.", "label": "Milton Keynes United Kingdom [Member]", "terseLabel": "Milton Keynes, UK [Member]" } } }, "localname": "MiltonKeynesUnitedKingdomMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_MonmouthUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Monmouth, UK.", "label": "Monmouth U K [Member]", "terseLabel": "Monmouth, UK [Member]" } } }, "localname": "MonmouthUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_MontclairNJMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Montclair, NJ.", "label": "Montclair N J [Member]", "terseLabel": "Montclair, NJ [Member]" } } }, "localname": "MontclairNJMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_MontclairNewJerseyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Montclair New Jersey.", "label": "Montclair New Jersey [Member]", "terseLabel": "Montclair New Jersey" } } }, "localname": "MontclairNewJerseyMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_MortgageLoanOnRealEstateFinalMaturityYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mortgage Loan on Real Estate, Final Maturity Year", "label": "Mortgage Loan On Real Estate Final Maturity Year", "terseLabel": "Final Maturity Date" } } }, "localname": "MortgageLoanOnRealEstateFinalMaturityYear", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail" ], "xbrltype": "gYearItemType" }, "mpw_MortgageLoansOnRealEstateAdditionsGross": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Mortgage loans on real estate additions gross.", "label": "Mortgage Loans On Real Estate Additions Gross", "terseLabel": "Mortgage loans on real estate including additions during year" } } }, "localname": "MortgageLoansOnRealEstateAdditionsGross", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossDetail" ], "xbrltype": "monetaryItemType" }, "mpw_MortgageLoansOnRealEstateDeductions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Mortgage loans on real estate Deductions.", "label": "Mortgage Loans On Real Estate Deductions", "negatedLabel": "Deductions during year" } } }, "localname": "MortgageLoansOnRealEstateDeductions", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossDetail" ], "xbrltype": "monetaryItemType" }, "mpw_MortgageLoansOnRealEstateExchangeRateFluctuations": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Mortgage loans on real estate exchange rate fluctuations.", "label": "Mortgage Loans On Real Estate Exchange Rate Fluctuations", "terseLabel": "Exchange rate fluctuations" } } }, "localname": "MortgageLoansOnRealEstateExchangeRateFluctuations", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossDetail" ], "xbrltype": "monetaryItemType" }, "mpw_MountPleasantSCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mount Pleasant, SC.", "label": "Mount Pleasant S C [Member]", "terseLabel": "Mount Pleasant, SC [Member]" } } }, "localname": "MountPleasantSCMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_MptOperatingPartnershipLPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "MPT Operating Partnership L.P", "label": "Mpt Operating Partnership L P [Member]", "terseLabel": "MPT Operating Partnership, L.P. [Member]" } } }, "localname": "MptOperatingPartnershipLPMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlowsParenthetical", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveIncome", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapitalParenthetical", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "domainItemType" }, "mpw_NegativeHundredBasisPointsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Negative Hundred Basis Points.", "label": "Negative Hundred Basis Points [Member]", "terseLabel": "- 100 Basis Points [Member]" } } }, "localname": "NegativeHundredBasisPointsMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDLOMBySensitivityAnalysisByUsingBasisPointVariationsDetail" ], "xbrltype": "domainItemType" }, "mpw_NetDeferredTaxAssetNetOperatingLossCarryforward": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfNetNOLAndOtherTaxAttributeCarryforwardsDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net deferred tax asset, net operating loss carryforward.", "label": "Net Deferred Tax Asset Net Operating Loss Carryforward", "totalLabel": "Net deferred tax asset - NOL carryforwards" } } }, "localname": "NetDeferredTaxAssetNetOperatingLossCarryforward", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfNetNOLAndOtherTaxAttributeCarryforwardsDetail" ], "xbrltype": "monetaryItemType" }, "mpw_NetIncomeLessParticipatingSecuritiesShareInEarnings": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net income less participating securities share in earnings.", "label": "Net Income Less Participating Securities Share In Earnings", "totalLabel": "Net income, less participating securities\u2019 share in earnings" } } }, "localname": "NetIncomeLessParticipatingSecuritiesShareInEarnings", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail" ], "xbrltype": "monetaryItemType" }, "mpw_NetInvestmentInRealEstateAssets": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 0.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net Investment In Real Estate Assets", "label": "Net Investment In Real Estate Assets", "totalLabel": "Net investment in real estate assets" } } }, "localname": "NetInvestmentInRealEstateAssets", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "mpw_NewBraunfelsTexasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "New Braunfels Texas.", "label": "New Braunfels Texas [Member]", "terseLabel": "New Braunfels, TX [Member]" } } }, "localname": "NewBraunfelsTexasMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NewOrleansLouisianaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "New Orleans Louisiana.", "label": "New Orleans Louisiana [Member]", "terseLabel": "New Orleans, LA [Member]" } } }, "localname": "NewOrleansLouisianaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NewarkNewJerseyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Newark New Jersey .", "label": "Newark New Jersey [Member]", "terseLabel": "Newark, NJ [Member]" } } }, "localname": "NewarkNewJerseyMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NewburghINMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Newburgh, IN.", "label": "Newburgh I N [Member]", "terseLabel": "Newburgh, IN [Member]" } } }, "localname": "NewburghINMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenEightyEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen eighty eight.", "label": "Nineteen Eighty Eight [Member]", "terseLabel": "1988 [Member]" } } }, "localname": "NineteenEightyEightMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenEightyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen eighty five.", "label": "Nineteen Eighty Five [Member]", "terseLabel": "1985 [Member]" } } }, "localname": "NineteenEightyFiveMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenEightyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen eighty four.", "label": "Nineteen Eighty Four [Member]", "terseLabel": "1984 [Member]" } } }, "localname": "NineteenEightyFourMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenEightyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen eighty.", "label": "Nineteen Eighty [Member]", "terseLabel": "1980 [Member]" } } }, "localname": "NineteenEightyMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenEightyNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen eighty Nine.", "label": "Nineteen Eighty Nine [Member]", "terseLabel": "1989 [Member]" } } }, "localname": "NineteenEightyNineMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenEightyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen eighty one.", "label": "Nineteen Eighty One [Member]", "terseLabel": "1981 [Member]" } } }, "localname": "NineteenEightyOneMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenEightySevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen eighty seven.", "label": "Nineteen Eighty Seven [Member]", "terseLabel": "1987 [Member]" } } }, "localname": "NineteenEightySevenMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenEightySixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen eighty six.", "label": "Nineteen Eighty Six [Member]", "terseLabel": "1986 [Member]" } } }, "localname": "NineteenEightySixMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenEightyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen eighty three.", "label": "Nineteen Eighty Three [Member]", "terseLabel": "1983 [Member]" } } }, "localname": "NineteenEightyThreeMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenEightyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen eighty two.", "label": "Nineteen Eighty Two [Member]", "terseLabel": "1982 [Member]" } } }, "localname": "NineteenEightyTwoMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenEightyTwoOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen eighty two one.", "label": "Nineteen Eighty Two One [Member]", "terseLabel": "1982 One [Member]" } } }, "localname": "NineteenEightyTwoOneMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenElevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen eleven.", "label": "Nineteen Eleven [Member]", "terseLabel": "1911 [Member]" } } }, "localname": "NineteenElevenMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenFiftyEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen fifty eight.", "label": "Nineteen Fifty Eight [Member]", "terseLabel": "1958 [Member]" } } }, "localname": "NineteenFiftyEightMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenFiftyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen fifty five.", "label": "Nineteen Fifty Five [Member]", "terseLabel": "1955 [Member]" } } }, "localname": "NineteenFiftyFiveMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenFiftyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen fifty .", "label": "Nineteen Fifty [Member]", "terseLabel": "1950 [Member]" } } }, "localname": "NineteenFiftyMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenFiftyNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen fifty nine.", "label": "Nineteen Fifty Nine [Member]", "terseLabel": "1959 [Member]" } } }, "localname": "NineteenFiftyNineMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenFiftyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen fifty one.", "label": "Nineteen Fifty One [Member]", "terseLabel": "1951 [Member]" } } }, "localname": "NineteenFiftyOneMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenFiftySevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen fifty seven.", "label": "Nineteen Fifty Seven [Member]", "terseLabel": "1957 [Member]" } } }, "localname": "NineteenFiftySevenMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenFiftySixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen fifty six.", "label": "Nineteen Fifty Six [Member]", "terseLabel": "1956 [Member]" } } }, "localname": "NineteenFiftySixMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenFiftyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen fifty three.", "label": "Nineteen Fifty Three [Member]", "terseLabel": "1953 [Member]" } } }, "localname": "NineteenFiftyThreeMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenFiftyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen Fifty Two.", "label": "Nineteen Fifty Two [Member]", "terseLabel": "1952 [Member]" } } }, "localname": "NineteenFiftyTwoMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenFortyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen forty.", "label": "Nineteen Forty [Member]", "terseLabel": "1940 [Member]" } } }, "localname": "NineteenFortyMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenHundredMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen hundred.", "label": "Nineteen Hundred [Member]", "terseLabel": "1900 [Member]" } } }, "localname": "NineteenHundredMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenNineteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen nineteen.", "label": "Nineteen Nineteen [Member]", "terseLabel": "1919 [Member]" } } }, "localname": "NineteenNineteenMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenNinetyEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen ninety eight.", "label": "Nineteen Ninety Eight [Member]", "terseLabel": "1998 [Member]" } } }, "localname": "NineteenNinetyEightMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenNinetyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen ninety five.", "label": "Nineteen Ninety Five [Member]", "terseLabel": "1995 [Member]" } } }, "localname": "NineteenNinetyFiveMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenNinetyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen ninety four.", "label": "Nineteen Ninety Four [Member]", "terseLabel": "1994 [Member]" } } }, "localname": "NineteenNinetyFourMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenNinetyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen ninety.", "label": "Nineteen Ninety [Member]", "terseLabel": "1990 [Member]" } } }, "localname": "NineteenNinetyMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenNinetyNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen ninety nine.", "label": "Nineteen Ninety Nine [Member]", "terseLabel": "1999 [Member]" } } }, "localname": "NineteenNinetyNineMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenNinetyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen ninety one.", "label": "Nineteen Ninety One [Member]", "terseLabel": "1991 [Member]" } } }, "localname": "NineteenNinetyOneMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenNinetySevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen ninety seven.", "label": "Nineteen Ninety Seven [Member]", "terseLabel": "1997 [Member]" } } }, "localname": "NineteenNinetySevenMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenNinetySixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen ninety six.", "label": "Nineteen Ninety Six [Member]", "terseLabel": "1996 [Member]" } } }, "localname": "NineteenNinetySixMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenNinetyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen ninety three .", "label": "Nineteen Ninety Three [Member]", "terseLabel": "1993 [Member]" } } }, "localname": "NineteenNinetyThreeMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenNinetyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen ninety two.", "label": "Nineteen Ninety Two [Member]", "terseLabel": "1992 [Member]" } } }, "localname": "NineteenNinetyTwoMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenNinetyTwoOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen ninety two.", "label": "Nineteen Ninety Two One [Member]", "terseLabel": "1992 [Member]" } } }, "localname": "NineteenNinetyTwoOneMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenSeventeenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen seventeen .", "label": "Nineteen Seventeen [Member]", "terseLabel": "1917 [Member]" } } }, "localname": "NineteenSeventeenMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenSeventyEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen seventy eight.", "label": "Nineteen Seventy Eight [Member]", "terseLabel": "1978 [Member]" } } }, "localname": "NineteenSeventyEightMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenSeventyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen seventy Five.", "label": "Nineteen Seventy Five [Member]", "terseLabel": "1975 [Member]" } } }, "localname": "NineteenSeventyFiveMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenSeventyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen seventy four.", "label": "Nineteen Seventy Four [Member]", "terseLabel": "1974 [Member]" } } }, "localname": "NineteenSeventyFourMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenSeventyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen seventy.", "label": "Nineteen Seventy [Member]", "terseLabel": "1970 [Member]" } } }, "localname": "NineteenSeventyMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenSeventyNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen seventy nine.", "label": "Nineteen Seventy Nine [Member]", "terseLabel": "1979 [Member]" } } }, "localname": "NineteenSeventyNineMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenSeventyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen Seventy One.", "label": "Nineteen Seventy One [Member]", "terseLabel": "1971 [Member]" } } }, "localname": "NineteenSeventyOneMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenSeventySevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen seventy seven.", "label": "Nineteen Seventy Seven [Member]", "terseLabel": "1977 [Member]" } } }, "localname": "NineteenSeventySevenMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenSeventySixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen seventy six.", "label": "Nineteen Seventy Six [Member]", "terseLabel": "1976 [Member]" } } }, "localname": "NineteenSeventySixMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenSeventyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen seventy three.", "label": "Nineteen Seventy Three [Member]", "terseLabel": "1973 [Member]" } } }, "localname": "NineteenSeventyThreeMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenSeventyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen seventy two.", "label": "Nineteen Seventy Two [Member]", "terseLabel": "1972 [Member]" } } }, "localname": "NineteenSeventyTwoMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenSixtyEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen sixty eight.", "label": "Nineteen Sixty Eight [Member]", "terseLabel": "1978 [Member]" } } }, "localname": "NineteenSixtyEightMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenSixtyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen sixty five.", "label": "Nineteen Sixty Five [Member]", "terseLabel": "1965 [Member]" } } }, "localname": "NineteenSixtyFiveMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenSixtyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen sixty four.", "label": "Nineteen Sixty Four [Member]", "terseLabel": "1964 [Member]" } } }, "localname": "NineteenSixtyFourMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenSixtyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen sixty.", "label": "Nineteen Sixty [Member]", "terseLabel": "1960 [Member]" } } }, "localname": "NineteenSixtyMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenSixtyNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen Sixty Nine.", "label": "Nineteen Sixty Nine [Member]", "terseLabel": "1969 [Member]" } } }, "localname": "NineteenSixtyNineMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenSixtySevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen sixty seven.", "label": "Nineteen Sixty Seven [Member]", "terseLabel": "1967 [Member]" } } }, "localname": "NineteenSixtySevenMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenSixtySixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen sixty six.", "label": "Nineteen Sixty Six [Member]", "terseLabel": "1966 [Member]" } } }, "localname": "NineteenSixtySixMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenSixtyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen sixty two.", "label": "Nineteen Sixty Two [Member]", "terseLabel": "1962 [Member]" } } }, "localname": "NineteenSixtyTwoMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenThirteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen thirteen.", "label": "Nineteen Thirteen [Member]", "terseLabel": "1913 [Member]" } } }, "localname": "NineteenThirteenMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenThirtyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "1935 [Member]", "label": "Nineteen Thirty Five [Member]", "terseLabel": "1935 [Member]" } } }, "localname": "NineteenThirtyFiveMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenThirtyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen thirty.", "label": "Nineteen Thirty [Member]", "terseLabel": "1930 [Member]" } } }, "localname": "NineteenThirtyMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenTwentyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen twenty five.", "label": "Nineteen Twenty Five [Member]", "terseLabel": "1925 [Member]" } } }, "localname": "NineteenTwentyFiveMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenTwentyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen twenty four.", "label": "Nineteen Twenty Four [Member]", "terseLabel": "1924 [Member]" } } }, "localname": "NineteenTwentyFourMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenTwentyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen twenty.", "label": "Nineteen Twenty [Member]", "terseLabel": "1920 [Member]" } } }, "localname": "NineteenTwentyMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenTwentyNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen twenty nine.", "label": "Nineteen Twenty Nine [Member]", "terseLabel": "1929 [Member]" } } }, "localname": "NineteenTwentyNineMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenTwentySevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen Twenty Seven.", "label": "Nineteen Twenty Seven [Member]", "terseLabel": "1997 [Member]" } } }, "localname": "NineteenTwentySevenMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenTwentySixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen twenty six.", "label": "Nineteen Twenty Six [Member]", "terseLabel": "1926 [Member]" } } }, "localname": "NineteenTwentySixMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen Twenty Two.", "label": "Nineteen Twenty Two [Member]", "terseLabel": "1922 [Member]" } } }, "localname": "NineteenTwentyTwoMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenZeroOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen zero one.", "label": "Nineteen Zero One [Member]", "terseLabel": "1901 [Member]", "verboseLabel": "1901 [Member]" } } }, "localname": "NineteenZeroOneMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenZeroSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen zero six.", "label": "Nineteen Zero Six [Member]", "terseLabel": "1906 [Member]" } } }, "localname": "NineteenZeroSixMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NineteenZeroZeroMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nineteen zero zero.", "label": "Nineteen Zero Zero [Member]", "terseLabel": "1900 [Member]" } } }, "localname": "NineteenZeroZeroMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NonCashActivitiesRightOfUseAssetsObtainedInExchangeForLeaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non-cash activities right of use assets obtained in exchange for lease.", "label": "Non Cash Activities Right Of Use Assets Obtained In Exchange For Lease [Abstract]", "terseLabel": "Non-cash activities - Right-of-use assets obtained in exchange for lease obligations:" } } }, "localname": "NonCashActivitiesRightOfUseAssetsObtainedInExchangeForLeaseAbstract", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalCashFlowInformationDetail" ], "xbrltype": "stringItemType" }, "mpw_NonCashRent": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Non cash rent.", "label": "Non Cash Rent", "terseLabel": "Non-cash rent" } } }, "localname": "NonCashRent", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mpw_NonrecourseSecuredDebtPercentageOfAssetValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nonrecourse secured debt percentage of asset value.", "label": "Nonrecourse Secured Debt Percentage Of Asset Value", "terseLabel": "Nonrecourse secured debt percentage of asset value" } } }, "localname": "NonrecourseSecuredDebtPercentageOfAssetValue", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_NorthlandMOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Northland, MO.", "label": "Northland M O [Member]", "terseLabel": "Northland, MO [Member]" } } }, "localname": "NorthlandMOMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NorwalkCAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Norwalk, CA.", "label": "Norwalk C A [Member]", "terseLabel": "Norwalk, CA [Member]" } } }, "localname": "NorwalkCAMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NorwoodMAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Norwood, MA.", "label": "Norwood M A [Member]", "terseLabel": "Norwood, MA [Member]" } } }, "localname": "NorwoodMAMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NottinghamUnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nottingham United Kingdom.", "label": "Nottingham United Kingdom [Member]", "terseLabel": "Nottingham, UK [Member]" } } }, "localname": "NottinghamUnitedKingdomMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NottinghamUnitedKingdomOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nottingham, UK.", "label": "Nottingham United Kingdom One [Member]", "terseLabel": "Nottingham, UK [Member]" } } }, "localname": "NottinghamUnitedKingdomOneMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NottinghamUnitedKingdomTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nottingham, UK.", "label": "Nottingham United Kingdom Two [Member]", "terseLabel": "Nottingham, UK [Member]" } } }, "localname": "NottinghamUnitedKingdomTwoMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_NumberOfAdditionalLeasedProperties": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of additional leased properties.", "label": "Number Of Additional Leased Properties", "terseLabel": "Number of additional leased properties" } } }, "localname": "NumberOfAdditionalLeasedProperties", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "mpw_NumberOfAncillaryPropertiesSold": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of ancillary properties sold.", "label": "Number Of Ancillary Properties Sold", "terseLabel": "Number of ancillary properties sold" } } }, "localname": "NumberOfAncillaryPropertiesSold", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDisposalsAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "mpw_NumberOfDevelopmentOfNewProjects": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of development of new projects.", "label": "Number Of Development Of New Projects", "terseLabel": "Number of development of new projects" } } }, "localname": "NumberOfDevelopmentOfNewProjects", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "mpw_NumberOfDirectFinancingLeases": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of direct financing leases.", "label": "Number Of Direct Financing Leases", "terseLabel": "Number of direct financing leases" } } }, "localname": "NumberOfDirectFinancingLeases", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "mpw_NumberOfFacilities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of facilities.", "label": "Number Of Facilities", "terseLabel": "Number of facilities" } } }, "localname": "NumberOfFacilities", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "mpw_NumberOfFacilitiesSold": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of facilities sold.", "label": "Number Of Facilities Sold", "terseLabel": "Number of facilities sold" } } }, "localname": "NumberOfFacilitiesSold", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDisposalsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherDisposalTransactionsAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "mpw_NumberOfFinancingLeases": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of financing leases.", "label": "Number Of Financing Leases", "terseLabel": "Number of financing leases" } } }, "localname": "NumberOfFinancingLeases", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "mpw_NumberOfHospitalsSold": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of hospitals sold.", "label": "Number Of Hospitals Sold", "terseLabel": "Number of hospitals sold" } } }, "localname": "NumberOfHospitalsSold", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherDisposalTransactionsAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "mpw_NumberOfLeaseExtensionOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of lease extension options.", "label": "Number Of Lease Extension Options", "terseLabel": "Number of lease extension options" } } }, "localname": "NumberOfLeaseExtensionOptions", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "mpw_NumberOfLeasedFacilities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of leased facilities.", "label": "Number Of Leased Facilities", "terseLabel": "Number of leased facilities" } } }, "localname": "NumberOfLeasedFacilities", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "mpw_NumberOfLeasedProperties": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of leased properties.", "label": "Number Of Leased Properties", "terseLabel": "Number of leased properties" } } }, "localname": "NumberOfLeasedProperties", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "mpw_NumberOfLessorProperties": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of lessor properties.", "label": "Number Of Lessor Properties", "terseLabel": "Number of properties" } } }, "localname": "NumberOfLessorProperties", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "mpw_NumberOfOperationsSold": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of operations sold.", "label": "Number Of Operations Sold", "terseLabel": "Number of operations sold" } } }, "localname": "NumberOfOperationsSold", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherDisposalTransactionsAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "mpw_NumberOfOperators": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of operators.", "label": "Number Of Operators", "terseLabel": "Number of operators" } } }, "localname": "NumberOfOperators", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "mpw_NumberOfProperties": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Properties", "label": "Number Of Properties", "terseLabel": "Number of properties" } } }, "localname": "NumberOfProperties", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateParentheticalDetail" ], "xbrltype": "integerItemType" }, "mpw_NumberOfPropertiesSold": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of properties sold.", "label": "Number Of Properties Sold", "terseLabel": "Number of properties sold" } } }, "localname": "NumberOfPropertiesSold", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDisposalsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherDisposalTransactionsAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "mpw_NumberOfPropertiesSoldAssociatedWithFinancingLeases": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of properties sold associated with financing leases.", "label": "Number Of Properties Sold Associated With Financing Leases", "terseLabel": "Number of properties sold associated with financing leases" } } }, "localname": "NumberOfPropertiesSoldAssociatedWithFinancingLeases", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "mpw_NumberOfPropertiesVacant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of properties vacant.", "label": "Number of Properties Vacant", "terseLabel": "Number of properties vacant" } } }, "localname": "NumberOfPropertiesVacant", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "mpw_NumberOfReLeasedProperties": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of re-leased properties.", "label": "Number Of Re Leased Properties", "terseLabel": "Number of re-leased properties" } } }, "localname": "NumberOfReLeasedProperties", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "mpw_ObligationsToTenantsAndOtherLeaseLiabilities": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Obligations to tenants and other lease liabilities.", "label": "Obligations To Tenants And Other Lease Liabilities", "terseLabel": "Obligations to tenants and other lease liabilities" } } }, "localname": "ObligationsToTenantsAndOtherLeaseLiabilities", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "mpw_OdessaTexasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Odessa Texas.", "label": "Odessa Texas [Member]", "terseLabel": "Odessa, TX [Member]" } } }, "localname": "OdessaTexasMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_OgdenUtahMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ogden Utah.", "label": "Ogden Utah [Member]", "terseLabel": "Ogden, UT [Member]" } } }, "localname": "OgdenUtahMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_OklahomaCityOKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Oklahoma City, OK.", "label": "Oklahoma City O K [Member]", "terseLabel": "Oklahoma City, OK [Member]" } } }, "localname": "OklahomaCityOKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_OlatheKansasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Olathe, Kansas.", "label": "Olathe Kansas [Member]", "terseLabel": "Olathe, KS [Member]" } } }, "localname": "OlatheKansasMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_OnCampusMedicalOfficeBuildingsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "On campus medical office buildings.", "label": "On Campus Medical Office Buildings [Member]", "terseLabel": "On Campus Medical Office Buildings [Member]" } } }, "localname": "OnCampusMedicalOfficeBuildingsMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_OperatingAndFinanceLeaseLiability": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating and finance lease liability.", "label": "Operating And Finance Lease Liability", "totalLabel": "Total lease liabilities" } } }, "localname": "OperatingAndFinanceLeaseLiability", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "xbrltype": "monetaryItemType" }, "mpw_OperatingLeasesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating Leases [Member]", "label": "Operating Leases [Member]", "terseLabel": "Operating Leases [Member]" } } }, "localname": "OperatingLeasesMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail" ], "xbrltype": "domainItemType" }, "mpw_OperatingLossCarryforwardsExpirationYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating loss carryforwards, expiration year.", "label": "Operating Loss Carryforwards Expiration Year", "terseLabel": "Expiration periods" } } }, "localname": "OperatingLossCarryforwardsExpirationYear", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfNetNOLAndOtherTaxAttributeCarryforwardsDetail" ], "xbrltype": "gYearItemType" }, "mpw_OperatingPartnershipMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating partnership.", "label": "Operating Partnership [Member]", "terseLabel": "Operating Partnership [Member]" } } }, "localname": "OperatingPartnershipMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_OperatorConcentrationRiskMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operator concentration risk.", "label": "Operator Concentration Risk [Member]", "terseLabel": "Operator Concentration Risk [Member]" } } }, "localname": "OperatorConcentrationRiskMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_OrdinaryDividendPerShare": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfPerShareDistributionsToStockholdersDetail": { "order": 0.0, "parentTag": "us-gaap_CommonStockDividendsPerShareCashPaid", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Ordinary dividend per share.", "label": "Ordinary Dividend Per Share", "terseLabel": "Ordinary dividend" } } }, "localname": "OrdinaryDividendPerShare", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfPerShareDistributionsToStockholdersDetail" ], "xbrltype": "perShareItemType" }, "mpw_OrpingtonUnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Orpington United Kingdom.", "label": "Orpington United Kingdom [Member]", "terseLabel": "Orpington, UK [Member]" } } }, "localname": "OrpingtonUnitedKingdomMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesNetOfTax": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other comprehensive income unrealized gain (loss) on derivatives net of tax.", "label": "Other Comprehensive Income Unrealized Gain Loss On Derivatives Net Of Tax", "terseLabel": "Unrealized gain (loss) on interest rate swaps, net of tax", "verboseLabel": "Unrealized gain (loss) on interest rate swaps, net of tax" } } }, "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesNetOfTax", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveIncome", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "xbrltype": "monetaryItemType" }, "mpw_OtherCorporateAssets": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureOtherAssetsSummaryOfOtherAssetsOnOurCondensedConsolidatedBalanceSheetsDetail": { "order": 1.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other corporate assets include leasehold improvements associated with our corporate office space, furniture and fixtures, equipment, software, deposits, etc.", "label": "Other Corporate Assets", "terseLabel": "Other corporate assets" } } }, "localname": "OtherCorporateAssets", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureOtherAssetsSummaryOfOtherAssetsOnOurCondensedConsolidatedBalanceSheetsDetail" ], "xbrltype": "monetaryItemType" }, "mpw_OtherFinancingLeasesNetOfAllowanceForCreditLoss": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail": { "order": 1.0, "parentTag": "us-gaap_NetInvestmentInLease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other financing leases, net of allowance for credit loss.", "label": "Other Financing Leases Net Of Allowance For Credit Loss", "terseLabel": "Other financing leases (net of allowance for credit loss)" } } }, "localname": "OtherFinancingLeasesNetOfAllowanceForCreditLoss", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail" ], "xbrltype": "monetaryItemType" }, "mpw_OtherLoan": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other loan.", "label": "Other Loan", "terseLabel": "Other loan to affiliates", "verboseLabel": "Other loan to affiliates" } } }, "localname": "OtherLoan", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mpw_OtherLoansAndAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other loans and assets.", "label": "Other Loans And Assets [Member]", "terseLabel": "Other Loans and Assets [Member]" } } }, "localname": "OtherLoansAndAssetsMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "xbrltype": "domainItemType" }, "mpw_OtherLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Loans", "label": "Other Loans [Member]", "terseLabel": "Other Loans [Member]" } } }, "localname": "OtherLoansMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_OtherMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other.", "label": "Other [Member]", "terseLabel": "Other [Member]" } } }, "localname": "OtherMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail" ], "xbrltype": "domainItemType" }, "mpw_OttumwaIAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ottumwa, IA.", "label": "Ottumwa I A [Member]", "terseLabel": "Ottumwa, IA [Member]" } } }, "localname": "OttumwaIAMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_OuluFinlandMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Oulu, Finland.", "label": "Oulu, Finland [Member]" } } }, "localname": "OuluFinlandMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_OverlandParkKansasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Overland park, Kansas.", "label": "Overland Park Kansas [Member]", "terseLabel": "Overland Park, KS [Member]" } } }, "localname": "OverlandParkKansasMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_OverlookTXMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Overlook, TX", "label": "Overlook T X [Member]", "terseLabel": "Overlook, TX [Member]" } } }, "localname": "OverlookTXMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_PalestineTexasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Palestine, Texas.", "label": "Palestine Texas [Member]", "terseLabel": "Palestine, TX [Member]" } } }, "localname": "PalestineTexasMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_ParkerCOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Parker, CO.", "label": "Parker C O [Member]", "terseLabel": "Parker, CO [Member]" } } }, "localname": "ParkerCOMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_PascoWashingtonMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pasco, Washington.", "label": "Pasco Washington [Member]", "terseLabel": "Pasco, WA [Member]" } } }, "localname": "PascoWashingtonMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_PayableDueToParentCompany": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payable due to parent company", "label": "Payable Due To Parent Company", "terseLabel": "Payable due to Medical Properties Trust, Inc.", "verboseLabel": "Payable due to Medical Properties Trust, Inc." } } }, "localname": "PayableDueToParentCompany", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "mpw_PaymentsForCapitalAdditionsAndOtherInvestmentsNet": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments for capital additions and other investments net.", "label": "Payments For Capital Additions And Other Investments Net", "negatedLabel": "Capital additions and other investments, net" } } }, "localname": "PaymentsForCapitalAdditionsAndOtherInvestmentsNet", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "mpw_PaymentsForProceedsFromLeaseDepositsAndOtherObligationsToTenants": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments for proceeds from lease deposits and other obligations to tenants.", "label": "Payments For Proceeds From Lease Deposits And Other Obligations To Tenants", "negatedLabel": "Lease deposits and other obligations to tenants" } } }, "localname": "PaymentsForProceedsFromLeaseDepositsAndOtherObligationsToTenants", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "mpw_PearlandTXMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pearland, TX.", "label": "Pearland T X [Member]", "terseLabel": "Pearland, TX [Member]" } } }, "localname": "PearlandTXMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_PercentageOfAnnuallyOperatingLease": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of annually operating lease.", "label": "Percentage of Annually Operating Lease", "terseLabel": "Percentage of annually operating lease" } } }, "localname": "PercentageOfAnnuallyOperatingLease", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_PercentageOfDeferedRentReceivable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of defered rent receivable.", "label": "Percentage of Defered Rent Receivable", "terseLabel": "Percentage of defered rent" } } }, "localname": "PercentageOfDeferedRentReceivable", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_PercentageOfDiscountOnInvestment": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of discount on investment.", "label": "Percentage of Discount on Investment", "terseLabel": "Percentage of discount on investment" } } }, "localname": "PercentageOfDiscountOnInvestment", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_PercentageOfDividendsPayableOnBasisOfAdjustedOperatingFunds": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of dividends payable on basis of adjusted operating funds.", "label": "Percentage Of Dividends Payable On Basis Of Adjusted Operating Funds", "terseLabel": "Percentage of dividends which could be paid from adjusted operating funds" } } }, "localname": "PercentageOfDividendsPayableOnBasisOfAdjustedOperatingFunds", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCovenantsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_PercentageOfDividendsPayableOnSeniorUnsecuredNotes": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of dividends payable on senior unsecured notes.", "label": "Percentage Of Dividends Payable On Senior Unsecured Notes", "terseLabel": "Percentage of dividends which could be paid from operation funds" } } }, "localname": "PercentageOfDividendsPayableOnSeniorUnsecuredNotes", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCovenantsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_PercentageOfLeaseInitialCashYield": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of lease initial cash yield.", "label": "Percentage of Lease Initial Cash Yield", "terseLabel": "Percentage of initial cash yield" } } }, "localname": "PercentageOfLeaseInitialCashYield", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_PercentageOfLeasedAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of leased assets.", "label": "Percentage Of Leased Assets", "terseLabel": "Percentage of total assets" } } }, "localname": "PercentageOfLeasedAssets", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_PercentageOfOrdinaryTaxableIncomeToBeDistributedForRealEstateInvestmentTrustQualification": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of ordinary taxable income to be distributed for REIT qualification.", "label": "Percentage Of Ordinary Taxable Income To Be Distributed For Real Estate Investment Trust Qualification", "terseLabel": "Percentage of ordinary taxable income to be distributed for real estate investment trust qualification" } } }, "localname": "PercentageOfOrdinaryTaxableIncomeToBeDistributedForRealEstateInvestmentTrustQualification", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_PercentageOfPropertiesOccupiedByTenants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of properties occupied by tenants.", "label": "Percentage of Properties Occupied By Tenants", "terseLabel": "Percentage of properties occupied by tenants" } } }, "localname": "PercentageOfPropertiesOccupiedByTenants", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_PercentageOfTaxableIncomeToBeDistributedForFederalIncomeTaxExemption": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of taxable income to be distributed for federal income tax exemption.", "label": "Percentage Of Taxable Income To Be Distributed For Federal Income Tax Exemption", "terseLabel": "Percentage of taxable income to be distributed for federal income tax assumption" } } }, "localname": "PercentageOfTaxableIncomeToBeDistributedForFederalIncomeTaxExemption", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_PercentageOfVacantOnLeasedProperty": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of vacant on leased property.", "label": "Percentage Of Vacant On Leased Property", "terseLabel": "Percentage of vacant on leased property" } } }, "localname": "PercentageOfVacantOnLeasedProperty", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_PerthAustraliaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Perth, Australia.", "label": "Perth Australia [Member]", "terseLabel": "Perth, Australia [Member]" } } }, "localname": "PerthAustraliaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_PetersburgVAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Petersburg, VA.", "label": "Petersburg V A [Member]", "terseLabel": "Petersburg, VA [Member]" } } }, "localname": "PetersburgVAMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_PhoenixAZMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Phoenix, AZ.", "label": "Phoenix A Z [Member]", "terseLabel": "Phoenix, AZ [Member]" } } }, "localname": "PhoenixAZMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_PhoenixAZOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Phoenix, AZ one.", "label": "Phoenix A Z One [Member]", "terseLabel": "Phoenix, AZ [Member]" } } }, "localname": "PhoenixAZOneMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_PipelineHealthSystemMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pipeline health system.", "label": "Pipeline Health System [Member]", "terseLabel": "Pipeline Health System [Member]" } } }, "localname": "PipelineHealthSystemMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_PlanoTXMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plano, TX.", "label": "Plano T X [Member]", "terseLabel": "Plano, TX [Member]" } } }, "localname": "PlanoTXMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_PoliclinicoDiMonzaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Policlinico di Monza.", "label": "Policlinico di Monza [Member]", "terseLabel": "Policlinico di Monza [Member]" } } }, "localname": "PoliclinicoDiMonzaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails" ], "xbrltype": "domainItemType" }, "mpw_PooleUnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Poole United Kingdom.", "label": "Poole United Kingdom [Member]", "terseLabel": "Poole, UK [Member]", "verboseLabel": "Poole, England [Member]" } } }, "localname": "PooleUnitedKingdomMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_PoplarBluffMissouriMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Poplar Bluff, Missouri.", "label": "Poplar Bluff Missouri [Member]", "terseLabel": "Poplar Bluff, MO [Member]" } } }, "localname": "PoplarBluffMissouriMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_PortArthurTXMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Port Arthur, TX.", "label": "Port Arthur T X [Member]", "terseLabel": "Port Arthur, TX [Member]" } } }, "localname": "PortArthurTXMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_PortHuronMIMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Port Huron MI.", "label": "Port Huron M I [Member]", "terseLabel": "Port Huron, MI" } } }, "localname": "PortHuronMIMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_PositiveHundredBasisPointsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Positive Hundred Basis Points.", "label": "Positive Hundred Basis Points [Member]", "terseLabel": "+ 100 Basis Points [Member]" } } }, "localname": "PositiveHundredBasisPointsMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDLOMBySensitivityAnalysisByUsingBasisPointVariationsDetail" ], "xbrltype": "domainItemType" }, "mpw_PostFallsIdahoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Post Falls Idaho.", "label": "Post Falls Idaho [Member]", "terseLabel": "Post Falls Idaho" } } }, "localname": "PostFallsIdahoMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_PreAcquisitionRentCollectedCircleTransaction": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Pre acquisition rent collected circle transaction.", "label": "Pre Acquisition Rent Collected Circle Transaction", "negatedLabel": "Pre-acquisition rent collected - Circle Transaction" } } }, "localname": "PreAcquisitionRentCollectedCircleTransaction", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "mpw_PrestonUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preston UK.", "label": "Preston U K [Member]", "terseLabel": "Preston, UK [Member]" } } }, "localname": "PrestonUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_PrimeFacilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prime facilities.", "label": "Prime Facilities [Member]", "terseLabel": "Prime Facilities [Member]" } } }, "localname": "PrimeFacilitiesMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_PrimeHealthCareServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prime Health Care Services.", "label": "Prime Health Care Services [Member]", "terseLabel": "Prime [Member]" } } }, "localname": "PrimeHealthCareServicesMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDisposalsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_PrimeHealthcareServicesIncFacilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prime Healthcare Services, Inc. facilities.", "label": "Prime Healthcare Services, Inc. Facilities [Member]", "terseLabel": "Prime Healthcare Services, Inc. Facilities [Member]" } } }, "localname": "PrimeHealthcareServicesIncFacilitiesMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDisposalsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_PrimotopHoldingsSARLMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primotop holdings s.a.r.l.", "label": "Primotop Holdings S A R L [Member]", "terseLabel": "Primotop Holdings S.a.r.l. [Member]" } } }, "localname": "PrimotopHoldingsSARLMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_PrincesRisboroughUnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Princes Risborough United Kingdom.", "label": "Princes Risborough United Kingdom [Member]", "terseLabel": "Princes Risborough, UK [Member]" } } }, "localname": "PrincesRisboroughUnitedKingdomMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_PrioryGroupMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Priory Group.", "label": "Priory Group [Member]", "terseLabel": "Priory Group [Member]", "verboseLabel": "Priory [Member]" } } }, "localname": "PrioryGroupMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "xbrltype": "domainItemType" }, "mpw_PrivateAcuteCareHospitalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private acute care hospital.", "label": "Private Acute Care Hospital [Member]", "terseLabel": "Private Acute Care Hospital [Member]" } } }, "localname": "PrivateAcuteCareHospitalMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_PropertyIncludingHeldForSaleMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Property including held for sale.", "label": "Property Including Held For Sale [Member]", "terseLabel": "Property Including Held for Sale [Member]" } } }, "localname": "PropertyIncludingHeldForSaleMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_PropertyRelatedExpensesAndWriteOffStraightLineRent": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails": { "order": 3.0, "parentTag": "mpw_GainLossOnDispositionOfRealEstate", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Property-related Expenses and Write-off Straight Line Rent", "label": "Property-related Expenses and Write-off Straight Line Rent", "terseLabel": "Property-related expenses" } } }, "localname": "PropertyRelatedExpensesAndWriteOffStraightLineRent", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails" ], "xbrltype": "monetaryItemType" }, "mpw_PropertyRelatedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Property related.", "label": "Property Related [Member]", "terseLabel": "Property-related [Member]" } } }, "localname": "PropertyRelatedMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseParentheticalDetail" ], "xbrltype": "domainItemType" }, "mpw_ProspectMedicalHoldingsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prospect Medical Holdings Inc.", "label": "Prospect Medical Holdings Inc [Member]", "terseLabel": "Prospect [Member]" } } }, "localname": "ProspectMedicalHoldingsIncMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_ProspectMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prospect.", "label": "Prospect [Member]", "terseLabel": "Prospect [Member]" } } }, "localname": "ProspectMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail" ], "xbrltype": "domainItemType" }, "mpw_PublicOfferingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Public\u200b offering.\u200b", "label": "Public Offering [Member]", "terseLabel": "Public Offering [Member]" } } }, "localname": "PublicOfferingMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_PurchaseOfNonControllingInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Purchase of non controlling interest.", "label": "Purchase Of Non Controlling Interest", "terseLabel": "Acquisition of non-controlling interest" } } }, "localname": "PurchaseOfNonControllingInterest", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "xbrltype": "monetaryItemType" }, "mpw_QualifiedBusinessIncomeDeductionDividendsPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Qualified business income deduction dividends per share.", "label": "Qualified Business Income Deduction Dividends Per Share", "terseLabel": "Section 199A Dividends" } } }, "localname": "QualifiedBusinessIncomeDeductionDividendsPerShare", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureIncomeTaxesScheduleOfPerShareDistributionsToStockholdersParentheticalDetails" ], "xbrltype": "perShareItemType" }, "mpw_RaleighNCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Raleigh, NC.", "label": "Raleigh N C [Member]", "terseLabel": "Raleigh, NC [Member]" } } }, "localname": "RaleighNCMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_ReadingUnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reading, United Kingdom.", "label": "Reading United Kingdom [Member]", "terseLabel": "Reading, United Kingdom [Member]" } } }, "localname": "ReadingUnitedKingdomMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_RealEstateAccumulatedDepreciationCapitalExpendituresAndTransfersFromConstructionInProgress": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Real estate accumulated depreciation capital expenditures and transfers from construction in progress.", "label": "Real Estate Accumulated Depreciation Capital Expenditures And Transfers From Construction In Progress", "terseLabel": "Transfers from construction in progress" } } }, "localname": "RealEstateAccumulatedDepreciationCapitalExpendituresAndTransfersFromConstructionInProgress", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIChangesInTotalRealEstateAssetsDetail" ], "xbrltype": "monetaryItemType" }, "mpw_RealEstateAccumulatedDepreciationForeignCurrencyTranslationDifference": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Real estate accumulated depreciation, foreign currency translation difference.", "label": "Real Estate Accumulated Depreciation Foreign Currency Translation Difference", "negatedLabel": "Other" } } }, "localname": "RealEstateAccumulatedDepreciationForeignCurrencyTranslationDifference", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIChangesInAccumulatedDepreciationDetail" ], "xbrltype": "monetaryItemType" }, "mpw_RealEstateAcquisitions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Real estate acquisitions.", "label": "Real Estate Acquisitions", "terseLabel": "Acquisitions" } } }, "localname": "RealEstateAcquisitions", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIChangesInTotalRealEstateAssetsDetail" ], "xbrltype": "monetaryItemType" }, "mpw_RealEstateAdditions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Real estate additions.", "label": "Real Estate Additions", "terseLabel": "Additions" } } }, "localname": "RealEstateAdditions", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIChangesInTotalRealEstateAssetsDetail" ], "xbrltype": "monetaryItemType" }, "mpw_RealEstateAndAccumulatedDepreciationCostsCapitalizedSubsequentToAcquisitionCarryingCostsAdjustments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "SEC Schedule III, Real estate and accumulated depreciation, costs capitalized subsequent to acquisition, carrying costs including adjustments.", "label": "Real Estate And Accumulated Depreciation Costs Capitalized Subsequent To Acquisition Carrying Costs Adjustments", "terseLabel": "Additions subsequent to acquisition, carrying costs" } } }, "localname": "RealEstateAndAccumulatedDepreciationCostsCapitalizedSubsequentToAcquisitionCarryingCostsAdjustments", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "monetaryItemType" }, "mpw_RealEstateAndAccumulatedDepreciationCostsCapitalizedSubsequentToAcquisitionImpairmentAdjustments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "SEC Schedule III, Real Estate and Accumulated Depreciation, Costs Capitalized Subsequent to Acquisition, Impairment Adjustments", "label": "Real Estate And Accumulated Depreciation Costs Capitalized Subsequent To Acquisition Impairment Adjustments", "terseLabel": "Additions subsequent to acquisition, Improvements" } } }, "localname": "RealEstateAndAccumulatedDepreciationCostsCapitalizedSubsequentToAcquisitionImpairmentAdjustments", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "monetaryItemType" }, "mpw_RealEstateAndAccumulatedDepreciationPropertyDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Real Estate And Accumulated Depreciation Property Description", "label": "Real Estate And Accumulated Depreciation Property Description", "terseLabel": "Type of property" } } }, "localname": "RealEstateAndAccumulatedDepreciationPropertyDescription", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "stringItemType" }, "mpw_RealEstateAndAccumulatedDepreciationYearOfConstruction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Real Estate And Accumulated Depreciation Year Of Construction", "label": "Real Estate And Accumulated Depreciation Year Of Construction", "terseLabel": "Date of Construction" } } }, "localname": "RealEstateAndAccumulatedDepreciationYearOfConstruction", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "gYearItemType" }, "mpw_RealEstateAndDepreciationPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Real estate and depreciation.", "label": "Real Estate And Depreciation Policy [Text Block]", "terseLabel": "Real Estate and Depreciation" } } }, "localname": "RealEstateAndDepreciationPolicyTextBlock", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "mpw_RealEstateAndOtherImpairmentCharges": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Real estate and other impairment charges.", "label": "Real Estate And Other Impairment Charges", "negatedLabel": "Real estate and other impairment charges, net", "terseLabel": "Real estate and other impairment charges" } } }, "localname": "RealEstateAndOtherImpairmentCharges", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "monetaryItemType" }, "mpw_RealEstateAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Real Estate Assets [Abstract]", "label": "Real Estate Assets [Abstract]", "terseLabel": "Real estate assets" } } }, "localname": "RealEstateAssetsAbstract", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "mpw_RealEstateAssetsAccumulatedAmortization": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "mpw_NetInvestmentInRealEstateAssets", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Real estate assets accumulated amortization.", "label": "Real Estate Assets Accumulated Amortization", "negatedLabel": "Accumulated amortization" } } }, "localname": "RealEstateAssetsAccumulatedAmortization", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "mpw_RealEstateAssetsAccumulatedDepreciation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Real estate assets accumulated depreciation.", "label": "Real Estate Assets Accumulated Depreciation", "periodEndLabel": "Balance at end of period", "periodStartLabel": "Balance at beginning of period" } } }, "localname": "RealEstateAssetsAccumulatedDepreciation", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIChangesInAccumulatedDepreciationDetail" ], "xbrltype": "monetaryItemType" }, "mpw_RealEstateDepreciationAndAmortizationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Real estate depreciation and amortization.", "label": "Real Estate Depreciation And Amortization [Member]", "terseLabel": "Real Estate Depreciation and Amortization [Member]" } } }, "localname": "RealEstateDepreciationAndAmortizationMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail" ], "xbrltype": "domainItemType" }, "mpw_RealEstateFinancingByThirdPartySeller": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Real estate financing by third party seller.", "label": "Real Estate Financing By Third Party Seller", "terseLabel": "Real estate financing by third party seller" } } }, "localname": "RealEstateFinancingByThirdPartySeller", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mpw_RealEstateHeldForSaleAccumulatedDepreciation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Real estate held for sale accumulated depreciation.", "label": "Real Estate Held For Sale Accumulated Depreciation", "terseLabel": "Real estate held for sale accumulated depreciation" } } }, "localname": "RealEstateHeldForSaleAccumulatedDepreciation", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIChangesInAccumulatedDepreciationParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "mpw_RealEstateHeldForSaleLandAndBuildingCost": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Real estate held for sale land and building cost.", "label": "Real Estate Held For Sale Land And Building Cost", "terseLabel": "Land and building cost" } } }, "localname": "RealEstateHeldForSaleLandAndBuildingCost", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIChangesInAccumulatedDepreciationParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "mpw_RealEstateInvestmentInNumberOfFacilities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Real estate investment in number of facilities.", "label": "Real Estate Investment In Number Of Facilities", "terseLabel": "Investment in number of facilities" } } }, "localname": "RealEstateInvestmentInNumberOfFacilities", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "mpw_RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVenturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures [Member]", "label": "Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures [Member]", "terseLabel": "Investments in Unconsolidated Real Estate Joint Ventures [Member]" } } }, "localname": "RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVenturesMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "xbrltype": "domainItemType" }, "mpw_RealEstateLeaseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Real estate lease.", "label": "Real Estate Lease [Member]", "terseLabel": "Real Estate [Member]" } } }, "localname": "RealEstateLeaseMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_RealEstatePartnershipMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Real estate partnership.", "label": "Real Estate Partnership [Member]" } } }, "localname": "RealEstatePartnershipMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_RealEstateSecuredLoan": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Real estate secured loan.", "label": "Real Estate Secured Loan", "terseLabel": "Secured loan amount" } } }, "localname": "RealEstateSecuredLoan", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mpw_ReddingCaliforniaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redding, California.", "label": "Redding California [Member]", "terseLabel": "Redding, CA [Member]" } } }, "localname": "ReddingCaliforniaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_RehabilitationHospitalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rehabilitation hospital.", "label": "Rehabilitation Hospital [Member]", "terseLabel": "Rehabilitation Hospital", "verboseLabel": "Rehabilitation Facilities [Member]" } } }, "localname": "RehabilitationHospitalMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_RelatedPartyTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transactions [Member]", "label": "Related Party Transactions [Member]", "terseLabel": "Related Party Transactions [Member]" } } }, "localname": "RelatedPartyTransactionsMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_RemainingOutstandingDeferredRentToBeReceived": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Remaining outstanding deferred rent to be received.", "label": "Remaining Outstanding Deferred Rent To Be Received", "terseLabel": "Remaining outstanding deferred rent to be received" } } }, "localname": "RemainingOutstandingDeferredRentToBeReceived", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesRentDeferralsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mpw_RemscheidGermanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Remscheid, Germany,", "label": "Remscheid Germany [Member]", "terseLabel": "Remscheid, Germany [Member]" } } }, "localname": "RemscheidGermanyMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_RentBilled": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "order": 0.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Rent billed", "label": "Rent Billed", "terseLabel": "Rent billed" } } }, "localname": "RentBilled", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "monetaryItemType" }, "mpw_ReturnOfCapitalPerShare": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfPerShareDistributionsToStockholdersDetail": { "order": 2.0, "parentTag": "us-gaap_CommonStockDividendsPerShareCashPaid", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Return of capital per share", "label": "Return Of Capital Per Share", "terseLabel": "Return of capital" } } }, "localname": "ReturnOfCapitalPerShare", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfPerShareDistributionsToStockholdersDetail" ], "xbrltype": "perShareItemType" }, "mpw_RichmondTXMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Richmond, TX.", "label": "Richmond T X [Member]", "terseLabel": "Richmond, TX [Member]" } } }, "localname": "RichmondTXMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_RichmondVirginiaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Richmond, Virginia.", "label": "Richmond Virginia [Member]", "terseLabel": "Richmond, VA [Member]" } } }, "localname": "RichmondVirginiaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_RightOfUseAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right of use assets.", "label": "Right Of Use Assets [Abstract]", "terseLabel": "Right of use assets:" } } }, "localname": "RightOfUseAssetsAbstract", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "xbrltype": "stringItemType" }, "mpw_RingwoodAustraliaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ringwood, Australia.", "label": "Ringwood Australia [Member]", "terseLabel": "Ringwood, Australia [Member]" } } }, "localname": "RingwoodAustraliaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_RivertonWyomingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Riverton, Wyoming.", "label": "Riverton Wyoming [Member]", "terseLabel": "Riverton, WY [Member]" } } }, "localname": "RivertonWyomingMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_RoaringSpringsPAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Roaring Springs, PA.", "label": "Roaring Springs P A [Member]", "terseLabel": "Roaring Springs, PA [Member]" } } }, "localname": "RoaringSpringsPAMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_RochdaleMAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rochdale, MA.", "label": "Rochdale M A [Member]", "terseLabel": "Rochdale, MA [Member]" } } }, "localname": "RochdaleMAMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_RochdaleMassachusettsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rochdale, Massachusetts.", "label": "Rochdale Massachusetts [Member]", "terseLabel": "Rochdale, MA [Member]" } } }, "localname": "RochdaleMassachusettsMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_RochdaleUnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rochdale, UK.", "label": "Rochdale United Kingdom [Member]", "terseLabel": "Rochdale, UK [Member]" } } }, "localname": "RochdaleUnitedKingdomMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_RockledgeFLMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rockledge, FL.", "label": "Rockledge F L [Member]", "terseLabel": "Rockledge, FL [Member]" } } }, "localname": "RockledgeFLMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_RoelandParkKansasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Roeland Park, Kansas.", "label": "Roeland Park Kansas [Member]", "terseLabel": "Roeland Park, KS [Member]" } } }, "localname": "RoelandParkKansasMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_RomfordUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Romford, UK.", "label": "Romford U K [Member]", "terseLabel": "Romford, UK [Member]" } } }, "localname": "RomfordUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_RosenbergTexasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rosenberg Texas.", "label": "Rosenberg Texas [Member]", "terseLabel": "Rosenberg, TX [Member]" } } }, "localname": "RosenbergTexasMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_RowleyUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rowley, UK.", "label": "Rowley U K [Member]", "terseLabel": "Rowley, UK [Member]" } } }, "localname": "RowleyUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_RoystonUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Royston, UK.", "label": "Royston U K [Member]", "terseLabel": "Royston, UK [Member]" } } }, "localname": "RoystonUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_SaltLakeCityUTMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Salt Lake City, UT.", "label": "Salt Lake City U T [Member]", "terseLabel": "Salt Lake City, UT [Member]" } } }, "localname": "SaltLakeCityUTMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_SanAntonioTXMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "San Antonio TX.", "label": "San Antonio T X [Member]", "terseLabel": "San Antonio, TX [Member]" } } }, "localname": "SanAntonioTXMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_SanAntonioTXOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "San Antonio T X One.", "label": "San Antonio T X One [Member]", "terseLabel": "San Antonio, TX [Member]" } } }, "localname": "SanAntonioTXOneMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_SanBernardinoCAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "San Bernardino, CA.", "label": "San Bernardino C A [Member]", "terseLabel": "San Bernardino, CA [Member]" } } }, "localname": "SanBernardinoCAMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_SanDiegoCAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "San Diego, CA.", "label": "San Diego C A [Member]", "terseLabel": "San Diego, CA [Member]" } } }, "localname": "SanDiegoCAMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_SanDimasCAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "San Dimas, CA.", "label": "San Dimas C A [Member]", "terseLabel": "San Dimas, CA [member]" } } }, "localname": "SanDimasCAMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_SantaMariaDeFeiraPTMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Santa Maria de Feira PT.", "label": "Santa Maria De Feira P T [Member]", "terseLabel": "Santa Maria de Feira, PT [Member]" } } }, "localname": "SantaMariaDeFeiraPTMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_ScheduleOfDevelopmentProjectsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of development projects.", "label": "Schedule Of Development Projects Table [Text Block]", "terseLabel": "Summary of Status on Current Development Projects" } } }, "localname": "ScheduleOfDevelopmentProjectsTableTextBlock", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables" ], "xbrltype": "textBlockItemType" }, "mpw_ScheduleOfFutureMinimumRentalPaymentsForLeasesSubleaseReceivableAndNetPaymentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of future minimum rental payments for leases sublease receivable and net payments.", "label": "Schedule Of Future Minimum Rental Payments For Leases Sublease Receivable And Net Payments Table [Text Block]", "terseLabel": "Schedule Of Future Minimum Rental Payments For Leases Sublease Receivable And Net Payments" } } }, "localname": "ScheduleOfFutureMinimumRentalPaymentsForLeasesSubleaseReceivableAndNetPaymentsTableTextBlock", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeTables" ], "xbrltype": "textBlockItemType" }, "mpw_ScheduleOfJointVentureDesignatedAsHeldForSaleTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of joint venture designated as held for sale.", "label": "Schedule Of Joint Venture Designated As Held For Sale Table [Text Block]", "terseLabel": "Summary of Joint Venture Designated as Held for Sale" } } }, "localname": "ScheduleOfJointVentureDesignatedAsHeldForSaleTableTextBlock", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables" ], "xbrltype": "textBlockItemType" }, "mpw_ScheduleOfLoansReceivableTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of loans receivable.", "label": "Schedule Of Loans Receivable Table [Text Block]", "terseLabel": "Summary of Loans And Loans That Are Part Of Investments In Unconsolidated Real Estate Joint Ventures And Operating Entities (Net Of Allowance For Credit Loss)" } } }, "localname": "ScheduleOfLoansReceivableTableTextBlock", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables" ], "xbrltype": "textBlockItemType" }, "mpw_ScheduleOfPerShareDistributionsToStockholdersTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of per share distributions to stockholders.", "label": "Schedule Of Per Share Distributions To Stockholders Table [Text Block]", "terseLabel": "Schedule of Per Share Distributions to Stockholders" } } }, "localname": "ScheduleOfPerShareDistributionsToStockholdersTableTextBlock", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "mpw_ScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of supplemental balance sheet information related to leases.", "label": "Schedule Of Supplemental Balance Sheet Information Related To Leases Table [Text Block]", "terseLabel": "Summary of Supplemental Balance Sheet Information" } } }, "localname": "ScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeTables" ], "xbrltype": "textBlockItemType" }, "mpw_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of supplemental cash flow information related to leases.", "label": "Schedule Of Supplemental Cash Flow Information Related To Leases Table [Text Block]", "terseLabel": "Summary of Supplemental Cash Flow Information" } } }, "localname": "ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeTables" ], "xbrltype": "textBlockItemType" }, "mpw_ScionHealthMasterLeaseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ScionHealth master lease.", "label": "Scion Health Master Lease [Member]", "terseLabel": "ScionHealth Master Lease [Member]" } } }, "localname": "ScionHealthMasterLeaseMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_SebastianFlMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sebastian FL.", "label": "Sebastian Fl [Member]", "terseLabel": "Sebastian Fl" } } }, "localname": "SebastianFlMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_SecuredLoanPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Secured Loan Period", "label": "Secured Loan Period", "terseLabel": "Secured loan period" } } }, "localname": "SecuredLoanPeriod", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "mpw_SeniorUnsecuredTermLoanFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior unsecured term loan facility.", "label": "Senior Unsecured Term Loan Facility [Member]", "terseLabel": "Senior Unsecured Term Loan Facility [Member]" } } }, "localname": "SeniorUnsecuredTermLoanFacilityMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_ServiceBasedAwardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Service-Based Awards [Member]", "label": "Service Based Awards [Member]", "terseLabel": "Service-Based Awards [Member]" } } }, "localname": "ServiceBasedAwardsMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_SeventeenFourteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Seventeen Fourteen.", "label": "Seventeen Fourteen [Member]", "terseLabel": "1714 [Member]" } } }, "localname": "SeventeenFourteenMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_SeventeenHundredMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Seventeen hundred.", "label": "Seventeen Hundred [Member]", "terseLabel": "1700 [Member]" } } }, "localname": "SeventeenHundredMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_SeventeenNinetyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Seventeen ninety.", "label": "Seventeen Ninety [Member]", "terseLabel": "1790 [Member]" } } }, "localname": "SeventeenNinetyMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_SeventeenNinetySixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Seventeen nineteen six.", "label": "Seventeen Ninety Six [Member]", "terseLabel": "1796 [Member]" } } }, "localname": "SeventeenNinetySixMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_SeventeenSeventyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Seventeen seventy.", "label": "Seventeen Seventy [Member]", "terseLabel": "1770 [Member]" } } }, "localname": "SeventeenSeventyMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_ShareholderLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shareholder Loan.", "label": "Shareholder Loan [Member]" } } }, "localname": "ShareholderLoanMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "xbrltype": "domainItemType" }, "mpw_SharonPAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sharon PA.", "label": "Sharon P A [Member]", "terseLabel": "Sharon, PA [Member]" } } }, "localname": "SharonPAMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_ShawneeKansasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shawnee, Kansas.", "label": "Shawnee Kansas [Member]", "terseLabel": "Shawnee, KS [Member]" } } }, "localname": "ShawneeKansasMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_SheffieldUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sheffield, UK.", "label": "Sheffield U K [Member]", "terseLabel": "Sheffield, UK [Member]" } } }, "localname": "SheffieldUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_ShermanTexasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sherman, Texas.", "label": "Sherman Texas [Member]", "terseLabel": "Sherman, TX [Member]" } } }, "localname": "ShermanTexasMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_SignificantAccountingPoliciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Significant accounting policies.", "label": "Significant Accounting Policies [Line Items]", "terseLabel": "Significant Accounting Policies [Line Items]" } } }, "localname": "SignificantAccountingPoliciesLineItems", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "mpw_SignificantAccountingPoliciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Significant accounting policies.", "label": "Significant Accounting Policies [Table]", "terseLabel": "Significant Accounting Policies [Table]" } } }, "localname": "SignificantAccountingPoliciesTable", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "mpw_SixPointThreeSevenFivePercentageSeniorUnsecuredNotesDueTwoThousandTwentyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Six point three seven five percentage senior unsecured notes due two thousand twenty four.", "label": "Six Point Three Seven Five Percentage Senior Unsecured Notes Due Two Thousand Twenty Four [Member]", "terseLabel": "6.375% Senior Unsecured Notes due 2024 [Member]" } } }, "localname": "SixPointThreeSevenFivePercentageSeniorUnsecuredNotesDueTwoThousandTwentyFourMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_SouthamptonUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Southampton, UK.", "label": "Southampton U K [Member]", "terseLabel": "Southampton, UK [Member]" } } }, "localname": "SouthamptonUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_SpartaHoldcoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sparta Holdco Member", "label": "Sparta Holdco [Member]", "terseLabel": "Sparta Holdco [Member]" } } }, "localname": "SpartaHoldcoMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "mpw_SpartanburgSCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Spartanburg SC.", "label": "Spartanburg S C [Member]", "terseLabel": "Spartanburg, SC [Member]" } } }, "localname": "SpartanburgSCMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_SpringstoneHealthOpcoLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Springstone Health Opco, LLC.", "label": "Springstone Health Opco, LLC [Member]", "terseLabel": "Springstone Health Opco, LLC [Member]" } } }, "localname": "SpringstoneHealthOpcoLlcMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_SpringstoneIncAndInternationalJointVentureMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Springstone inc and international joint venture.", "label": "Springstone Inc And International Joint Venture [Member]", "terseLabel": "Springstone Inc. and International Joint Venture [Member]" } } }, "localname": "SpringstoneIncAndInternationalJointVentureMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDLOMBySensitivityAnalysisByUsingBasisPointVariationsDetail" ], "xbrltype": "domainItemType" }, "mpw_SpringstoneIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Springstone Inc.", "label": "Springstone Inc [Member]", "terseLabel": "Springstone Inc. [Member]" } } }, "localname": "SpringstoneIncMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail" ], "xbrltype": "domainItemType" }, "mpw_SpringstoneLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Springstone, LLC.", "label": "Springstone, LLC [Member]", "terseLabel": "Springstone [Member]" } } }, "localname": "SpringstoneLlcMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails" ], "xbrltype": "domainItemType" }, "mpw_SpringstoneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Springstone.", "label": "Springstone [Member]", "terseLabel": "Springstone [Member]" } } }, "localname": "SpringstoneMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_StAlbansParkAustraliaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "St. Albans Park, Australia.", "label": "St Albans Park Australia [Member]", "terseLabel": "St. Albans Park, Australia [Member]" } } }, "localname": "StAlbansParkAustraliaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_StewardEquityInterestMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Steward Equity Investment.", "label": "Steward Equity Investment [Member]", "terseLabel": "Steward Equity Investment [Member]" } } }, "localname": "StewardEquityInterestMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails" ], "xbrltype": "domainItemType" }, "mpw_StewardHealthCareSystemLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Steward Health Care System LLC.", "label": "Steward Health Care System L L C [Member]", "terseLabel": "Steward Health Care System LLC [Member]" } } }, "localname": "StewardHealthCareSystemLLCMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDisposalsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_StewardLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Steward Loan Investment.", "label": "Steward Loan Investment [Member]", "terseLabel": "Steward Loan Investment [Member]" } } }, "localname": "StewardLoanMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails" ], "xbrltype": "domainItemType" }, "mpw_StewardMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Steward.", "label": "Steward [Member]", "terseLabel": "Steward [Member]", "verboseLabel": "Steward (Macquarie Transaction) [Member]" } } }, "localname": "StewardMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_StirlingScotlandMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stirling, Scotland.", "label": "Stirling Scotland [Member]", "terseLabel": "Stirling, Scotland [Member]" } } }, "localname": "StirlingScotlandMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_StirlingUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stirling, UK.", "label": "Stirling U K [Member]", "terseLabel": "Stirling, UK [Member]" } } }, "localname": "StirlingUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_StockIssuedDuringPeriodSharesStockVestingAndAmortizationOfStockBasedCompensation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period, shares, stock vesting and amortization of stock-based compensation.", "label": "Stock Issued During Period Shares Stock Vesting And Amortization Of Stock Based Compensation", "terseLabel": "Stock (Unit) vesting and amortization of stock (unit)-based compensation (shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockVestingAndAmortizationOfStockBasedCompensation", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "xbrltype": "sharesItemType" }, "mpw_StockIssuedDuringPeriodValueStockVestingAndAmortizationOfStockBasedCompensation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during period value stock vesting and amortization of stock based compensation.", "label": "Stock Issued During Period Value Stock Vesting And Amortization Of Stock Based Compensation", "terseLabel": "Stock (Unit) vesting and amortization of stock-based compensation" } } }, "localname": "StockIssuedDuringPeriodValueStockVestingAndAmortizationOfStockBasedCompensation", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "xbrltype": "monetaryItemType" }, "mpw_StockIssuedDuringPeriodValueStockVestingSatisfactionOfTaxWithholding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during period value stock vesting satisfaction of tax withholding.", "label": "Stock Issued During Period Value Stock Vesting Satisfaction Of Tax Withholding", "terseLabel": "Stock (Unit) vesting - satisfaction of tax withholding" } } }, "localname": "StockIssuedDuringPeriodValueStockVestingSatisfactionOfTaxWithholding", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "xbrltype": "monetaryItemType" }, "mpw_StockIssuedDuringPeriodValueStockVestingSatisfactionOfTaxWithholdingShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period Value Stock Vesting Satisfaction Of Tax Withholding shares", "label": "Stock Issued During Period Value Stock Vesting Satisfaction Of Tax Withholding Shares", "terseLabel": "Stock (Unit) vesting - satisfaction of tax withholding (shares)" } } }, "localname": "StockIssuedDuringPeriodValueStockVestingSatisfactionOfTaxWithholdingShares", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "xbrltype": "sharesItemType" }, "mpw_StocktonCaliforniaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stockton, California.", "label": "Stockton California [Member]", "terseLabel": "Stockton, California [Member]" } } }, "localname": "StocktonCaliforniaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_StraightLineRentAndOtherRecoveryWriteOff": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Straight line rent and other (recovery) write off.", "label": "Straight Line Rent And Other Recovery Write Off", "terseLabel": "Straight-line rent and other write-off (recovery)" } } }, "localname": "StraightLineRentAndOtherRecoveryWriteOff", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "mpw_StraightLineRentAndOtherWriteOffNetOfTax": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Straight-line rent and other write-off net off tax.", "label": "Straight Line Rent And Other Write Off Net Of Tax", "terseLabel": "Straight-line rent and other write-off, net of tax" } } }, "localname": "StraightLineRentAndOtherWriteOffNetOfTax", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mpw_StraightLineRentReceivable": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Straight-line rent receivable", "label": "Straight Line Rent Receivable", "terseLabel": "Straight-line rent receivables" } } }, "localname": "StraightLineRentReceivable", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "mpw_StraightLineRentRevenueAndOther": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Straight-line rent revenue and other.", "label": "Straight Line Rent Revenue And Other", "negatedLabel": "Straight-line rent revenue and other" } } }, "localname": "StraightLineRentRevenueAndOther", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "mpw_StraightLineRentRevenueNetOfWriteOffs": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "order": 1.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Straight line rent revenue net of write offs.", "label": "Straight Line Rent Revenue Net Of Write Offs", "terseLabel": "Straight-line rent" } } }, "localname": "StraightLineRentRevenueNetOfWriteOffs", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "monetaryItemType" }, "mpw_StraightLineRentWriteOffs": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "straight-line rent write-offs.", "label": "straight-Line Rent Write-Offs", "terseLabel": "Straight-line rent write-offs" } } }, "localname": "StraightLineRentWriteOffs", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDisposalsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mpw_StrathpineAustraliaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Strathpine, Australia.", "label": "Strathpine Australia [Member]", "terseLabel": "Strathpine, Australia [Member]" } } }, "localname": "StrathpineAustraliaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_SubLeaseLeasePaymentsToBeReceived": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sub lease lease payments to be received.", "label": "Sub Lease Lease Payments To Be Received", "negatedTotalLabel": "Amounts To Be Received From Subleases, Total undiscounted minimum lease payments" } } }, "localname": "SubLeaseLeasePaymentsToBeReceived", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "xbrltype": "monetaryItemType" }, "mpw_SubLeaseLeasePaymentsToBeReceivedFiveYears": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "order": 4.0, "parentTag": "mpw_SubLeaseLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sub lease lease payments to be received five years.", "label": "Sub Lease Lease Payments To Be Received Five Years", "negatedLabel": "Amounts To Be Received From Subleases, 2027" } } }, "localname": "SubLeaseLeasePaymentsToBeReceivedFiveYears", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "xbrltype": "monetaryItemType" }, "mpw_SubLeaseLeasePaymentsToBeReceivedFourYears": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "order": 3.0, "parentTag": "mpw_SubLeaseLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sub lease lease payments to be received four years.", "label": "Sub Lease Lease Payments To Be Received Four Years", "negatedLabel": "Amounts To Be Received From Subleases, 2026" } } }, "localname": "SubLeaseLeasePaymentsToBeReceivedFourYears", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "xbrltype": "monetaryItemType" }, "mpw_SubLeaseLeasePaymentsToBeReceivedNextTwelveMonths": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "order": 0.0, "parentTag": "mpw_SubLeaseLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sub lease lease payments to be received next twelve months.", "label": "Sub Lease Lease Payments To Be Received Next Twelve Months", "negatedLabel": "Amounts To Be Received From Subleases, 2023" } } }, "localname": "SubLeaseLeasePaymentsToBeReceivedNextTwelveMonths", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "xbrltype": "monetaryItemType" }, "mpw_SubLeaseLeasePaymentsToBeReceivedThereafter": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "order": 5.0, "parentTag": "mpw_SubLeaseLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sub lease lease payments to be received thereafter.", "label": "Sub Lease Lease Payments To Be Received Thereafter", "negatedLabel": "Amounts To Be Received From Subleases, Thereafter" } } }, "localname": "SubLeaseLeasePaymentsToBeReceivedThereafter", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "xbrltype": "monetaryItemType" }, "mpw_SubLeaseLeasePaymentsToBeReceivedThreeYears": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "order": 2.0, "parentTag": "mpw_SubLeaseLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sub lease lease payments to be received three years.", "label": "Sub Lease Lease Payments To Be Received Three Years", "negatedLabel": "Amounts To Be Received From Subleases, 2025" } } }, "localname": "SubLeaseLeasePaymentsToBeReceivedThreeYears", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "xbrltype": "monetaryItemType" }, "mpw_SubLeaseLeasePaymentsToBeReceivedTwoYears": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "order": 1.0, "parentTag": "mpw_SubLeaseLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sub lease lease payments to be received two years.", "label": "Sub Lease Lease Payments To Be Received Two Years", "negatedLabel": "Amounts To Be Received From Subleases, 2024" } } }, "localname": "SubLeaseLeasePaymentsToBeReceivedTwoYears", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "xbrltype": "monetaryItemType" }, "mpw_SummaryOfInvestmentsInUnconsolidatedOperatingEntitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summary of investments in unconsolidated operating entities.", "label": "Summary Of Investments In Unconsolidated Operating Entities [Table Text Block]", "terseLabel": "Summary of Investments in Unconsolidated Operating Entities" } } }, "localname": "SummaryOfInvestmentsInUnconsolidatedOperatingEntitiesTableTextBlock", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables" ], "xbrltype": "textBlockItemType" }, "mpw_SummaryOfOperatingResultsFromPropertiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summary of Operating results from properties.", "label": "Summary Of Operating Results From Properties [Table Text Block]", "terseLabel": "Summary of Operating Results from Properties" } } }, "localname": "SummaryOfOperatingResultsFromPropertiesTableTextBlock", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables" ], "xbrltype": "textBlockItemType" }, "mpw_SunnybankAustraliaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sunnybank, Australia.", "label": "Sunnybank Australia [Member]", "terseLabel": "Sunnybank, Australia [Member]" } } }, "localname": "SunnybankAustraliaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_SupplementalScheduleOfNonCashFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Supplemental Schedule Of Non Cash Financing Activities [Abstract]", "label": "Supplemental Schedule Of Non Cash Financing Activities [Abstract]", "terseLabel": "Supplemental schedule of non-cash financing activities:" } } }, "localname": "SupplementalScheduleOfNonCashFinancingActivitiesAbstract", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "mpw_SurreyUnitedKingdomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Surrey, United Kingdom.", "label": "Surrey, United Kingdom [Member]", "terseLabel": "Surrey, UK [Member]" } } }, "localname": "SurreyUnitedKingdomMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_SussexNJMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sussex, NJ.", "label": "Sussex N J [Member]", "terseLabel": "Sussex, NJ [Member]" } } }, "localname": "SussexNJMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_SwindonUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Swindon, UK.", "label": "Swindon U K [Member]", "terseLabel": "Swindon, UK [Member]" } } }, "localname": "SwindonUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_SwissHealthcareRealEstateCompanyInfracoreSAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Swiss Healthcare Real Estate Company Infracore SA.", "label": "Swiss Healthcare Real Estate Company Infracore S A [Member]", "terseLabel": "Infracore [Member]" } } }, "localname": "SwissHealthcareRealEstateCompanyInfracoreSAMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_SwissMedicalNetworkMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Swiss medical network.", "label": "Swiss Medical Network [Member]", "terseLabel": "Swiss Medical Network [Member]" } } }, "localname": "SwissMedicalNetworkMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_SyndicatedTermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Syndicated term loan.", "label": "Syndicated Term Loan [Member]", "terseLabel": "Syndicated Term Loan [Member]" } } }, "localname": "SyndicatedTermLoanMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_TadleyUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tadley, UK.", "label": "Tadley U K [Member]", "terseLabel": "Tadley, UK [Member]" } } }, "localname": "TadleyUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_TauntonMAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Taunton, MA.", "label": "Taunton M A [Member]", "terseLabel": "Taunton, MA [Member]" } } }, "localname": "TauntonMAMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_TaxEffectedNetOperatingLossCarryforward": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfNetNOLAndOtherTaxAttributeCarryforwardsDetail": { "order": 0.0, "parentTag": "mpw_NetDeferredTaxAssetNetOperatingLossCarryforward", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Tax effected net operating loss carryforward.", "label": "Tax Effected Net Operating Loss Carryforward", "terseLabel": "Tax-effected NOL carryforwards" } } }, "localname": "TaxEffectedNetOperatingLossCarryforward", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfNetNOLAndOtherTaxAttributeCarryforwardsDetail" ], "xbrltype": "monetaryItemType" }, "mpw_TaxRateAndOtherChanges": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Tax rate and other changes.", "label": "Tax Rate And Other Changes", "terseLabel": "Tax rate and other changes" } } }, "localname": "TaxRateAndOtherChanges", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "mpw_TempeAZMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tempe AZ.", "label": "Tempe A Z [Member]", "terseLabel": "Tempe, AZ [Member]" } } }, "localname": "TempeAZMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_TermBenchmarkLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term Benchmark Loans.", "label": "Term Benchmark Loans [Member]" } } }, "localname": "TermBenchmarkLoansMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_TermBenchmarkLoansOrRfrLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term Benchmark Loans or RFR Loans.", "label": "Term Benchmark Loans or RFR Loans [Member]" } } }, "localname": "TermBenchmarkLoansOrRfrLoansMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_TermLoanDueTwoThousandTwentyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term loan due two thousand twenty five.", "label": "Term Loan Due Two Thousand Twenty Five [Member]", "terseLabel": "Term loan due 2025" } } }, "localname": "TermLoanDueTwoThousandTwentyFiveMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail" ], "xbrltype": "domainItemType" }, "mpw_TermLoanDueTwoThousandTwentyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term loan due two thousand twenty four.", "label": "Term Loan Due Two Thousand Twenty Four [Member]", "terseLabel": "Term loan due 2024" } } }, "localname": "TermLoanDueTwoThousandTwentyFourMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail" ], "xbrltype": "domainItemType" }, "mpw_TermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term loan.", "label": "Term Loan [Member]", "terseLabel": "Term Loan [Member]", "verboseLabel": "Term Loans [Member]" } } }, "localname": "TermLoanMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail" ], "xbrltype": "domainItemType" }, "mpw_TermLoanReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Term loan receivable.", "label": "Term Loan Receivable", "terseLabel": "Term loan" } } }, "localname": "TermLoanReceivable", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mpw_TermOfFederalIncomeTaxAtCorporateRatesOnFailureToQualifyAsRealEstateInvestmentTrust": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term Of Federal Income Tax At Corporate Rates On Failure To Qualify As Real Estate Investment Trust", "label": "Term Of Federal Income Tax At Corporate Rates On Failure To Qualify As Real Estate Investment Trust", "terseLabel": "Number of years of federal income tax at corporate rates on failure to qualify as REIT" } } }, "localname": "TermOfFederalIncomeTaxAtCorporateRatesOnFailureToQualifyAsRealEstateInvestmentTrust", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "mpw_TexarkanaTXMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Texarkana TX.", "label": "Texarkana T X [Member]", "terseLabel": "Texarkana, Texas [Member]" } } }, "localname": "TexarkanaTXMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_TheWoodlandsTexasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The woodlands Texas.", "label": "The Woodlands Texas [Member]", "terseLabel": "The Woodlands, TX [Member]" } } }, "localname": "TheWoodlandsTexasMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_ThorntonCOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Thornton, CO.", "label": "Thornton C O [Member]", "terseLabel": "Thornton, CO [Member]" } } }, "localname": "ThorntonCOMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_ThreePointFiveZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandThirtyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Three point five zero zero percentage senior unsecured notes due two thousand thirty one.", "label": "Three Point Five Zero Zero Percentage Senior Unsecured Notes Due Two Thousand Thirty One [Member]", "terseLabel": "3.500% Senior Unsecured Notes Due 2031 [Member]" } } }, "localname": "ThreePointFiveZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandThirtyOneMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "xbrltype": "domainItemType" }, "mpw_ThreePointSixNineTwoPercentageSeniorUnsecuredNotesDueTwoThousandTwentyEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Three point six nine two percentage senior unsecured notes due two thousand twenty eight.", "label": "Three Point Six Nine Two Percentage Senior Unsecured Notes Due Two Thousand Twenty Eight [Member]", "terseLabel": "3.692% Senior Unsecured Notes due 2028 [Member]" } } }, "localname": "ThreePointSixNineTwoPercentageSeniorUnsecuredNotesDueTwoThousandTwentyEightMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "xbrltype": "domainItemType" }, "mpw_ThreePointThreeSevenFivePercentageSeniorUnsecuredNotesDueTwoThousandThirtyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Three point three seven five percentage senior unsecured notes due two thousand thirty.", "label": "Three Point Three Seven Five Percentage Senior Unsecured Notes Due Two Thousand Thirty [Member]", "terseLabel": "3.375% Senior Unsecured Notes Due 2030 [Member]" } } }, "localname": "ThreePointThreeSevenFivePercentageSeniorUnsecuredNotesDueTwoThousandThirtyMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtInterimCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "xbrltype": "domainItemType" }, "mpw_ThreePointThreeTwoFivePercentageSeniorUnsecuredNotesDueTwoThousandTwentyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Three point three two five percentage senior unsecured notes due two thousand twenty five.", "label": "Three Point Three Two Five Percentage Senior Unsecured Notes Due Two Thousand Twenty Five [Member]", "terseLabel": "3.325% Senior Unsecured Notes Due 2025 [Member]" } } }, "localname": "ThreePointThreeTwoFivePercentageSeniorUnsecuredNotesDueTwoThousandTwentyFiveMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "xbrltype": "domainItemType" }, "mpw_ThresholdOwnershipPercentageForInterCompanyBalancesAndTransactionsElimination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold ownership percentage for inter-company balances and transactions elimination.", "label": "Threshold Ownership Percentage For Inter Company Balances And Transactions Elimination", "terseLabel": "Threshold ownership percentage for inter company balances and transactions elimination" } } }, "localname": "ThresholdOwnershipPercentageForInterCompanyBalancesAndTransactionsElimination", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_TimeBasedAwardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Time Based Awards", "label": "Time Based Awards [Member]", "terseLabel": "Time-Based Awards [Member]" } } }, "localname": "TimeBasedAwardsMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_ToledoOhMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Toledo, OH [Member]", "label": "Toledo Oh [Member]", "terseLabel": "Toledo, OH [Member]" } } }, "localname": "ToledoOhMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_TomballTXMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tomball, TX.", "label": "Tomball T X [Member]", "terseLabel": "Tomball, TX [Member]" } } }, "localname": "TomballTXMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_TorquayUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Torquay, UK.", "label": "Torquay U K [Member]", "terseLabel": "Torquay, UK [Member]" } } }, "localname": "TorquayUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_TurkuFinlandMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Turku, Finland.", "label": "Turku, Finland [Member]", "terseLabel": "Turku, Finland [Member]" } } }, "localname": "TurkuFinlandMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_TwoPointFiveFiveZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two point five five zero percentage senior unsecured notes due two thousand twenty three.", "label": "Two Point Five Five Zero Percentage Senior Unsecured Notes Due Two Thousand Twenty Three [Member]", "terseLabel": "2.550% Senior Unsecured Notes due 2023 [Member]" } } }, "localname": "TwoPointFiveFiveZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentyThreeMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "xbrltype": "domainItemType" }, "mpw_TwoPointFiveZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two point five zero zero percentage senior unsecured notes due two thousand twenty six.", "label": "Two Point Five Zero Zero Percentage Senior Unsecured Notes Due Two Thousand Twenty Six [Member]", "terseLabel": "2.500% Senior Unsecured Notes due 2026 [Member]" } } }, "localname": "TwoPointFiveZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtInterimCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "xbrltype": "domainItemType" }, "mpw_TwoThousandEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand eight.", "label": "Two Thousand Eight [Member]", "terseLabel": "2008 [Member]" } } }, "localname": "TwoThousandEightMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_TwoThousandEighteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand eighteen.", "label": "Two Thousand Eighteen [Member]", "terseLabel": "2018 [Member]" } } }, "localname": "TwoThousandEighteenMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_TwoThousandElevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand eleven.", "label": "Two Thousand Eleven [Member]", "terseLabel": "2011 [Member]" } } }, "localname": "TwoThousandElevenMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_TwoThousandFifteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand fifteen.", "label": "Two Thousand Fifteen [Member]", "terseLabel": "2015 [Member]" } } }, "localname": "TwoThousandFifteenMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_TwoThousandFifteenOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand fifteen one.", "label": "Two Thousand Fifteen One [Member]", "terseLabel": "2015 One [Member]", "verboseLabel": "2015 [Member]" } } }, "localname": "TwoThousandFifteenOneMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_TwoThousandFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand five.", "label": "Two Thousand Five [Member]", "terseLabel": "2005 [Member]" } } }, "localname": "TwoThousandFiveMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_TwoThousandFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand four.", "label": "Two Thousand Four [Member]", "terseLabel": "2004 [Member]" } } }, "localname": "TwoThousandFourMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_TwoThousandFourteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand fourteen.", "label": "Two Thousand Fourteen [Member]", "terseLabel": "2014 [Member]" } } }, "localname": "TwoThousandFourteenMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_TwoThousandMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand.", "label": "Two Thousand [Member]", "terseLabel": "2000 [Member]" } } }, "localname": "TwoThousandMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_TwoThousandNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand nine.", "label": "Two Thousand Nine [Member]", "terseLabel": "2009 [Member]" } } }, "localname": "TwoThousandNineMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_TwoThousandNineteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand nineteen.", "label": "Two Thousand Nineteen [Member]", "terseLabel": "2019 [Member]" } } }, "localname": "TwoThousandNineteenMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_TwoThousandOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand one .", "label": "Two Thousand One [Member]", "terseLabel": "2001 [Member]" } } }, "localname": "TwoThousandOneMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_TwoThousandSevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand seven.", "label": "Two Thousand Seven [Member]", "terseLabel": "2007 [Member]" } } }, "localname": "TwoThousandSevenMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_TwoThousandSeventeenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand seventeen.", "label": "Two Thousand Seventeen [Member]", "terseLabel": "2017 [Member]" } } }, "localname": "TwoThousandSeventeenMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_TwoThousandSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand six.", "label": "Two Thousand Six [Member]", "terseLabel": "2006 [Member]" } } }, "localname": "TwoThousandSixMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_TwoThousandSixteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand Sixteen.", "label": "Two Thousand Sixteen [Member]", "terseLabel": "2016 [Member]" } } }, "localname": "TwoThousandSixteenMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_TwoThousandSixteenOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand sixteen one.", "label": "Two Thousand Sixteen One [Member]", "terseLabel": "2016 [Member]" } } }, "localname": "TwoThousandSixteenOneMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_TwoThousandTenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand ten.", "label": "Two Thousand Ten [Member]", "terseLabel": "2010 [Member]" } } }, "localname": "TwoThousandTenMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_TwoThousandThirteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand thirteen.", "label": "Two Thousand Thirteen [Member]", "terseLabel": "2013 [Member]" } } }, "localname": "TwoThousandThirteenMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_TwoThousandThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand three.", "label": "Two Thousand Three [Member]", "terseLabel": "2003 [Member]" } } }, "localname": "TwoThousandThreeMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_TwoThousandTwelveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand twelve.", "label": "Two Thousand Twelve [Member]", "terseLabel": "2012 [Member]" } } }, "localname": "TwoThousandTwelveMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_TwoThousandTwentyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand twenty.", "label": "Two Thousand Twenty [Member]", "terseLabel": "2020 [Member]" } } }, "localname": "TwoThousandTwentyMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_TwoThousandTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand twenty one.", "label": "Two Thousand Twenty One [Member]", "terseLabel": "2021 [Member]" } } }, "localname": "TwoThousandTwentyOneMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_TwoThousandTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand twenty two.", "label": "Two Thousand Twenty Two [Member]", "terseLabel": "2022 [Member]" } } }, "localname": "TwoThousandTwentyTwoMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_TwoThousandTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand two.", "label": "Two Thousand Two [Member]", "terseLabel": "2002 [Member]" } } }, "localname": "TwoThousandTwoMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_UndistributedEarningAllocatedToParticipatingSecurities": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail": { "order": 2.0, "parentTag": "mpw_NetIncomeLessParticipatingSecuritiesShareInEarnings", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Undistributed earning allocated to participating securities.", "label": "Undistributed Earning Allocated To Participating Securities", "negatedLabel": "Participating securities\u2019 share in earnings" } } }, "localname": "UndistributedEarningAllocatedToParticipatingSecurities", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail" ], "xbrltype": "monetaryItemType" }, "mpw_UnearnedRentRevenue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Unearned rent revenue.", "label": "Unearned Rent Revenue", "terseLabel": "Unearned rent revenue" } } }, "localname": "UnearnedRentRevenue", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mpw_UnsecuredRevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Unsecured Revolving Credit Facility [Member]", "label": "Unsecured Revolving Credit Facility [Member]", "terseLabel": "Unsecured Revolving Credit Facility [Member]" } } }, "localname": "UnsecuredRevolvingCreditFacilityMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_UskUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Usk, UK.", "label": "Usk U K [Member]", "terseLabel": "Usk, UK [Member]" } } }, "localname": "UskUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_ValenciaSpainMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Valencia, Spain.", "label": "Valencia Spain [Member]", "terseLabel": "Valencia, Spain [Member]" } } }, "localname": "ValenciaSpainMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_VestingBasedOnMarketPerformanceConditionsSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vesting based on market/performance conditions shares [member]", "label": "Vesting Based On Market Performance Conditions Shares [Member]", "terseLabel": "Vesting Based on Market/Performance Conditions [Member]" } } }, "localname": "VestingBasedOnMarketPerformanceConditionsSharesMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsStockBasedAwardActivityDetail" ], "xbrltype": "domainItemType" }, "mpw_VestingBasedOnServiceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vesting based on service [member]", "label": "Vesting Based On Service [Member]", "terseLabel": "Vesting Based on Service [Member]" } } }, "localname": "VestingBasedOnServiceMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsStockBasedAwardActivityDetail" ], "xbrltype": "domainItemType" }, "mpw_VibraMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vibra.", "label": "Vibra [Member]", "terseLabel": "Vibra [Member]" } } }, "localname": "VibraMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail" ], "xbrltype": "domainItemType" }, "mpw_ViseuPortugalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Viseu, Portugal.", "label": "Viseu Portugal [Member]", "terseLabel": "Viseu, Portugal [Member]" } } }, "localname": "ViseuPortugalMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_WantirnaAustraliaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Wantirna, Australia.", "label": "Wantirna Australia [Member]", "terseLabel": "Wantirna, Australia [Member]" } } }, "localname": "WantirnaAustraliaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_WarrenOHMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warren, OH.", "label": "Warren O H [Member]", "terseLabel": "Warren, OH [Member]" } } }, "localname": "WarrenOHMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_WaterlandPrivateEquityFundVIICVAffiliateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Waterland Private Equity Fund VII C. V. affiliate.", "label": "Waterland Private Equity Fund V I I C V Affiliate [Member]", "terseLabel": "Waterland Private Equity Fund VII C.V. Affiliate [Member]" } } }, "localname": "WaterlandPrivateEquityFundVIICVAffiliateMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_WaterlandPrivateEquityFundVIICVMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Waterland Private Equity Fund VII C.V.", "label": "Waterland Private Equity Fund V I I C V [Member]", "terseLabel": "Waterland Private Equity Fund VII C.V. [Member]", "verboseLabel": "Waterland Private Equity Fund VII C.V. [Member]" } } }, "localname": "WaterlandPrivateEquityFundVIICVMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_WatsonvilleCAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Watsonville, CA.", "label": "Watsonville C A [Member]", "terseLabel": "Watsonville, CA [Member]" } } }, "localname": "WatsonvilleCAMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_WatsonvilleCaliforniaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Watsonville California.", "label": "Watsonville California [Member]", "terseLabel": "Watsonville, California [Member]" } } }, "localname": "WatsonvilleCaliforniaMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "xbrltype": "domainItemType" }, "mpw_WatsonvilleCommunityHospitalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Watsonville community hospital.", "label": "Watsonville Community Hospital [Member]" } } }, "localname": "WatsonvilleCommunityHospitalMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_WebsterTexasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Webster, Texas.", "label": "Webster Texas [Member]", "terseLabel": "Webster, TX [Member]" } } }, "localname": "WebsterTexasMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_WeightedAverageDiscountRateAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate.", "label": "Weighted Average Discount Rate [Abstract]", "terseLabel": "Weighted-average discount rate:" } } }, "localname": "WeightedAverageDiscountRateAbstract", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "xbrltype": "stringItemType" }, "mpw_WeightedAverageRemainingLeaseTermAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term.", "label": "Weighted Average Remaining Lease Term [Abstract]", "terseLabel": "Weighted-average remaining lease term:" } } }, "localname": "WeightedAverageRemainingLeaseTermAbstract", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "xbrltype": "stringItemType" }, "mpw_WestChesterOHMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "West Chester, OH.", "label": "West Chester O H [Member]", "terseLabel": "West Chester, OH [Member]" } } }, "localname": "WestChesterOHMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_WestJordanUTMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "West Jordan, UT.", "label": "West Jordan U T [Member]", "terseLabel": "West Jordan, UT [Member]" } } }, "localname": "WestJordanUTMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_WestMonroeLAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "West Monroe LA.", "label": "West Monroe L A [Member]", "terseLabel": "West Monroe, LA [Member]" } } }, "localname": "WestMonroeLAMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_WestValleyCityUTMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "West valley city, UT.", "label": "West Valley City U T [Member]", "terseLabel": "West Valley City, UT [Member]" } } }, "localname": "WestValleyCityUTMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_WichitaKSMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Wichita, KS.", "label": "Wichita K S [Member]", "terseLabel": "Wichita, KS [Member]" } } }, "localname": "WichitaKSMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_WillenhallUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Willenhall, UK.", "label": "Willenhall U K [Member]", "terseLabel": "Willenhall, UK [Member]" } } }, "localname": "WillenhallUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_WinchesterUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Winchester, UK.", "label": "Winchester U K [Member]", "terseLabel": "Winchester, UK [Member]" } } }, "localname": "WinchesterUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_WindsorUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Windsor, UK.", "label": "Windsor U K [Member]", "terseLabel": "Windsor, UK [Member]" } } }, "localname": "WindsorUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_WokingUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Woking, UK.", "label": "Woking U K [Member]", "terseLabel": "Woking, UK [Member]" } } }, "localname": "WokingUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_WorthingUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Worthing, UK.", "label": "Worthing U K [Member]", "terseLabel": "Worthing, UK [Member]" } } }, "localname": "WorthingUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_WriteOffOfBilledAndStraightLineRentReceivables": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Write off of billed and straight-line rent receivables.", "label": "Write off of Billed and Straight-Line Rent Receivables", "terseLabel": "Write off of billed and straight-line rent receivables" } } }, "localname": "WriteOffOfBilledAndStraightLineRentReceivables", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "mpw_WriteOffOfUnbilledRentAndOther": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Write-off of unbilled rent and other.", "label": "Write Off of Unbilled Rent And Other", "terseLabel": "Write-off of unbilled rent and other" } } }, "localname": "WriteOffOfUnbilledRentAndOther", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "mpw_YorkUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "York, UK.", "label": "York U K [Member]", "terseLabel": "York, UK [Member]" } } }, "localname": "YorkUKMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_YoungstownOHMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Youngstown OH.", "label": "Youngstown O H [Member]", "terseLabel": "Youngstown, OH [Member]" } } }, "localname": "YoungstownOHMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "mpw_ZeroPointNineNineThreePercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Zero point nine nine three percentage senior unsecured notes due two thousand twenty six.", "label": "Zero Point Nine Nine Three Percentage Senior Unsecured Notes Due Two Thousand Twenty Six [Member]", "terseLabel": "0.993% Senior Unsecured Notes due 2026 [Member]" } } }, "localname": "ZeroPointNineNineThreePercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember", "nsuri": "http://medicalpropertiestrust.com/20221231", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "xbrltype": "domainItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r268", "r515", "r516", "r519", "r520", "r609", "r728", "r738", "r854", "r857", "r858", "r947", "r948", "r949" ], "lang": { "en-us": { "role": { "documentation": "Information by consolidated entity or group of entities.", "label": "Consolidated Entities [Axis]", "terseLabel": "Consolidated Entities" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlowsParenthetical", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveIncome", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapitalParenthetical", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r268", "r515", "r516", "r519", "r520", "r609", "r728", "r738", "r854", "r857", "r858", "r947", "r948", "r949" ], "lang": { "en-us": { "role": { "documentation": "Entity or group of entities consolidated into reporting entity.", "label": "Consolidated Entities [Domain]", "terseLabel": "Consolidated Entities" } } }, "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlowsParenthetical", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveIncome", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapitalParenthetical", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "domainItemType" }, "srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock": { "auth_ref": [ "r937" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation.", "label": "Contractual Obligation, Fiscal Year Maturity [Table Text Block]", "terseLabel": "Principal Payments Due on Debt" } } }, "localname": "ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtTables" ], "xbrltype": "textBlockItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r265", "r266", "r407", "r426", "r759", "r762", "r764" ], "lang": { "en-us": { "role": { "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.", "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtJuly2021InterimCreditFacilityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": { "auth_ref": [ "r223", "r280", "r288", "r294", "r359", "r473", "r474", "r475", "r496", "r497", "r527", "r530", "r532", "r533", "r604" ], "lang": { "en-us": { "role": { "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards.", "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]", "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment [Member]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAxis": { "auth_ref": [ "r223", "r280", "r288", "r294", "r359", "r473", "r474", "r475", "r496", "r497", "r527", "r530", "r532", "r533", "r604" ], "lang": { "en-us": { "role": { "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.", "label": "Cumulative Effect, Period of Adoption [Axis]", "terseLabel": "Cumulative Effect, Period of Adoption" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionDomain": { "auth_ref": [ "r223", "r280", "r288", "r294", "r359", "r473", "r474", "r475", "r496", "r497", "r527", "r530", "r532", "r533", "r604" ], "lang": { "en-us": { "role": { "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.", "label": "Cumulative Effect, Period of Adoption [Domain]", "terseLabel": "Cumulative Effect, Period of Adoption" } } }, "localname": "CumulativeEffectPeriodOfAdoptionDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "xbrltype": "domainItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of investment including named security. Excludes entity that is consolidated.", "label": "Investment, Name [Domain]", "terseLabel": "Investment, Name" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_EuropeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Continent of Europe.", "label": "Europe [Member]", "terseLabel": "Europe [Member]" } } }, "localname": "EuropeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r344", "r782", "r862", "r920" ], "lang": { "en-us": { "role": { "documentation": "Information by name or description of a single external customer or a group of external customers.", "label": "Customer [Axis]", "terseLabel": "Customer" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDisposalsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r391", "r392", "r393", "r394", "r437", "r643", "r677", "r732", "r733", "r780", "r785", "r793", "r859", "r908", "r909", "r910", "r911", "r912", "r913" ], "lang": { "en-us": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]", "terseLabel": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r391", "r392", "r393", "r394", "r437", "r643", "r677", "r732", "r733", "r780", "r785", "r793", "r859", "r908", "r909", "r910", "r911", "r912", "r913" ], "lang": { "en-us": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_MortgageLoansOnRealEstateAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]" } } }, "localname": "MortgageLoansOnRealEstateAbstract", "nsuri": "http://fasb.org/srt/2022", "xbrltype": "stringItemType" }, "srt_MortgageLoansOnRealEstateByLoanDisclosureTextBlock": { "auth_ref": [ "r716", "r758" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate. Includes, but is not limited to, information for each mortgage loan receivable equaling or exceeding 3 percent of carrying amount of mortgage.", "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Text Block]", "terseLabel": "SCHEDULE IV - MORTGAGE LOANS ON REAL ESTATE" } } }, "localname": "MortgageLoansOnRealEstateByLoanDisclosureTextBlock", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSCHEDULEIVMORTGAGELOANSONREALESTATE" ], "xbrltype": "textBlockItemType" }, "srt_MortgageLoansOnRealEstateCollectionsOfPrincipal": { "auth_ref": [ "r714", "r742" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from collection of principal.", "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Collections of Principal", "negatedLabel": "Collection of principal" } } }, "localname": "MortgageLoansOnRealEstateCollectionsOfPrincipal", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossDetail" ], "xbrltype": "monetaryItemType" }, "srt_MortgageLoansOnRealEstateDescriptionLoanCategoryAxis": { "auth_ref": [ "r713", "r739" ], "lang": { "en-us": { "role": { "documentation": "Information by loan category for investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate.", "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Loan Category [Axis]", "terseLabel": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Loan Category" } } }, "localname": "MortgageLoansOnRealEstateDescriptionLoanCategoryAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateParentheticalDetail" ], "xbrltype": "stringItemType" }, "srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis": { "auth_ref": [ "r713", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r737", "r739" ], "lang": { "en-us": { "role": { "documentation": "Information by type of real estate property.", "label": "Real Estate, Type of Property [Axis]", "terseLabel": "Real Estate, Type of Property" } } }, "localname": "MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail" ], "xbrltype": "stringItemType" }, "srt_MortgageLoansOnRealEstateFaceAmountOfMortgages": { "auth_ref": [ "r711", "r752" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contractual principal due at origination of mortgage loan within investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate.", "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Face Amount of Mortgages", "terseLabel": "Face Amount of Mortgages" } } }, "localname": "MortgageLoansOnRealEstateFaceAmountOfMortgages", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail" ], "xbrltype": "monetaryItemType" }, "srt_MortgageLoansOnRealEstateFederalIncomeTaxBasis1": { "auth_ref": [ "r715", "r743" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of federal income tax basis of investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate.", "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Federal Income Tax Basis", "terseLabel": "Carrying amount of mortgages, federal income tax purposes" } } }, "localname": "MortgageLoansOnRealEstateFederalIncomeTaxBasis1", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "srt_MortgageLoansOnRealEstateInterestRate": { "auth_ref": [ "r708", "r745" ], "lang": { "en-us": { "role": { "documentation": "Interest rate of mortgage loan within investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate.", "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Interest Rate", "terseLabel": "Loans, Weighted Average Interest Rate", "verboseLabel": "Interest Rate" } } }, "localname": "MortgageLoansOnRealEstateInterestRate", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail" ], "xbrltype": "percentItemType" }, "srt_MortgageLoansOnRealEstateLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]", "terseLabel": "Mortgage Loans on Real Estate [Line Items]" } } }, "localname": "MortgageLoansOnRealEstateLineItems", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateParentheticalDetail" ], "xbrltype": "stringItemType" }, "srt_MortgageLoansOnRealEstateLoanCategoryDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loan category for investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate.", "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Loan Category [Domain]", "terseLabel": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Loan Category" } } }, "localname": "MortgageLoansOnRealEstateLoanCategoryDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateParentheticalDetail" ], "xbrltype": "domainItemType" }, "srt_MortgageLoansOnRealEstateNamePropertyTypeDomain": { "auth_ref": [ "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r737", "r744", "r746", "r747", "r749", "r751", "r753", "r754", "r755" ], "lang": { "en-us": { "role": { "documentation": "Land and any structures permanently fixed to it.", "label": "Real Estate [Domain]", "terseLabel": "Real Estate" } } }, "localname": "MortgageLoansOnRealEstateNamePropertyTypeDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail" ], "xbrltype": "domainItemType" }, "srt_MortgageLoansOnRealEstatePeriodicPaymentTerms": { "auth_ref": [ "r709", "r748" ], "lang": { "en-us": { "role": { "documentation": "Description of contractual payment terms of mortgage loan within investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate. Includes, but is not limited to, whether mortgage loan is payable at level or varying amount to maturity, balloon payment requirement at maturity, and prepayment penalty.", "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Periodic Payment Terms, Description", "terseLabel": "Periodic Payment Terms" } } }, "localname": "MortgageLoansOnRealEstatePeriodicPaymentTerms", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail" ], "xbrltype": "stringItemType" }, "srt_MortgageLoansOnRealEstatePriorLiens1": { "auth_ref": [ "r710", "r750" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of prior lien on real estate securing mortgage loan within investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate.", "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Prior Lien, Amount", "terseLabel": "Prior Liens" } } }, "localname": "MortgageLoansOnRealEstatePriorLiens1", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "srt_MortgageLoansOnRealEstateScheduleTable": { "auth_ref": [ "r716", "r758" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate.", "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate Schedule [Table]", "terseLabel": "Mortgage Loans On Real Estate Schedule [Table]" } } }, "localname": "MortgageLoansOnRealEstateScheduleTable", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateParentheticalDetail" ], "xbrltype": "stringItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r344", "r782", "r862", "r920" ], "lang": { "en-us": { "role": { "documentation": "Single external customer or group of external customers.", "label": "Customer [Domain]", "terseLabel": "Customer" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDisposalsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.", "label": "Ownership [Axis]", "terseLabel": "Ownership" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.", "label": "Ownership [Domain]", "terseLabel": "Ownership" } } }, "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_ProFormaMember": { "auth_ref": [ "r294", "r806", "r807" ], "lang": { "en-us": { "role": { "documentation": "Information reported based on historical fact adjusted for potential activity. Includes, but is not limited to, information expected to be reported in future period for effect on historical fact. Excludes forecast information.", "label": "Pro Forma [Member]", "terseLabel": "Pro Forma [Member]" } } }, "localname": "ProFormaMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r391", "r392", "r393", "r394", "r435", "r437", "r465", "r466", "r467", "r619", "r643", "r677", "r732", "r733", "r780", "r785", "r793", "r851", "r859", "r909", "r910", "r911", "r912", "r913" ], "lang": { "en-us": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r391", "r392", "r393", "r394", "r435", "r437", "r465", "r466", "r467", "r619", "r643", "r677", "r732", "r733", "r780", "r785", "r793", "r851", "r859", "r909", "r910", "r911", "r912", "r913" ], "lang": { "en-us": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_RealEstateAndAccumulatedDepreciationAmountOfEncumbrances": { "auth_ref": [ "r719", "r744" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lien or mortgage outstanding on real estate investment properties for entities with a substantial portion of business acquiring and holding investment real estate.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Amount of Encumbrances", "terseLabel": "Encumbrances" } } }, "localname": "RealEstateAndAccumulatedDepreciationAmountOfEncumbrances", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "monetaryItemType" }, "srt_RealEstateAndAccumulatedDepreciationByPropertyTable": { "auth_ref": [ "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r737", "r744", "r746", "r747", "r749", "r751", "r753", "r754", "r755" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about real estate investments and accompanying accumulated depreciation for entities with a substantial portion of business acquiring and holding investment real estate.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, by Property [Table]", "terseLabel": "Real Estate And Accumulated Depreciation By Property [Table]" } } }, "localname": "RealEstateAndAccumulatedDepreciationByPropertyTable", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "stringItemType" }, "srt_RealEstateAndAccumulatedDepreciationDateAcquired1": { "auth_ref": [ "r725", "r754" ], "lang": { "en-us": { "role": { "documentation": "Date real estate investment property was acquired for entities with a substantial portion of business acquiring and holding investment real estate, in YYYY-MM-DD format.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Date Acquired", "terseLabel": "Date Acquired" } } }, "localname": "RealEstateAndAccumulatedDepreciationDateAcquired1", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "dateItemType" }, "srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis": { "auth_ref": [ "r729", "r740", "r760", "r922", "r923", "r924", "r925", "r926", "r927", "r928", "r929", "r939", "r940", "r941", "r942", "r943", "r944", "r945", "r946" ], "lang": { "en-us": { "role": { "documentation": "Information by name of property.", "label": "Name of Property [Axis]", "terseLabel": "Name of Property" } } }, "localname": "RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "stringItemType" }, "srt_RealEstateAndAccumulatedDepreciationDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation Disclosure [Abstract]" } } }, "localname": "RealEstateAndAccumulatedDepreciationDisclosureAbstract", "nsuri": "http://fasb.org/srt/2022", "xbrltype": "stringItemType" }, "srt_RealEstateAndAccumulatedDepreciationDisclosureTextBlock": { "auth_ref": [ "r731", "r757" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of real estate investments and associated accumulated depreciation for entities with a significant portion of their business acquiring and holding investment real estate.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation Disclosure [Text Block]", "terseLabel": "SCHEDULE III - REAL ESTATE INVESTMENTS AND ACCUMULATED DEPRECIATION" } } }, "localname": "RealEstateAndAccumulatedDepreciationDisclosureTextBlock", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSCHEDULEIIIREALESTATEINVESTMENTSANDACCUMULATEDDEPRECIATION" ], "xbrltype": "textBlockItemType" }, "srt_RealEstateAndAccumulatedDepreciationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]", "terseLabel": "SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items]" } } }, "localname": "RealEstateAndAccumulatedDepreciationLineItems", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "stringItemType" }, "srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain": { "auth_ref": [ "r729", "r740", "r922", "r923", "r924", "r925", "r926", "r927", "r928", "r929", "r939", "r940", "r941", "r942", "r943", "r944", "r945", "r946" ], "lang": { "en-us": { "role": { "documentation": "Name of the property, for example, but not limited to, ABC Shopping Center.", "label": "Name of Property [Domain]", "terseLabel": "Name of Property" } } }, "localname": "RealEstateAndAccumulatedDepreciationNameOfPropertyDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "srt_RealEstateFederalIncomeTaxBasis": { "auth_ref": [ "r730", "r741" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cost basis of real estate investments for federal income tax purposes for entities with a substantial portion of business acquiring and holding investment real estate.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Federal Income Tax Basis", "terseLabel": "Aggregate cost for federal income tax purposes" } } }, "localname": "RealEstateFederalIncomeTaxBasis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r265", "r266", "r407", "r426", "r763", "r764" ], "lang": { "en-us": { "role": { "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.", "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtJuly2021InterimCreditFacilityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r438", "r838", "r938" ], "lang": { "en-us": { "role": { "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact.", "label": "Forecast [Member]", "terseLabel": "Forecast [Member]" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r294", "r438", "r806", "r838" ], "lang": { "en-us": { "role": { "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Scenario [Domain]", "terseLabel": "Scenario" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r350" ], "lang": { "en-us": { "role": { "documentation": "Information by name of investment including named security. Excludes entity that is consolidated.", "label": "Investment, Name [Axis]", "terseLabel": "Investment, Name" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": { "auth_ref": [ "r276", "r756" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]", "terseLabel": "Schedule II: Valuation and Qualifying Accounts" } } }, "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIValuationAndQualifyingAccounts" ], "xbrltype": "textBlockItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r342", "r343", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r737", "r744", "r746", "r747", "r749", "r751", "r753", "r754", "r755", "r781", "r792", "r862" ], "lang": { "en-us": { "role": { "documentation": "Geographical area.", "label": "Geographical [Domain]", "terseLabel": "Geographical" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfNetNOLAndOtherTaxAttributeCarryforwardsDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateParentheticalDetail" ], "xbrltype": "domainItemType" }, "srt_SouthAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Continent of South America.", "label": "South America [Member]", "terseLabel": "South America [Member]" } } }, "localname": "SouthAmericaMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r342", "r343", "r713", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r737", "r739", "r781", "r792", "r862" ], "lang": { "en-us": { "role": { "documentation": "Information by geographical components.", "label": "Geographical [Axis]", "terseLabel": "Geographical" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfNetNOLAndOtherTaxAttributeCarryforwardsDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateParentheticalDetail" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r294", "r438", "r806", "r807", "r838" ], "lang": { "en-us": { "role": { "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Scenario [Axis]", "terseLabel": "Scenario" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_ValuationAndQualifyingAccountsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]" } } }, "localname": "ValuationAndQualifyingAccountsAbstract", "nsuri": "http://fasb.org/srt/2022", "xbrltype": "stringItemType" }, "stpr_AZ": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ARIZONA", "terseLabel": "Arizona [Member]" } } }, "localname": "AZ", "nsuri": "http://xbrl.sec.gov/stpr/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "stpr_CA": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CALIFORNIA", "terseLabel": "California [Member]" } } }, "localname": "CA", "nsuri": "http://xbrl.sec.gov/stpr/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "stpr_CA-BC": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BRITISH COLUMBIA", "terseLabel": "British Pound Sterling [Member]" } } }, "localname": "CA-BC", "nsuri": "http://xbrl.sec.gov/stpr/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "stpr_CT": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONNECTICUT", "terseLabel": "Connecticut [Member]" } } }, "localname": "CT", "nsuri": "http://xbrl.sec.gov/stpr/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "stpr_FL": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FLORIDA", "terseLabel": "Florida [Member]" } } }, "localname": "FL", "nsuri": "http://xbrl.sec.gov/stpr/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "stpr_PA": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PENNSYLVANIA", "terseLabel": "Pennsylvania" } } }, "localname": "PA", "nsuri": "http://xbrl.sec.gov/stpr/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "stpr_SC": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SOUTH CAROLINA", "terseLabel": "South Carolina [Member]", "verboseLabel": "Cayce, South Carolina [member]" } } }, "localname": "SC", "nsuri": "http://xbrl.sec.gov/stpr/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "stpr_TX": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "TEXAS", "terseLabel": "Texas [Member]" } } }, "localname": "TX", "nsuri": "http://xbrl.sec.gov/stpr/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "stpr_UT": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UTAH", "terseLabel": "Utah [Member]" } } }, "localname": "UT", "nsuri": "http://xbrl.sec.gov/stpr/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdate201602Member": { "auth_ref": [ "r570" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).", "label": "Accounting Standards Update 2016-02 [Member]", "terseLabel": "Accounting Standards Update 2016-02" } } }, "localname": "AccountingStandardsUpdate201602Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingStandardsUpdate201613Member": { "auth_ref": [ "r352" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2016-13 Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.", "label": "Accounting Standards Update 2016-13 [Member]", "terseLabel": "Accounting Standards Update 2016-13" } } }, "localname": "AccountingStandardsUpdate201613Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingStandardsUpdateExtensibleList": { "auth_ref": [ "r221", "r222", "r223", "r224", "r225", "r282", "r283", "r284", "r346", "r347", "r356", "r357", "r358", "r359", "r360", "r361", "r473", "r474", "r475", "r496", "r497", "r510", "r511", "r512", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r544", "r545", "r547", "r548", "r549", "r550", "r551", "r552", "r565", "r566", "r572", "r573", "r574", "r601", "r602", "r603", "r604", "r605", "r606", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r836" ], "lang": { "en-us": { "role": { "documentation": "Indicates amendment to accounting standards.", "label": "Accounting Standards Update [Extensible Enumeration]", "terseLabel": "Accounting Standards Update [Extensible List]" } } }, "localname": "AccountingStandardsUpdateExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": { "auth_ref": [ "r179", "r202" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.", "label": "Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and accrued expenses", "totalLabel": "Accounts Payable and Accrued Liabilities, Total" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r26", "r27", "r28", "r236", "r667", "r685", "r689" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive loss", "totalLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax, Total" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r25", "r28", "r141", "r606", "r680", "r681", "r810", "r811", "r812", "r833", "r834", "r835" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Loss [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r84" ], "lang": { "en-us": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life", "terseLabel": "Weighted-average useful life of acquired intangible lease assets (in years)", "verboseLabel": "Capitalized lease intangibles, weighted average life (in years)" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesIntangibleAssetsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r9" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid in Capital, Common Stock", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r473", "r474", "r475", "r833", "r834", "r835", "r896" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r221", "r222", "r223", "r224", "r225", "r282", "r283", "r284", "r285", "r294", "r346", "r347", "r356", "r357", "r358", "r359", "r360", "r361", "r473", "r474", "r475", "r494", "r495", "r496", "r497", "r510", "r511", "r512", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r544", "r545", "r547", "r548", "r549", "r550", "r551", "r552", "r565", "r566", "r572", "r573", "r574", "r575", "r601", "r602", "r603", "r604", "r605", "r606", "r646", "r647", "r648", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689" ], "lang": { "en-us": { "role": { "documentation": "Information by amendment to accounting standards.", "label": "Accounting Standards Update [Axis]", "terseLabel": "Accounting Standards Update" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock": { "auth_ref": [ "r76", "r849" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allowance for credit loss on financing receivable.", "label": "Financing Receivable, Allowance for Credit Loss [Table Text Block]", "terseLabel": "Summary of Credit Loss Reserves" } } }, "localname": "AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "auth_ref": [ "r419", "r568", "r778", "r779", "r819" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.", "label": "Amortization of Debt Issuance Costs and Discounts", "terseLabel": "Amortization of deferred financing costs and debt discount", "totalLabel": "Amortization of Debt Issuance Costs and Discounts, Total" } } }, "localname": "AmortizationOfFinancingCostsAndDiscounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative" } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r171", "r191", "r232", "r260", "r328", "r333", "r339", "r351", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r515", "r519", "r543", "r791", "r855", "r856", "r906" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsSoldUnderAgreementsToRepurchaseAxis": { "auth_ref": [ "r264" ], "lang": { "en-us": { "role": { "documentation": "Information by securities or other assets sold under repurchase agreements. Repurchase agreements are agreements under which the transferor (repo party) transfers a security to a transferee (repo counterparty or reverse party) in exchange for cash and concurrently agrees to reacquire that security at a future date for an amount equal to the cash exchanged plus a stipulated interest factor.", "label": "Securities or Other Assets Sold under Agreements to Repurchase [Axis]" } } }, "localname": "AssetsSoldUnderAgreementsToRepurchaseAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsSoldUnderAgreementsToRepurchaseTypeDomain": { "auth_ref": [ "r264" ], "lang": { "en-us": { "role": { "documentation": "This is the type of such assets (for example, US Treasury Obligations, US Government agency obligations and loans, and so forth). This item may be presented as an element in the table that is disclosed when the carrying amount (or market value, if higher than the carrying amount) of securities or other assets sold under repurchase agreements exceed 10 percent of total assets, as of the most recent balance sheet date.", "label": "Assets Sold under Agreements to Repurchase, Type [Domain]" } } }, "localname": "AssetsSoldUnderAgreementsToRepurchaseTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AssetsTotalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total assets, when it serves as a benchmark in a concentration of risk calculation, representing the sum of all reported assets as of the balance sheet date.", "label": "Assets, Total [Member]", "terseLabel": "Total Gross Assets [Member]" } } }, "localname": "AssetsTotalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AwardDateAxis": { "auth_ref": [ "r863", "r864", "r865", "r866", "r867", "r868", "r869", "r870", "r871", "r872", "r873", "r874", "r875", "r876", "r877", "r878", "r879", "r880", "r881", "r882", "r883", "r884", "r885", "r886", "r887", "r888" ], "lang": { "en-us": { "role": { "documentation": "Information by date or year award under share-based payment arrangement is granted.", "label": "Award Date [Axis]", "terseLabel": "Award Date" } } }, "localname": "AwardDateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateDomain": { "auth_ref": [ "r863", "r864", "r865", "r866", "r867", "r868", "r869", "r870", "r871", "r872", "r873", "r874", "r875", "r876", "r877", "r878", "r879", "r880", "r881", "r882", "r883", "r884", "r885", "r886", "r887", "r888" ], "lang": { "en-us": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted.", "label": "Award Date [Domain]", "terseLabel": "Award Date" } } }, "localname": "AwardDateDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsStockBasedAwardActivityDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r150", "r151" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "xbrltype": "domainItemType" }, "us-gaap_BuildingAndBuildingImprovementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.", "label": "Building and Building Improvements [Member]", "terseLabel": "Buildings and improvements [Member]" } } }, "localname": "BuildingAndBuildingImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfRelatedRealEstateAndOtherAssetsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_BuildingMember": { "auth_ref": [ "r88" ], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building [Member]", "terseLabel": "Building [Member]" } } }, "localname": "BuildingMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "xbrltype": "domainItemType" }, "us-gaap_BuildingsAndImprovementsGross": { "auth_ref": [ "r88" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "mpw_GrossInvestmentInRealEstateAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.", "label": "Buildings and Improvements, Gross", "terseLabel": "Buildings and improvements" } } }, "localname": "BuildingsAndImprovementsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r509", "r783", "r784" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDLOMBySensitivityAnalysisByUsingBasisPointVariationsDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDisposalsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r124", "r125", "r509", "r783", "r784" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDLOMBySensitivityAnalysisByUsingBasisPointVariationsDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDisposalsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDisposalsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherDisposalTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesRentDeferralsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "auth_ref": [ "r123" ], "lang": { "en-us": { "role": { "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.", "label": "Business Acquisition, Percentage of Voting Interests Acquired", "terseLabel": "Ownership interest" } } }, "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r128", "r129", "r130" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "terseLabel": "Purchase price of acquisition", "totalLabel": "Business Combination, Consideration Transferred, Total", "verboseLabel": "Funded for interim mortgage loan" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDisposalsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferredOther1": { "auth_ref": [ "r131" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash.", "label": "Business Combination, Consideration Transferred, Other", "terseLabel": "Consideration of other transaction costs" } } }, "localname": "BusinessCombinationConsiderationTransferredOther1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "auth_ref": [ "r127" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail": { "order": 0.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets acquired at the acquisition date.", "label": "Additional mortgage loan", "terseLabel": "Total assets acquired", "totalLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Total", "verboseLabel": "Acquisition loan" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "auth_ref": [ "r127" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities", "negatedLabel": "Liabilities assumed", "totalLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities, Total" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "auth_ref": [ "r126", "r127" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net", "totalLabel": "Total net assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r55", "r229", "r761" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "periodEndLabel": "Cash and cash equivalents at end of period", "periodStartLabel": "Cash and cash equivalents at beginning of period", "terseLabel": "Cash and cash equivalents", "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r56" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]", "verboseLabel": "Cash, cash equivalents, and restricted cash are comprised of the following:" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r49", "r55", "r57" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of year", "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of year", "terseLabel": "Cash, cash equivalents, and restricted cash at beginning of year", "totalLabel": "Cash, cash equivalents, and restricted cash at beginning of year" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r49", "r161" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "Decrease in cash, cash equivalents, and restricted cash for the year" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted": { "auth_ref": [ "r221", "r222", "r281", "r346", "r347", "r353", "r354", "r355", "r356", "r357", "r494", "r510", "r511", "r522", "r524", "r525", "r535", "r544", "r546", "r547", "r548", "r551", "r552", "r565", "r571", "r572", "r573", "r574", "r601", "r602", "r646", "r647", "r678", "r679" ], "lang": { "en-us": { "role": { "documentation": "Indicates (true false) whether accounting standards update was adopted.", "label": "Change in Accounting Principle, Accounting Standards Update, Adopted [true false]", "terseLabel": "Change in Accounting Principle, Accounting Standards Update, Adopted [true false]" } } }, "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "booleanItemType" }, "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate": { "auth_ref": [ "r221", "r222", "r346", "r347", "r353", "r354", "r355", "r356", "r357", "r494", "r510", "r511", "r512", "r522", "r524", "r525", "r526", "r529", "r535", "r544", "r546", "r547", "r548", "r551", "r552", "r565", "r571", "r572", "r573", "r574", "r601", "r602", "r646", "r647", "r678", "r679", "r837" ], "lang": { "en-us": { "role": { "documentation": "Date accounting standards update was adopted, in YYYY-MM-DD format.", "label": "Change in Accounting Principle, Accounting Standards Update, Adoption Date", "terseLabel": "Change in Accounting Principle, Accounting Standards Update, Adoption Date" } } }, "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "dateItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]", "terseLabel": "Class Of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r20", "r180", "r199" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r90", "r389", "r390", "r718", "r852" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockDividendsPerShareCashPaid": { "auth_ref": [ "r104" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfPerShareDistributionsToStockholdersDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding.", "label": "Common Stock, Dividends, Per Share, Cash Paid", "terseLabel": "Common share distribution", "totalLabel": "Total" } } }, "localname": "CommonStockDividendsPerShareCashPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfPerShareDistributionsToStockholdersDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r104" ], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Common Stock, Dividends, Per Share, Declared", "terseLabel": "Dividends (Distributions) declared per common share / unit" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapitalParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r833", "r834", "r896" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Units [Member]", "verboseLabel": "Common Par Value [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapitalParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r8", "r97" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "Common Stock, Shares, Outstanding, Ending Balance", "periodStartLabel": "Common Stock, Shares, Outstanding, Beginning Balance", "terseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r8", "r791" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.001 par value. Authorized 750,000 shares; issued and outstanding - 597,476 shares at December 31, 2022 and 596,748 shares at December 31, 2021" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationRelatedCostsPolicyTextBlock": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.", "label": "Compensation Related Costs, Policy [Policy Text Block]", "terseLabel": "Stock-Based Compensation" } } }, "localname": "CompensationRelatedCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r29", "r242", "r244", "r253", "r664", "r670" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive income attributable to MPT common stockholders (Operating Partnership Partners)" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r135", "r136", "r144", "r242", "r244", "r252", "r663", "r669" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "negatedLabel": "Comprehensive income attributable to non-controlling interests", "totalLabel": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest, Total" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r134", "r144", "r242", "r244", "r251", "r662", "r668" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveIncome": { "order": 0.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Total comprehensive income" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r67", "r68", "r159", "r160", "r344", "r717" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r67", "r68", "r159", "r160", "r344", "r690", "r717" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r67", "r68", "r159", "r160", "r344", "r717", "r921" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r67", "r68", "r159", "r160", "r344" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Percentage of total assets", "verboseLabel": "Percentage of concentration risk" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r67", "r68", "r159", "r160", "r344", "r717" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r138", "r766" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConstructionInProgressGross": { "auth_ref": [ "r88" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "mpw_GrossInvestmentInRealEstateAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction in Progress, Gross", "terseLabel": "Construction in progress" } } }, "localname": "ConstructionInProgressGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r432", "r433", "r434" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability", "terseLabel": "Deferred revenue", "totalLabel": "Contract with Customer, Liability, Total" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CorporateJointVentureMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Corporation owned and operated by a small group of ventures to accomplish a mutually beneficial venture or project.", "label": "Corporate Joint Venture [Member]", "terseLabel": "Joint Venture [Member]" } } }, "localname": "CorporateJointVentureMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CorporateMember": { "auth_ref": [ "r841" ], "lang": { "en-us": { "role": { "documentation": "Component of an entity that usually provides financial, operational and administrative support and is considered an operating segment. Excludes intersegment elimination and reconciling items.", "label": "Corporate Segment [Member]", "terseLabel": "Corporate [Member]" } } }, "localname": "CorporateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r34", "r645" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Costs Incurred as of December 31, 2022", "totalLabel": "Cost of Goods and Services Sold, Total" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r33" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs and Expenses", "totalLabel": "Total expenses" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Costs and Expenses [Abstract]", "terseLabel": "Expenses" } } }, "localname": "CostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtInterimCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtJuly2021InterimCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtInterimCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtJuly2021InterimCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "auth_ref": [ "r824", "r892", "r894" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfIncomeTaxExpenseBenefitDetail": { "order": 0.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Current Federal Tax Expense (Benefit)", "negatedLabel": "Domestic" } } }, "localname": "CurrentFederalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfIncomeTaxExpenseBenefitDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "auth_ref": [ "r824", "r892" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfIncomeTaxExpenseBenefitDetail": { "order": 1.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Foreign Tax Expense (Benefit)", "negatedLabel": "Foreign" } } }, "localname": "CurrentForeignTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfIncomeTaxExpenseBenefitDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r122", "r491", "r501", "r824" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfIncomeTaxExpenseBenefitDetail": { "order": 0.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current Income Tax Expense (Benefit)", "negatedTotalLabel": "Total income tax expense", "totalLabel": "Current Income Tax Expense (Benefit), Total" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfIncomeTaxExpenseBenefitDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Current income tax (expense) benefit:" } } }, "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfIncomeTaxExpenseBenefitDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r65", "r344" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentration Risk [Member]", "verboseLabel": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r1", "r2", "r3", "r172", "r175", "r189", "r268", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r569", "r775", "r776", "r777", "r778", "r779", "r822" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtInterimCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r3", "r175", "r189", "r421" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail": { "order": 0.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-Term Debt, Gross", "terseLabel": "Debt", "totalLabel": "Total" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r163", "r165", "r404", "r569", "r776", "r777" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "verboseLabel": "Par Value" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFrequencyOfPeriodicPayment": { "auth_ref": [ "r19", "r186" ], "lang": { "en-us": { "role": { "documentation": "Description of the frequency of periodic payments (monthly, quarterly, annual).", "label": "Debt Instrument, Frequency of Periodic Payment", "terseLabel": "Interest Payment Frequency" } } }, "localname": "DebtInstrumentFrequencyOfPeriodicPayment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r17", "r163", "r423", "r569" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument, Interest Rate, Effective Percentage", "terseLabel": "Interest rate at end of period", "verboseLabel": "Effective interest rate" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r17", "r405" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Senior unsecured notes, interest rate", "verboseLabel": "Senior unsecured notes, interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtInterimCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtInterimCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtJuly2021InterimCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSeniorUnsecuredNotesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r238", "r775", "r897" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Debt Instrument, Maturity Date", "terseLabel": "Debt instrument maturity date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentMaturityDateDescription": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.", "label": "Debt Instrument, Maturity Date, Description", "terseLabel": "Debt instrument amendment extended maturity date description" } } }, "localname": "DebtInstrumentMaturityDateDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r19", "r268", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r569", "r775", "r776", "r777", "r778", "r779", "r822" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtInterimCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r19", "r98", "r101", "r102", "r103", "r162", "r163", "r165", "r187", "r268", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r569", "r775", "r776", "r777", "r778", "r779", "r822" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table]", "terseLabel": "Debt Instrument [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBasicTermsOfSeniorUnsecuredNotesDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtInterimCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtJuly2021InterimCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSeniorUnsecuredNotesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredChargesPolicyTextBlock": { "auth_ref": [ "r231" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges.", "label": "Deferred Charges, Policy [Policy Text Block]", "terseLabel": "Deferred Costs" } } }, "localname": "DeferredChargesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]" } } }, "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [ "r824", "r893", "r894" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfIncomeTaxExpenseBenefitDetail": { "order": 0.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred Federal Income Tax Expense (Benefit)", "negatedLabel": "Domestic" } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfIncomeTaxExpenseBenefitDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsGross": { "auth_ref": [ "r164" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Gross", "terseLabel": "Accelerated debt issue cost amortization expense" } } }, "localname": "DeferredFinanceCostsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r164", "r860" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Net", "negatedLabel": "Debt issue costs and discount, net", "totalLabel": "Debt Issuance Costs, Net, Total" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "auth_ref": [ "r122", "r824", "r893" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfIncomeTaxExpenseBenefitDetail": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Foreign Income Tax Expense (Benefit)", "negatedLabel": "Foreign" } } }, "localname": "DeferredForeignIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfIncomeTaxExpenseBenefitDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeNoncurrent": { "auth_ref": [ "r853" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Deferred Income, Noncurrent", "terseLabel": "Deferred lease income" } } }, "localname": "DeferredIncomeNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesRentDeferralsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r53", "r122", "r492", "r500", "r501", "r824" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfIncomeTaxExpenseBenefitDetail": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "negatedTotalLabel": "Total income tax expense", "totalLabel": "Deferred Income Tax Expense (Benefit), Total" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfIncomeTaxExpenseBenefitDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Deferred income tax (expense) benefit:" } } }, "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfIncomeTaxExpenseBenefitDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r5", "r6", "r173", "r188", "r486" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred Tax Liabilities, Gross", "negatedTotalLabel": "Total deferred tax liabilities", "totalLabel": "Deferred Tax Liabilities, Gross, Total" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRentReceivablesNet": { "auth_ref": [ "r217", "r218", "r219", "r902" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of rental income recognized over rental payment required by lease.", "label": "Deferred Rent Receivables, Net", "terseLabel": "Cash rent" } } }, "localname": "DeferredRentReceivablesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r487" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 0.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "totalLabel": "Total deferred tax assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r890" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 0.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Net of Valuation Allowance", "totalLabel": "Total net deferred tax assets" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r120", "r891" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 0.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards", "terseLabel": "Operating loss and interest deduction carry forwards", "totalLabel": "Deferred Tax Assets, Operating Loss Carryforwards, Total" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOther": { "auth_ref": [ "r120", "r891" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.", "label": "Deferred Tax Assets, Other", "terseLabel": "Other" } } }, "localname": "DeferredTaxAssetsOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r488" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r113", "r890" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Deferred Tax Liabilities, Net", "negatedTotalLabel": "Net deferred tax asset (liability)", "totalLabel": "Deferred Tax Liabilities, Net, Total" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesInvestments": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from investments (excludes investments in subsidiaries and equity method investments).", "label": "Deferred Tax Liabilities, Investments", "negatedLabel": "Partnership investments" } } }, "localname": "DeferredTaxLiabilitiesInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesOther": { "auth_ref": [ "r120", "r891" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 3.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.", "label": "Deferred Tax Liabilities, Other", "negatedLabel": "Other" } } }, "localname": "DeferredTaxLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": { "auth_ref": [ "r120", "r891" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 0.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.", "label": "Deferred Tax Liabilities, Property, Plant and Equipment", "negatedLabel": "Property and equipment" } } }, "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r53", "r87" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails": { "order": 0.0, "parentTag": "mpw_GainLossOnDispositionOfRealEstate", "weight": -1.0 }, "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "order": 1.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation, Depletion and Amortization, Nonproduction", "negatedLabel": "Real estate depreciation and amortization", "terseLabel": "Real estate depreciation and amortization", "totalLabel": "Depreciation, Depletion and Amortization, Nonproduction, Total" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r53", "r323" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization", "totalLabel": "Depreciation, Depletion and Amortization, Total" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration": { "auth_ref": [ "r521" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes derivative asset.", "label": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r239", "r240", "r542", "r764" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset", "terseLabel": "Derivative asset", "totalLabel": "Derivative Asset, Total" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r239", "r240", "r542", "r764" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "terseLabel": "Derivative liability", "totalLabel": "Derivative Liability, Total" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration": { "auth_ref": [ "r521" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes derivative liability.", "label": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r146", "r147", "r148", "r149", "r152", "r267" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivatives, Policy [Policy Text Block]", "terseLabel": "Derivative Financial Investments and Hedging Activities" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock": { "auth_ref": [ "r311", "r598" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of components of lease income from direct financing lease.", "label": "Direct Financing Lease, Lease Income [Table Text Block]", "terseLabel": "Components of Total Investment in Financing Leases" } } }, "localname": "DirectFinancingLeaseLeaseIncomeTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DirectFinancingLeaseLeaseReceivable": { "auth_ref": [ "r599" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail": { "order": 0.0, "parentTag": "us-gaap_DirectFinancingLeaseNetInvestmentInLease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Present value of lease payments not yet received by lessor and amount expected to be derived from underlying asset, following end of lease term, guaranteed by lessee or other third party unrelated to lessor, from direct financing lease.", "label": "Direct Financing Lease, Lease Receivable", "terseLabel": "Minimum lease payments receivable" } } }, "localname": "DirectFinancingLeaseLeaseReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DirectFinancingLeaseNetInvestmentInLease": { "auth_ref": [ "r345", "r368", "r599", "r848" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail": { "order": 0.0, "parentTag": "us-gaap_NetInvestmentInLease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of net investment in direct financing lease.", "label": "Direct Financing Lease, Net Investment in Lease, before Allowance for Credit Loss", "totalLabel": "Net investment in direct financing leases" } } }, "localname": "DirectFinancingLeaseNetInvestmentInLease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DirectFinancingLeaseNetInvestmentInLeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Direct Financing Lease, Net Investment in Lease, before Allowance for Credit Loss [Abstract]", "terseLabel": "Direct Financing Lease Net Investment In Leases [Abstract]" } } }, "localname": "DirectFinancingLeaseNetInvestmentInLeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DirectFinancingLeaseRevenue": { "auth_ref": [ "r311", "r597" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "order": 2.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of direct financing lease revenue.", "label": "Direct Financing Lease, Revenue", "terseLabel": "Income from financing leases" } } }, "localname": "DirectFinancingLeaseRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_DirectFinancingLeaseUnguaranteedResidualAsset": { "auth_ref": [ "r599" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail": { "order": 1.0, "parentTag": "us-gaap_DirectFinancingLeaseNetInvestmentInLease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Present value expected to be derived from underlying asset, following end of lease term, not guaranteed by lessee or other third party unrelated to lessor.", "label": "Direct Financing Lease, Unguaranteed Residual Asset", "terseLabel": "Estimated residual values", "verboseLabel": "Estimated unguaranteed residual values" } } }, "localname": "DirectFinancingLeaseUnguaranteedResidualAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r442", "r469", "r470", "r472", "r476", "r786" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-Based Payment Arrangement [Text Block]", "terseLabel": "Stock Awards" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwards" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupClassificationAxis": { "auth_ref": [ "r227" ], "lang": { "en-us": { "role": { "documentation": "Information by disposal group classification.", "label": "Disposal Group Classification [Axis]" } } }, "localname": "DisposalGroupClassificationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupClassificationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.", "label": "Disposal Group Classification [Domain]" } } }, "localname": "DisposalGroupClassificationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupNotDiscontinuedOperationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disposal group that is not classified as discontinued operations.", "label": "Disposal Group, Not Discontinued Operations [Member]", "terseLabel": "Disposal Group, Not Discontinued Operations [Member]" } } }, "localname": "DisposalGroupNotDiscontinuedOperationsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DividendsCommonStockCash": { "auth_ref": [ "r104" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.", "label": "Dividends, Common Stock, Cash", "negatedLabel": "Dividends (Distributions) declared" } } }, "localname": "DividendsCommonStockCash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPayableCurrentAndNoncurrent": { "auth_ref": [ "r2", "r4", "r174", "r192" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.", "label": "Dividends Payable", "terseLabel": "Dividends declared, unpaid" } } }, "localname": "DividendsPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueFromJointVentures": { "auth_ref": [ "r166", "r167", "r203" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For an unclassified balance sheet, amounts due from an entity in which the reporting entity shares joint control with another party or group.", "label": "Due from Joint Ventures", "terseLabel": "Shareholder loan to joint venture" } } }, "localname": "DueFromJointVentures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings per common share - basic and diluted" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r254", "r286", "r287", "r288", "r289", "r290", "r295", "r297", "r303", "r304", "r305", "r309", "r533", "r534", "r665", "r671", "r770" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Net income attributable to MPT common stockholders (Operating Partnership partners), basic", "totalLabel": "Earnings Per Share, Basic, Total" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic [Abstract]", "terseLabel": "Earnings per common share (units) basic" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasicLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]", "terseLabel": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]" } } }, "localname": "EarningsPerShareBasicLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r254", "r286", "r287", "r288", "r289", "r290", "r297", "r303", "r304", "r305", "r309", "r533", "r534", "r665", "r671", "r770" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Net income attributable to MPT common stockholders (Operating Partnership partners), diluted", "totalLabel": "Earnings Per Share, Diluted, Total" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted [Abstract]", "terseLabel": "Earnings per common share (units) diluted" } } }, "localname": "EarningsPerShareDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r60", "r61" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Earnings Per Share/Units" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r306", "r307", "r308", "r310" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings Per Share/Unit" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureEarningsPerShareUnit" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r555" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "terseLabel": "Effect of exchange rate changes" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r262", "r481", "r503" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "Income tax at the US statutory federal rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxBenefitExpenseFromStatutoryIncomeTaxRateToEffectiveTaxRateBasedOnIncomeBeforeIncomeTaxesParentheticalDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r471" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Stock-based compensation expense, unrecognized cost", "totalLabel": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r471" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Stock-based compensation expense, unrecognized cost, reorganization period (in years)" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r97", "r223", "r246", "r247", "r248", "r277", "r278", "r279", "r283", "r291", "r293", "r312", "r359", "r431", "r473", "r474", "r475", "r496", "r497", "r532", "r557", "r558", "r559", "r560", "r561", "r562", "r606", "r680", "r681", "r682" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapitalParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentAggregateCost": { "auth_ref": [ "r14" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the aggregate cost of investments accounted for under the equity method of accounting.", "label": "Equity Method Investment, Aggregate Cost", "terseLabel": "Equity investment" } } }, "localname": "EquityMethodInvestmentAggregateCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r82" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Passive equity interest", "terseLabel": "Ownership interest", "verboseLabel": "Percentage of equity investment" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDisposalsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Method Investments and Joint Ventures [Abstract]" } } }, "localname": "EquityMethodInvestmentsAndJointVenturesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": { "auth_ref": [ "r672", "r846" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).", "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)", "terseLabel": "Equity investments unrealized gain/loss", "totalLabel": "Equity Securities, FV-NI, Unrealized Gain (Loss), Total" } } }, "localname": "EquitySecuritiesFvNiUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTextBlock": { "auth_ref": [ "r155", "r158" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.", "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]", "terseLabel": "Summary of Fair Value Information of Financial Instruments" } } }, "localname": "FairValueByBalanceSheetGroupingTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r536", "r537", "r538", "r539", "r541" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r540" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r540", "r541" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Fair Value, Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r156", "r157" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair Value Measurement" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinanceLeaseInterestExpense": { "auth_ref": [ "r579", "r584", "r790" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail": { "order": 2.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense on finance lease liability.", "label": "Finance Lease, Interest Expense", "terseLabel": "Interest on lease liabilities" } } }, "localname": "FinanceLeaseInterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseInterestPaymentOnLiability": { "auth_ref": [ "r580", "r587" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest paid on finance lease liability.", "label": "Finance Lease, Interest Payment on Liability", "terseLabel": "Operating cash flows used for finance leases" } } }, "localname": "FinanceLeaseInterestPaymentOnLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalCashFlowInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiability": { "auth_ref": [ "r577", "r592" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail2": { "order": 1.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 }, "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail": { "order": 1.0, "parentTag": "mpw_OperatingAndFinanceLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.", "label": "Finance Lease, Liability", "terseLabel": "Finance Leases, Present value of lease liabilities", "totalLabel": "Finance Lease, Liability, Total", "verboseLabel": "Financing leases" } } }, "localname": "FinanceLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDue": { "auth_ref": [ "r592" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail2": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.", "label": "Finance Lease, Liability, to be Paid", "totalLabel": "Finance Leases, Total undiscounted minimum lease payments" } } }, "localname": "FinanceLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r592" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "order": 5.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, after Year Five", "terseLabel": "Finance Leases, Thereafter" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r592" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "order": 0.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year One", "terseLabel": "Finance Leases, 2023" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r592" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "order": 4.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Five", "terseLabel": "Finance Leases, 2027" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r592" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "order": 3.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Four", "terseLabel": "Finance Leases, 2026" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r592" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "order": 2.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Three", "terseLabel": "Finance Leases, 2025" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r592" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "order": 1.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Two", "terseLabel": "Finance Leases, 2024" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r578" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes finance lease liability.", "label": "Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r592" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail2": { "order": 0.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.", "label": "Finance Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Finance Leases, Less: interest" } } }, "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAsset": { "auth_ref": [ "r576" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail": { "order": 1.0, "parentTag": "mpw_LesseeOperatingLeaseAndFinanceLeaseRealEstateRightOfUseAssetNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.", "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization", "terseLabel": "Finance leases", "totalLabel": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization, Total" } } }, "localname": "FinanceLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAssetAmortization": { "auth_ref": [ "r579", "r584", "r790" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail": { "order": 1.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.", "label": "Finance Lease, Right-of-Use Asset, Amortization", "terseLabel": "Amortization of right-of-use assets" } } }, "localname": "FinanceLeaseRightOfUseAssetAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r578" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset.", "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]" } } }, "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r590", "r790" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for finance lease calculated at point in time.", "label": "Finance Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Finance leases" } } }, "localname": "FinanceLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r589", "r790" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Finance Lease, Weighted Average Remaining Lease Term", "terseLabel": "Finance leases" } } }, "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r348", "r349", "r363", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r420", "r429", "r523", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r621", "r622", "r623", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r773", "r843", "r844", "r845", "r930", "r931", "r932", "r933", "r934", "r935", "r936" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivableAllowanceForCreditLosses": { "auth_ref": [ "r73", "r237", "r362", "r364", "r366", "r734", "r735", "r736", "r915" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on financing receivable. Excludes allowance for financing receivable covered under loss sharing agreement.", "label": "Financing Receivable, Allowance for Credit Loss", "periodEndLabel": "Balance at end of year", "periodStartLabel": "Balance at beginning of the year", "terseLabel": "Credit loss reserve" } } }, "localname": "FinancingReceivableAllowanceForCreditLosses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCreditLossReservesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease": { "auth_ref": [ "r72", "r849" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in allowance for credit loss on financing receivable.", "label": "Financing Receivable, Allowance for Credit Loss, Period Increase (Decrease)", "terseLabel": "Increase in credit loss reserves on financing-type receivables", "totalLabel": "Financing Receivable, Allowance for Credit Loss, Period Increase (Decrease), Total" } } }, "localname": "FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r230", "r383" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "terseLabel": "Accumulated amortization, net" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesIntangibleAssetsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r86" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAmortizationExpenseFromExistingLeaseIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r86" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "terseLabel": "2027" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAmortizationExpenseFromExistingLeaseIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r86" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAmortizationExpenseFromExistingLeaseIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r86" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAmortizationExpenseFromExistingLeaseIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r86" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAmortizationExpenseFromExistingLeaseIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FirstMortgageMember": { "auth_ref": [ "r794" ], "lang": { "en-us": { "role": { "documentation": "Loan secured by real property that has a first (highest) lien on such property in the event of default by the borrower.", "label": "First Mortgage [Member]", "terseLabel": "Long-Term First Mortgage Loan [Member]" } } }, "localname": "FirstMortgageMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateParentheticalDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.", "label": "Foreign Tax Authority [Member]", "terseLabel": "United Kingdom [Member]" } } }, "localname": "ForeignCountryMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r564" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "terseLabel": "Foreign Currency Translation and Transactions" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GainLossOnDispositionOfRealEstateDiscontinuedOperations": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between the carrying amount and the sales price of real estate properties sold as part of discontinued operations.", "label": "Gain (Loss) on Disposition of Real Estate, Discontinued Operations", "verboseLabel": "Gain (loss) on real estate dispositions" } } }, "localname": "GainLossOnDispositionOfRealEstateDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDisposalsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherDisposalTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfInvestments": { "auth_ref": [ "r53" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.", "label": "Gain (Loss) on Sale of Investments", "negatedLabel": "Gain on sale of equity investments", "terseLabel": "Gains", "totalLabel": "Gain (Loss) on Sale of Investments, Total" } } }, "localname": "GainLossOnSaleOfInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnSalesOfInvestmentRealEstate": { "auth_ref": [ "r674", "r675", "r676", "r813", "r814", "r819", "r916", "r918" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net gain (loss) resulting from sales and other disposals of real estate owned for investment purposes.", "label": "Gains (Losses) on Sales of Investment Real Estate", "negatedLabel": "(Gain) loss from sale of real estate", "terseLabel": "Gain (loss) on sale of real estate" } } }, "localname": "GainsLossesOnSalesOfInvestmentRealEstate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r35" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "order": 3.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative", "totalLabel": "General and Administrative Expense, Total" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralPartnerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Party to a partnership business who has unlimited liability.", "label": "General Partner [Member]", "terseLabel": "General Partner [Member]" } } }, "localname": "GeneralPartnerMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapitalParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_GeneralPartnersCapitalAccount": { "auth_ref": [ "r107" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of the general partner's ownership interest.", "label": "General Partners' Capital Account", "terseLabel": "General partner - issued and outstanding - 5976 units at December 31, 2022 and 5,968 units at December 31, 2021", "totalLabel": "General Partners' Capital Account, Total" } } }, "localname": "GeneralPartnersCapitalAccount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralPartnersCapitalAccountUnitsIssued": { "auth_ref": [ "r107" ], "lang": { "en-us": { "role": { "documentation": "The number of general partner units issued.", "label": "General Partners' Capital Account, Units Issued", "terseLabel": "General partner, units issued" } } }, "localname": "GeneralPartnersCapitalAccountUnitsIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_GeneralPartnersCapitalAccountUnitsOutstanding": { "auth_ref": [ "r107" ], "lang": { "en-us": { "role": { "documentation": "The number of general partner units outstanding.", "label": "General Partners' Capital Account, Units Outstanding", "terseLabel": "General partner, units outstanding" } } }, "localname": "GeneralPartnersCapitalAccountUnitsOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_GeographicConcentrationRiskMember": { "auth_ref": [ "r66", "r717" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa).", "label": "Geographic Concentration Risk [Member]", "terseLabel": "Geographic Concentration [Member]" } } }, "localname": "GeographicConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairmentOfRealEstate": { "auth_ref": [ "r819", "r850" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The charge against earnings in the period to reduce the carrying amount of real property to fair value.", "label": "Impairment of Real Estate", "terseLabel": "Impairment charge", "verboseLabel": "Real estate impairment charge" } } }, "localname": "ImpairmentOfRealEstate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "auth_ref": [ "r261", "r502" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic", "terseLabel": "Amount of domestic income (loss) before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r30", "r168", "r182", "r206", "r328", "r332", "r338", "r340", "r666", "r772" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "order": 0.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "terseLabel": "Income before income tax", "totalLabel": "Income before income tax" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitFromStatutoryIncomeTaxRateToEffectiveTaxRateBasedOnIncomeBeforeIncomeTaxesDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "auth_ref": [ "r261", "r502" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign", "terseLabel": "Amount of foreign income (loss) before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r31", "r53", "r81", "r181", "r204", "r325" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "order": 5.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Income (Loss) from Equity Method Investments", "terseLabel": "Earnings from equity interests" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r384", "r386" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r386" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseParentheticalDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r115" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]", "terseLabel": "Income Tax Authority" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]", "terseLabel": "Income Tax Authority" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r262", "r482", "r484", "r490", "r498", "r504", "r506", "r507", "r508" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r263", "r292", "r293", "r326", "r480", "r499", "r505", "r673" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfIncomeTaxExpenseBenefitDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitFromStatutoryIncomeTaxRateToEffectiveTaxRateBasedOnIncomeBeforeIncomeTaxesDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Income tax expense", "negatedTotalLabel": "Income tax (expense)", "terseLabel": "Income tax expense (benefit)", "totalLabel": "Income Tax Expense (Benefit), Total" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfIncomeTaxExpenseBenefitDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitFromStatutoryIncomeTaxRateToEffectiveTaxRateBasedOnIncomeBeforeIncomeTaxesDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]", "terseLabel": "Decrease (increase) in income tax resulting from:" } } }, "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitFromStatutoryIncomeTaxRateToEffectiveTaxRateBasedOnIncomeBeforeIncomeTaxesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r245", "r478", "r479", "r484", "r485", "r489", "r493" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r889" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitFromStatutoryIncomeTaxRateToEffectiveTaxRateBasedOnIncomeBeforeIncomeTaxesDetail": { "order": 5.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount", "negatedLabel": "Change in valuation allowance" } } }, "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitFromStatutoryIncomeTaxRateToEffectiveTaxRateBasedOnIncomeBeforeIncomeTaxesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": { "auth_ref": [ "r477", "r481" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitFromStatutoryIncomeTaxRateToEffectiveTaxRateBasedOnIncomeBeforeIncomeTaxesDetail": { "order": 6.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.", "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount", "negatedLabel": "Statutory tax rate change", "terseLabel": "Change in the corporate income tax rate , charge" } } }, "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitFromStatutoryIncomeTaxRateToEffectiveTaxRateBasedOnIncomeBeforeIncomeTaxesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": { "auth_ref": [ "r889" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitFromStatutoryIncomeTaxRateToEffectiveTaxRateBasedOnIncomeBeforeIncomeTaxesDetail": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount", "negatedLabel": "Foreign rate differential" } } }, "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitFromStatutoryIncomeTaxRateToEffectiveTaxRateBasedOnIncomeBeforeIncomeTaxesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r481" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitFromStatutoryIncomeTaxRateToEffectiveTaxRateBasedOnIncomeBeforeIncomeTaxesDetail": { "order": 0.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount", "negatedLabel": "Income tax (expense) at the U.S. statutory federal rate (21% in 2022, 2021, and 2020)" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitFromStatutoryIncomeTaxRateToEffectiveTaxRateBasedOnIncomeBeforeIncomeTaxesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationOtherAdjustments": { "auth_ref": [ "r889" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitFromStatutoryIncomeTaxRateToEffectiveTaxRateBasedOnIncomeBeforeIncomeTaxesDetail": { "order": 8.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount", "negatedLabel": "Other items, net" } } }, "localname": "IncomeTaxReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitFromStatutoryIncomeTaxRateToEffectiveTaxRateBasedOnIncomeBeforeIncomeTaxesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r889" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitFromStatutoryIncomeTaxRateToEffectiveTaxRateBasedOnIncomeBeforeIncomeTaxesDetail": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount", "negatedLabel": "State income taxes, net of federal benefit" } } }, "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitFromStatutoryIncomeTaxRateToEffectiveTaxRateBasedOnIncomeBeforeIncomeTaxesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationTaxExemptIncome": { "auth_ref": [ "r889" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitFromStatutoryIncomeTaxRateToEffectiveTaxRateBasedOnIncomeBeforeIncomeTaxesDetail": { "order": 3.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income (loss) exempt from income taxes.", "label": "Effective Income Tax Rate Reconciliation, Tax Exempt Income, Amount", "terseLabel": "U.S. earnings not subject to federal income tax" } } }, "localname": "IncomeTaxReconciliationTaxExemptIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitFromStatutoryIncomeTaxRateToEffectiveTaxRateBasedOnIncomeBeforeIncomeTaxesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r52" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and accrued expenses", "totalLabel": "Increase (Decrease) in Accounts Payable and Accrued Liabilities, Total" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r644", "r818" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "terseLabel": "Deferred revenue" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDerivativeAssets": { "auth_ref": [ "r818" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the carrying value of derivative instruments reported as assets that are due to be disposed of within one year (or the normal operating cycle, if longer).", "label": "Increase (Decrease) in Derivative Assets", "terseLabel": "Increase in derivative assets" } } }, "localname": "IncreaseDecreaseInDerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureOtherAssetsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r52" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other assets", "totalLabel": "Increase (Decrease) in Other Operating Assets, Total" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r298", "r299", "r300", "r305", "r441" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "terseLabel": "Dilutive potential common shares" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_InterestAndOtherIncome": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "order": 3.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).", "label": "Interest and Other Income", "terseLabel": "Interest and other income" } } }, "localname": "InterestAndOtherIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r164", "r185", "r249", "r322", "r567" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "order": 0.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "terseLabel": "Interest", "totalLabel": "Interest Expense, Total" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaid": { "auth_ref": [ "r820" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.", "label": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities", "terseLabel": "Interest paid, including capitalized interest of $6,454 in 2022, $3,289 in 2021, and $3,030 in 2020", "totalLabel": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities, Total" } } }, "localname": "InterestPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidCapitalized": { "auth_ref": [ "r765", "r820" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest capitalized, classified as investing activity.", "label": "Interest Paid, Capitalized, Investing Activities", "terseLabel": "Interest paid, capitalized" } } }, "localname": "InterestPaidCapitalized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlowsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterimPeriodCostsNotAllocableDomain": { "auth_ref": [ "r63" ], "lang": { "en-us": { "role": { "documentation": "This element represents the type of costs and expenses incurred during an interim period that cannot be readily identified with the activities or benefits of other interim periods and are charged to the interim period in which incurred.", "label": "Interim Period, Costs Not Allocable [Domain]", "terseLabel": "Interim Period, Costs Not Allocable" } } }, "localname": "InterimPeriodCostsNotAllocableDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentCompanyDividendDistribution": { "auth_ref": [ "r207", "r208" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of dividend distribution from ordinary income and capital gain. Excludes distribution for tax return of capital.", "label": "Investment Company, Dividend Distribution", "terseLabel": "Distribution on Steward equity investment", "verboseLabel": "Distribution on equity investment" } } }, "localname": "InvestmentCompanyDividendDistribution", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeDividend": { "auth_ref": [ "r36" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of dividend income on nonoperating securities.", "label": "Investment Income, Dividend", "terseLabel": "Dividend income" } } }, "localname": "InvestmentIncomeDividend", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentOwnedAtCost": { "auth_ref": [ "r209" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cost of the investment.", "label": "Investment Owned, at Cost", "verboseLabel": "Original Cost" } } }, "localname": "InvestmentOwnedAtCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentOwnedAtFairValue": { "auth_ref": [ "r209", "r697", "r703" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities.", "label": "Investment Owned, at Fair Value", "terseLabel": "Fair Value", "verboseLabel": "Real estate fair value" } } }, "localname": "InvestmentOwnedAtFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r691", "r692", "r693", "r694", "r695", "r696", "r698", "r699", "r700", "r701", "r702", "r704", "r705", "r706", "r707" ], "lang": { "en-us": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]", "terseLabel": "Investment Type" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r691", "r692", "r693", "r694", "r695", "r696", "r698", "r699", "r700", "r701", "r702", "r704", "r705", "r706", "r707" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value.", "label": "Investments [Domain]", "terseLabel": "Investments" } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentsFairValueDisclosure": { "auth_ref": [ "r536" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.", "label": "Investments, Fair Value Disclosure", "terseLabel": "Total investments", "totalLabel": "Investments, Fair Value Disclosure, Total" } } }, "localname": "InvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease": { "auth_ref": [ "r211" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the investments in and advances to affiliates.", "label": "Investments in and Advances to Affiliates, at Fair Value, Period Increase (Decrease)", "terseLabel": "Estimated Increase (Decrease) in Fair Value", "totalLabel": "Investments in and Advances to Affiliates, at Fair Value, Period Increase (Decrease), Total" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDLOMBySensitivityAnalysisByUsingBasisPointVariationsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_Land": { "auth_ref": [ "r809" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 0.0, "parentTag": "mpw_GrossInvestmentInRealEstateAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.", "label": "Land", "terseLabel": "Land" } } }, "localname": "Land", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LandAndLandImprovementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Real estate held and assets that are an addition or improvement to real estate held.", "label": "Land and Land Improvements [Member]", "terseLabel": "Land and Land Improvements [Member]" } } }, "localname": "LandAndLandImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseCost": { "auth_ref": [ "r591", "r790" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease cost recognized by lessee for lease contract.", "label": "Lease, Cost", "totalLabel": "Total lease cost" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lease, Cost [Abstract]", "terseLabel": "Finance lease cost:" } } }, "localname": "LeaseCostAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r901" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Summary of Lease Expense" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r88" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfRelatedRealEstateAndOtherAssetsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee, Lease, Description [Line Items]", "terseLabel": "Lessee Lease Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r583" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee, Lease, Description [Table]", "terseLabel": "Lessee Lease Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r582" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee, Leases [Policy Text Block]", "terseLabel": "Leases (Lessee)" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r592" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail2": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Operating Leases, Total undiscounted minimum lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r592" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "terseLabel": "Operating Leases, Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r592" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "order": 0.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "Operating Leases, 2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r592" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "terseLabel": "Operating Leases, 2027" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r592" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "Operating Leases, 2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r592" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "Operating Leases, 2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r592" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "Operating Leases, 2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r592" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail2": { "order": 0.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Operating Leases, Less: interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "auth_ref": [ "r900" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Term of Contract", "terseLabel": "Initial lease term" } } }, "localname": "LesseeOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_LessorLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessor, Lease, Description [Line Items]", "terseLabel": "Lessor Lease Description [Line Items]" } } }, "localname": "LessorLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LessorLeaseDescriptionTable": { "auth_ref": [ "r596" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about lessor's leases.", "label": "Lessor, Lease, Description [Table]", "terseLabel": "Lessor Lease Description [Table]" } } }, "localname": "LessorLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LessorOperatingLeaseExistenceOfOptionToExtend": { "auth_ref": [ "r595" ], "lang": { "en-us": { "role": { "documentation": "Indicates (true false) whether lessor has option to extend operating lease.", "label": "Lessor, Operating Lease, Existence of Option to Extend [true false]", "terseLabel": "Existence of option to extend" } } }, "localname": "LessorOperatingLeaseExistenceOfOptionToExtend", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail" ], "xbrltype": "booleanItemType" }, "us-gaap_LessorOperatingLeaseOptionToExtend": { "auth_ref": [ "r595" ], "lang": { "en-us": { "role": { "documentation": "Description of terms and conditions of option to extend lessor's operating lease.", "label": "Lessor, Operating Lease, Option to Extend", "terseLabel": "Lease extension options, description", "verboseLabel": "Number of years to extend current lease" } } }, "localname": "LessorOperatingLeaseOptionToExtend", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lessor, Operating Lease, Payments to be Received, Fiscal Year Maturity [Abstract]" } } }, "localname": "LessorOperatingLeasePaymentsFiscalYearMaturityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceived": { "auth_ref": [ "r594" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payments to be received by lessor for operating lease.", "label": "Lessor, Operating Lease, Payments to be Received", "totalLabel": "Future minimum lease payments to be received" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceived", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears": { "auth_ref": [ "r594" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail": { "order": 4.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, Year Five", "terseLabel": "2027" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedFiveYears", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears": { "auth_ref": [ "r594" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail": { "order": 3.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, Year Four", "terseLabel": "2026" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedFourYears", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock": { "auth_ref": [ "r903" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity of undiscounted cash flows to be received by lessor on annual basis for operating lease.", "label": "Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Table Text Block]", "terseLabel": "Summary of Total Future Minimum Lease Payments to be Received" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths": { "auth_ref": [ "r594" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail": { "order": 0.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, Year One", "terseLabel": "2023" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter": { "auth_ref": [ "r594" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail": { "order": 5.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedThereafter", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears": { "auth_ref": [ "r594" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail": { "order": 2.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, Year Three", "terseLabel": "2025" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedThreeYears", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears": { "auth_ref": [ "r594" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail": { "order": 1.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, Year Two", "terseLabel": "2024" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedTwoYears", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeaseRenewalTerm": { "auth_ref": [ "r904" ], "lang": { "en-us": { "role": { "documentation": "Term of lessor's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessor, Operating Lease, Renewal Term", "terseLabel": "Term of lease extension, years", "verboseLabel": "Lease renewal term" } } }, "localname": "LessorOperatingLeaseRenewalTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_LessorOperatingLeaseTermOfContract": { "auth_ref": [ "r904" ], "lang": { "en-us": { "role": { "documentation": "Term of lessor's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessor, Operating Lease, Term of Contract", "terseLabel": "Term of lease" } } }, "localname": "LessorOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r16", "r260", "r351", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r516", "r519", "r520", "r543", "r771", "r855", "r906", "r907" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 0.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "terseLabel": "Liabilities" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r13", "r177", "r197", "r791", "r823", "r847", "r899" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Equity / Capital" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest": { "auth_ref": [ "r64" ], "lang": { "en-us": { "role": { "documentation": "Percentage investment held by the managing member or general partner of the limited liability company (LLC) or limited partnership (LP).", "label": "Limited Liability Company (LLC) or Limited Partnership (LP), Managing Member or General Partner, Ownership Interest", "terseLabel": "Percentage of ownership of general partner" } } }, "localname": "LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest": { "auth_ref": [ "r64" ], "lang": { "en-us": { "role": { "documentation": "Percentage investment held by members or limited partners of limited liability company (LLC) or limited partnership (LP).", "label": "Limited Liability Company or Limited Partnership, Members or Limited Partners, Ownership Interest", "verboseLabel": "Percentage of ownership limited partner" } } }, "localname": "LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_LimitedPartnerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Party to a partnership business who has limited liability.", "label": "Limited Partner [Member]", "terseLabel": "Limited Partner [Member]" } } }, "localname": "LimitedPartnerMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapitalParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_LimitedPartnersCapitalAccount": { "auth_ref": [ "r107" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of the limited partners' ownership interests.", "label": "Limited Partners' Capital Account", "terseLabel": "Limited Partners - issued and outstanding - 591,500 units at December 31, 2022 and 590,780 units at December 31, 2021", "totalLabel": "Limited Partners' Capital Account, Total" } } }, "localname": "LimitedPartnersCapitalAccount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LimitedPartnersCapitalAccountUnitsIssued": { "auth_ref": [ "r107" ], "lang": { "en-us": { "role": { "documentation": "The number of limited partner units issued.", "label": "Limited Partners' Capital Account, Units Issued", "terseLabel": "Limited Partners, units issued" } } }, "localname": "LimitedPartnersCapitalAccountUnitsIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding": { "auth_ref": [ "r107" ], "lang": { "en-us": { "role": { "documentation": "The number of limited partner units outstanding.", "label": "Limited Partners' Capital Account, Units Outstanding", "terseLabel": "Limited Partners, units outstanding" } } }, "localname": "LimitedPartnersCapitalAccountUnitsOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r3", "r175", "r189" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-Term Line of Credit", "terseLabel": "Line of credit", "totalLabel": "Long-Term Line of Credit, Total", "verboseLabel": "Credit facilities, amount outstanding" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtInterimCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtJuly2021InterimCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityAxis": { "auth_ref": [ "r15", "r822" ], "lang": { "en-us": { "role": { "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.", "label": "Lender Name [Axis]", "terseLabel": "Lender Name" } } }, "localname": "LineOfCreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityCommitmentFeeAmount": { "auth_ref": [ "r15" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the fee for available but unused credit capacity under the credit facility.", "label": "Line of Credit Facility, Commitment Fee Amount", "terseLabel": "Underwriting and other fees" } } }, "localname": "LineOfCreditFacilityCommitmentFeeAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityExpirationDate1": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Date the credit facility terminates, in YYYY-MM-DD format.", "label": "Line of Credit Facility, Expiration Date", "terseLabel": "Line of credit, terminated date" } } }, "localname": "LineOfCreditFacilityExpirationDate1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtInterimCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtJuly2021InterimCreditFacilityAdditionalInformationDetail" ], "xbrltype": "dateItemType" }, "us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet": { "auth_ref": [ "r822" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of the credit facility.", "label": "Line of Credit Facility, Increase (Decrease), Net", "terseLabel": "Increase in revolving credit facility", "totalLabel": "Line of Credit Facility, Increase (Decrease), Net, Total" } } }, "localname": "LineOfCreditFacilityIncreaseDecreaseForPeriodNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityLenderDomain": { "auth_ref": [ "r15", "r822" ], "lang": { "en-us": { "role": { "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.", "label": "Line of Credit Facility, Lender [Domain]", "terseLabel": "Line of Credit Facility, Lender" } } }, "localname": "LineOfCreditFacilityLenderDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r15" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Line of credit facility, Borrowing capacity", "verboseLabel": "Line of credit facility, Borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtInterestRateSwapsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtInterimCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtJuly2021InterimCreditFacilityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LoanCommitmentsPolicy": { "auth_ref": [ "r153", "r154" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for loan commitments accounted for as derivatives, including the methods and assumptions used to estimate fair value and any associated hedging strategies.", "label": "Loan Commitments, Policy [Policy Text Block]", "terseLabel": "Loans" } } }, "localname": "LoanCommitmentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LoansAndLeasesReceivableAllowance": { "auth_ref": [ "r73", "r75", "r80", "r842" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance to cover probable credit losses on loans and leases. Includes carryover of or adjustments to the allowance for loan losses in connection with business combinations. Excludes allowance for loans and leases covered under loss sharing agreements.", "label": "Loans and Leases Receivable, Allowance", "terseLabel": "Cumulative effect of change in accounting principle", "verboseLabel": "Credit loss reserve" } } }, "localname": "LoansAndLeasesReceivableAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LoansHeldForSaleFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of loans held-for-sale including, but not limited to, mortgage loans and finance receivables.", "label": "Loans Held-for-sale, Fair Value Disclosure", "terseLabel": "Loans, Fair value" } } }, "localname": "LoansHeldForSaleFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LoansMember": { "auth_ref": [ "r78", "r769" ], "lang": { "en-us": { "role": { "documentation": "When a lender gives money or property over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for [must receive] repayment [prior] relative to junior and unsecured (general) creditors.", "label": "Loans [Member]" } } }, "localname": "LoansMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r3", "r175", "r193", "r411", "r422", "r776", "r777" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 0.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.", "label": "Long-Term Debt", "negatedLabel": "Debt, net Book value", "terseLabel": "Debt, net", "totalLabel": "Debt, net" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.", "label": "Long-Term Debt, Fair Value", "negatedLabel": "Debt, net Fair value" } } }, "localname": "LongTermDebtFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": { "auth_ref": [ "r91", "r268", "r861" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail": { "order": 5.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r91", "r268", "r415" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail": { "order": 0.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year One", "terseLabel": "2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": { "auth_ref": [ "r91", "r268", "r415" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail": { "order": 4.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Five", "terseLabel": "2027" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "auth_ref": [ "r91", "r268", "r415" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail": { "order": 3.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Four", "terseLabel": "2026" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "auth_ref": [ "r91", "r268", "r415" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail": { "order": 2.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Three", "terseLabel": "2025" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r91", "r268", "r415" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail": { "order": 1.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Two", "terseLabel": "2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtTextBlock": { "auth_ref": [ "r93" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-term debt.", "label": "Long-Term Debt [Text Block]", "terseLabel": "Debt" } } }, "localname": "LongTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebt" ], "xbrltype": "textBlockItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSeniorUnsecuredNotesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r19", "r92" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-Term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSeniorUnsecuredNotesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_LongtermDebtWeightedAverageInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.", "label": "Long-Term Debt, Weighted Average Interest Rate, at Point in Time", "terseLabel": "Credit facilities, weighted average interest rate" } } }, "localname": "LongtermDebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_MajorPropertyClassAxis": { "auth_ref": [ "r220" ], "lang": { "en-us": { "role": { "documentation": "Amount of property owned but leased or available for lease to third parties, by major property class.", "label": "Major Property Class [Axis]", "terseLabel": "Major Property Class" } } }, "localname": "MajorPropertyClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherDisposalTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_MajorPropertyClassDomain": { "auth_ref": [ "r220" ], "lang": { "en-us": { "role": { "documentation": "The major classes of assets leased or available for lease to third parties under operating lease agreements as of the balance sheet date.", "label": "Major Property Class [Domain]", "terseLabel": "Major Property Class" } } }, "localname": "MajorPropertyClassDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherDisposalTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r23", "r176", "r196", "r260", "r351", "r395", "r397", "r398", "r399", "r402", "r403", "r543" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "periodEndLabel": "Stockholders' Equity Attributable to Noncontrolling Interest, Ending Balance", "periodStartLabel": "Stockholders' Equity Attributable to Noncontrolling Interest, Beginning Balance", "terseLabel": "Non-controlling interests", "totalLabel": "Stockholders' Equity Attributable to Noncontrolling Interest, Total" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": { "auth_ref": [ "r104" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.", "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders", "negatedTerseLabel": "Distributions to non-controlling interests, net" } } }, "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "xbrltype": "monetaryItemType" }, "us-gaap_MortgageLoansOnRealEstate": { "auth_ref": [ "r712" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate.", "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate", "periodEndLabel": "Balance at end of year", "periodStartLabel": "Balance at beginning of year", "verboseLabel": "Carrying Amount of Mortgages" } } }, "localname": "MortgageLoansOnRealEstate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet": { "auth_ref": [ "r200" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "mpw_GrossInvestmentInRealEstateAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The balance represents the amount of loans that are secured by real estate mortgages, offset by the reserve to cover probable credit losses on the loan portfolio.", "label": "Mortgage Loans on Real Estate, Commercial and Consumer, Net", "terseLabel": "Mortgage loans", "totalLabel": "Mortgage Loans on Real Estate, Commercial and Consumer, Net, Total" } } }, "localname": "MortgageLoansOnRealEstateCommercialAndConsumerNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MortgageLoansOnRealEstateNewMortgageLoans": { "auth_ref": [ "r714" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from new investment.", "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, New Mortgage Loan", "terseLabel": "New mortgage loans and additional advances on existing loans", "verboseLabel": "Mortgage loan" } } }, "localname": "MortgageLoansOnRealEstateNewMortgageLoans", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_MortgagesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A loan to finance the purchase of real estate where the lender has a lien on the property as collateral for the loan.", "label": "Mortgages [Member]", "terseLabel": "Mortgage Loans [Member]" } } }, "localname": "MortgagesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureScheduleIvChangesInMortgageLoansExcludingAllowanceForCreditLossParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "xbrltype": "domainItemType" }, "us-gaap_NatureOfExpenseAxis": { "auth_ref": [ "r63" ], "lang": { "en-us": { "role": { "documentation": "Information by type of cost or expense.", "label": "Nature of Expense [Axis]", "terseLabel": "Financing Leases [Member]" } } }, "localname": "NatureOfExpenseAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesSummaryOfTotalFutureMinimumLeasePaymentsToBeReceivedDetail" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r258" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash (used for) provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r258" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by (used for) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r49", "r51", "r54" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 0.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r32", "r54", "r183", "r205", "r228", "r241", "r243", "r248", "r260", "r282", "r286", "r287", "r288", "r289", "r292", "r293", "r302", "r328", "r332", "r338", "r340", "r351", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r534", "r543", "r772", "r855" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net income attributable to MPT common stockholders (Operating Partnership partners)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r139", "r143", "r241", "r243", "r292", "r293", "r812" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail": { "order": 1.0, "parentTag": "mpw_NetIncomeLessParticipatingSecuritiesShareInEarnings", "weight": -1.0 }, "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "negatedLabel": "Net income attributable to non-controlling interests", "negatedTerseLabel": "Non-controlling interests\u2019 share in earnings", "totalLabel": "Net Income (Loss) Attributable to Noncontrolling Interest, Total" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentInLease": { "auth_ref": [ "r345", "r368", "r593", "r848" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "mpw_GrossInvestmentInRealEstateAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of net investment in sales-type and direct financing leases.", "label": "Net Investment in Lease, before Allowance for Credit Loss", "terseLabel": "Investment in financing leases", "totalLabel": "Total investment in financing leases" } } }, "localname": "NetInvestmentInLease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Developments" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonUsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Countries excluding the United States of America (US).", "label": "Non-US [Member]", "terseLabel": "Foreign [Member]" } } }, "localname": "NonUsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfNetNOLAndOtherTaxAttributeCarryforwardsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest": { "auth_ref": [ "r105", "r137", "r140" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.", "label": "Noncontrolling Interest, Increase from Sale of Parent Equity Interest", "terseLabel": "Sale of non-controlling interests" } } }, "localname": "NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance": { "auth_ref": [ "r105", "r137", "r140" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.", "label": "Noncontrolling Interest, Increase from Subsidiary Equity Issuance", "terseLabel": "Issuance of non-controlling interest" } } }, "localname": "NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r132", "r431", "r833", "r834", "r835" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Non-Controlling Interests [Member]" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r37" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other income (expense)" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other income (expense)" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "stringItemType" }, "us-gaap_NumberOfBusinessesAcquired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of businesses acquired by the entity during the period.", "label": "Number of Businesses Acquired", "terseLabel": "Number of facilities acquired" } } }, "localname": "NumberOfBusinessesAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDisposalsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfCountriesInWhichEntityOperates": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of countries in which the entity operates as of balance sheet date.", "label": "Number of Countries in which Entity Operates", "terseLabel": "Number of countries" } } }, "localname": "NumberOfCountriesInWhichEntityOperates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfRealEstateProperties": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of real estate properties owned as of the balance sheet date.", "label": "Number of Real Estate Properties", "terseLabel": "Number of real estate assets acquired" } } }, "localname": "NumberOfRealEstateProperties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfStatesInWhichEntityOperates": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of states the entity operates in as of the balance sheet date.", "label": "Number of States in which Entity Operates", "terseLabel": "Number of states" } } }, "localname": "NumberOfStatesInWhichEntityOperates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r585", "r790" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail": { "order": 0.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "terseLabel": "Operating lease cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r577" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail2": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 }, "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail": { "order": 0.0, "parentTag": "mpw_OperatingAndFinanceLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "terseLabel": "Operating leases", "totalLabel": "Operating Lease, Liability, Total", "verboseLabel": "Operating Leases, Present value of lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeScheduleOfFixedMinimumRentalPaymentsDueUnderLeasesWithNonCancelableTermsDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r578" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes operating lease liability.", "label": "Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r581", "r587" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "terseLabel": "Operating cash flows used for operating leases" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalCashFlowInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r576" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail": { "order": 1.0, "parentTag": "mpw_LesseeOperatingLeaseAndFinanceLeaseRightOfUseAssetNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating leases" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r578" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.", "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r590", "r790" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Operating leases" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r589", "r790" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted average remaining lease term", "verboseLabel": "Operating leases" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r118" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards", "terseLabel": "Gross NOL carryforwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfNetNOLAndOtherTaxAttributeCarryforwardsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsValuationAllowance": { "auth_ref": [ "r116" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfNetNOLAndOtherTaxAttributeCarryforwardsDetail": { "order": 1.0, "parentTag": "mpw_NetDeferredTaxAssetNetOperatingLossCarryforward", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.", "label": "Operating Loss Carryforwards, Valuation Allowance", "negatedLabel": "Valuation allowance" } } }, "localname": "OperatingLossCarryforwardsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfNetNOLAndOtherTaxAttributeCarryforwardsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r0", "r145" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "Organization" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureOrganization" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssets": { "auth_ref": [ "r170", "r190", "r231" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureOtherAssetsSummaryOfOtherAssetsOnOurCondensedConsolidatedBalanceSheetsDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets classified as other.", "label": "Other Assets", "terseLabel": "Other assets", "totalLabel": "Total other assets" } } }, "localname": "OtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureOtherAssetsSummaryOfOtherAssetsOnOurCondensedConsolidatedBalanceSheetsDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Assets [Abstract]" } } }, "localname": "OtherAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherAssetsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets.", "label": "Other Assets Disclosure [Text Block]", "terseLabel": "Other Assets" } } }, "localname": "OtherAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureOtherAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherCommitmentsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of other commitment.", "label": "Other Commitments [Axis]" } } }, "localname": "OtherCommitmentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCommitmentsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other future obligation.", "label": "Other Commitments [Domain]" } } }, "localname": "OtherCommitmentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": { "auth_ref": [ "r24", "r26", "r553", "r554", "r556" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax", "terseLabel": "Foreign currency translation (loss) gain", "verboseLabel": "Foreign currency translation gain (loss)" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveIncome", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]", "terseLabel": "Other comprehensive income:" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_OtherNoncashIncomeExpense": { "auth_ref": [ "r54" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.", "label": "Other Noncash Income (Expense)", "negatedLabel": "Other adjustments", "totalLabel": "Other Noncash Income (Expense), Total" } } }, "localname": "OtherNoncashIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r38" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails": { "order": 1.0, "parentTag": "mpw_GainLossOnDispositionOfRealEstate", "weight": 1.0 }, "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "order": 7.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "terseLabel": "Other (including fair value adjustments on securities)", "totalLabel": "Other Nonoperating Income (Expense), Total", "verboseLabel": "Other income" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).", "label": "Other Nonoperating Income (Expense) [Member]", "terseLabel": "Other [Member]" } } }, "localname": "OtherNonoperatingIncomeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PartnerTypeOfPartnersCapitalAccountAxis": { "auth_ref": [ "r106" ], "lang": { "en-us": { "role": { "documentation": "Information by type or class of partner's capital account. Examples of classes of partners include, but not limited to, general partners, limited partners, preferred partners, and other ownership interests.", "label": "Partner Type [Axis]", "terseLabel": "Partner Type" } } }, "localname": "PartnerTypeOfPartnersCapitalAccountAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapitalParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain": { "auth_ref": [ "r107", "r210" ], "lang": { "en-us": { "role": { "documentation": "Capital accounts of each type or class of partner. Examples of classes of partners include, but are not limited to, general partners, limited partners, preferred partners, and other ownership interests.", "label": "Partner Type of Partners' Capital Account, Name [Domain]", "terseLabel": "Partner Type of Partners' Capital Account, Name" } } }, "localname": "PartnerTypeOfPartnersCapitalAccountNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapitalParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_PartnersCapitalAccountRedemptions": { "auth_ref": [ "r104", "r107" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total change in each class of partners' capital accounts during the year due to redemptions and adjustments to redemption value. All partners include general, limited and preferred partners.", "label": "Partners' Capital Account, Redemptions", "negatedLabel": "Redemption of MOP units", "terseLabel": "Redemption of common units" } } }, "localname": "PartnersCapitalAccountRedemptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "xbrltype": "monetaryItemType" }, "us-gaap_PartnersCapitalAccountUnitsRedeemed": { "auth_ref": [ "r104", "r107" ], "lang": { "en-us": { "role": { "documentation": "The number of units redeemed during the year of each class of partners' capital account. Units represent shares of ownership of the general, limited, and preferred partners.", "label": "Partners' Capital Account, Units, Redeemed", "negatedLabel": "Redemption of common units (shares)" } } }, "localname": "PartnersCapitalAccountUnitsRedeemed", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "xbrltype": "sharesItemType" }, "us-gaap_PartnersCapitalNotesDisclosureTextBlock": { "auth_ref": [ "r109" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the formation, structure, control and ownership of the partnership. Disclosures related to accounts comprising partners' capital. Includes balances of general partners' capital account, limited partners' capital account, preferred partners' capital account and total partners' capital account and units outstanding; accumulated other comprehensive income; amount and nature of changes to amount of partner's capital and units outstanding by class, rights and privileges for each class of units; distribution policies and distributions paid by unit class; impact of and correction of an error in previously issued financial statements; limitations of partners' liability; redemption, conversion and distribution policies; and deferred compensation related to the issuance of units.", "label": "Partners' Capital Notes Disclosure [Text Block]", "terseLabel": "Common Stock/Partner's Capital" } } }, "localname": "PartnersCapitalNotesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnerSCapital" ], "xbrltype": "textBlockItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r46" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Repurchase of common stock / unit" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfOrdinaryDividends": { "auth_ref": [ "r46" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash outflow in the form of ordinary dividends to common shareholders, preferred shareholders and noncontrolling interests, generally out of earnings.", "label": "Payments of Ordinary Dividends", "negatedLabel": "Dividends / Distribution paid", "totalLabel": "Payments of Ordinary Dividends, Total" } } }, "localname": "PaymentsOfOrdinaryDividends", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r255" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payment, Tax Withholding, Share-Based Payment Arrangement", "negatedLabel": "Stock / Unit vesting - satisfaction of tax withholdings", "terseLabel": "Unit vesting - satisfaction of tax withholdings" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r42", "r513" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "terseLabel": "Payment for acquisition" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireLoansReceivable": { "auth_ref": [ "r41" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the purchase of loan receivable arising from the financing of goods and services.", "label": "Payments to Acquire Loans Receivable", "negatedLabel": "Investment in loans receivable" } } }, "localname": "PaymentsToAcquireLoansReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireRealEstate": { "auth_ref": [ "r43" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow from the acquisition of a piece of land, anything permanently fixed to it, including buildings, structures on it and so forth; includes real estate intended to generate income for the owner; excludes real estate acquired for use by the owner.", "label": "Payments to Acquire Real Estate", "negatedLabel": "Cash paid for acquisitions and other related investments", "totalLabel": "Payments to Acquire Real Estate, Total" } } }, "localname": "PaymentsToAcquireRealEstate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToFundPolicyLoans": { "auth_ref": [ "r41" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The initial funding or additional funding of loans receivable to policy holders principally secured by the benefits under the policy.", "label": "Payments to Fund Policy Loans", "terseLabel": "Capital funding" } } }, "localname": "PaymentsToFundPolicyLoans", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PerformanceSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement awarded for meeting performance target.", "label": "Performance Shares [Member]", "terseLabel": "Performance-Based Awards [Member]" } } }, "localname": "PerformanceSharesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]", "terseLabel": "Preferred Par Value [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r7", "r424" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "periodEndLabel": "Preferred Stock, Shares Outstanding, Ending Balance", "periodStartLabel": "Preferred Stock, Shares Outstanding, Beginning Balance", "terseLabel": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r7", "r791" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 0.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.001 par value. Authorized 10,000 shares; no shares outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssets": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureOtherAssetsSummaryOfOtherAssetsOnOurCondensedConsolidatedBalanceSheetsDetail": { "order": 2.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.", "label": "Prepaid Expense and Other Assets", "terseLabel": "Prepaids and other assets" } } }, "localname": "PrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureOtherAssetsSummaryOfOtherAssetsOnOurCondensedConsolidatedBalanceSheetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "auth_ref": [ "r808" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.", "label": "Reclassification, Comparability Adjustment [Policy Text Block]", "terseLabel": "Reclassification" } } }, "localname": "PriorPeriodReclassificationAdjustmentDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ProceedsFromCollectionOfLoansReceivable": { "auth_ref": [ "r39" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the collection, including prepayments, of loans receivable issued for financing of goods and services.", "label": "Proceeds from Collection of Loans Receivable", "terseLabel": "Principal received on loans receivable" } } }, "localname": "ProceedsFromCollectionOfLoansReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital": { "auth_ref": [ "r257", "r815" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities.", "label": "Proceeds from Equity Method Investment, Distribution, Return of Capital", "terseLabel": "Proceeds from sale and return of equity investment" } } }, "localname": "ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonLimitedPartnersUnits": { "auth_ref": [ "r44" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of common limited partners units during the period.", "label": "Proceeds from Issuance of Common Limited Partners Units", "terseLabel": "Proceeds from sale of units, net of offering costs" } } }, "localname": "ProceedsFromIssuanceOfCommonLimitedPartnersUnits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r44" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Proceeds from sale of common shares, net of offering costs", "verboseLabel": "Proceeds from sale of common shares / units, net of offering costs" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r45" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds from Issuance of Long-Term Debt", "terseLabel": "Proceeds from term debt, net of discount", "totalLabel": "Proceeds from Issuance of Long-Term Debt, Total" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfSecuredDebt": { "auth_ref": [ "r45" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.", "label": "Proceeds from Issuance of Secured Debt", "terseLabel": "Proceeds from expected secured debt" } } }, "localname": "ProceedsFromIssuanceOfSecuredDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDisposalsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "auth_ref": [ "r816", "r817" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.", "label": "Proceeds from (Payments for) Other Financing Activities", "terseLabel": "Payment of debt refinancing, deferred financing costs and other financing activities" } } }, "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfLinesOfCredit": { "auth_ref": [], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).", "label": "Proceeds from (Repayments of) Lines of Credit", "terseLabel": "Revolving credit facilities, net" } } }, "localname": "ProceedsFromRepaymentsOfLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfMortgageLoansHeldForSale": { "auth_ref": [ "r48", "r50" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from sales of loans that are secured with real estate mortgages and are held with the intention to resell in the near future.", "label": "Proceeds from Sale of Mortgage Loans Held-for-sale", "terseLabel": "Proceeds from sale of mortgage loans" } } }, "localname": "ProceedsFromSaleOfMortgageLoansHeldForSale", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfProductiveAssets": { "auth_ref": [ "r40" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.", "label": "Proceeds from Sale of Productive Assets", "terseLabel": "Net proceeds from sale of real estate", "totalLabel": "Proceeds from Sale of Productive Assets, Total" } } }, "localname": "ProceedsFromSaleOfProductiveAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfRealEstate": { "auth_ref": [ "r40" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash received for the sale of real estate that is not part of an investing activity during the current period.", "label": "Proceeds from Sale of Real Estate", "terseLabel": "Proceeds from sale of facilities", "verboseLabel": "Expected cash proceeds on transaction close" } } }, "localname": "ProceedsFromSaleOfRealEstate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDisposalsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherDisposalTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r228", "r241", "r243", "r256", "r260", "r282", "r292", "r293", "r328", "r332", "r338", "r340", "r351", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r514", "r517", "r518", "r534", "r543", "r666", "r772", "r788", "r789", "r812", "r855" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail": { "order": 0.0, "parentTag": "mpw_NetIncomeLessParticipatingSecuritiesShareInEarnings", "weight": 1.0 }, "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveIncome": { "order": 0.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "order": 0.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net income", "totalLabel": "Net income" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveIncome", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r89" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Long-Lived Tangible Asset" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfRelatedRealEstateAndOtherAssetsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfRelatedRealEstateAndOtherAssetsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r89" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Estimated Useful Lives of Related Real Estate and Other Assets" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r88" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Long-Lived Tangible Asset" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfRelatedRealEstateAndOtherAssetsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Weighted average useful lives of related real estate and other assets" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfRelatedRealEstateAndOtherAssetsDetail" ], "xbrltype": "durationItemType" }, "us-gaap_ProvisionForLoanLeaseAndOtherLosses": { "auth_ref": [ "r52", "r74", "r184" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense related loan transactions, lease transactions, credit loss from transactions other than loan and lease transactions, and other loss based on assessment of uncollectability from the counterparty to reduce the account to their net realizable value.", "label": "Provision for Loan, Lease, and Other Losses", "terseLabel": "Provision (recovery) for credit loss", "totalLabel": "Provision for Loan, Lease, and Other Losses, Total" } } }, "localname": "ProvisionForLoanLeaseAndOtherLosses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProvisionForLoanLossesExpensed": { "auth_ref": [ "r365", "r661" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of credit loss expense (reversal of expense) for financing receivable.", "label": "Financing Receivable, Credit Loss, Expense (Reversal)", "terseLabel": "Provision (recovery) for credit loss, net" } } }, "localname": "ProvisionForLoanLossesExpensed", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCreditLossReservesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Real Estate [Abstract]" } } }, "localname": "RealEstateAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RealEstateAccumulatedDepreciation": { "auth_ref": [ "r723" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "mpw_NetInvestmentInRealEstateAssets", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation pertaining to real estate investments for entities with a substantial portion of business acquiring and holding investment real estate.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation", "negatedLabel": "Accumulated depreciation", "periodEndLabel": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation, Ending Balance", "periodStartLabel": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation, Beginning Balance", "terseLabel": "Accumulated Depreciation" } } }, "localname": "RealEstateAccumulatedDepreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateAccumulatedDepreciationRealEstateSold": { "auth_ref": [ "r728" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease to accumulated depreciation for real estate investments sold for entities with a substantial portion of business acquiring and holding investment real estate.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation, Investment in Real Estate Sold", "negatedLabel": "Depreciation on disposed property" } } }, "localname": "RealEstateAccumulatedDepreciationRealEstateSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIChangesInAccumulatedDepreciationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements": { "auth_ref": [ "r722" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail": { "order": 1.0, "parentTag": "us-gaap_RealEstateGrossAtCarryingValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation of buildings and improvements for entities with a substantial portion of business acquiring and holding investment real estate. Excludes real estate not held as an investment or interest.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Building and Improvements, Amount", "terseLabel": "Buildings at cost" } } }, "localname": "RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand": { "auth_ref": [ "r722" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail": { "order": 0.0, "parentTag": "us-gaap_RealEstateGrossAtCarryingValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of land for entities with a substantial portion of business acquiring and holding investment real estate. Excludes real estate not held as an investment or interest.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Land, Amount", "terseLabel": "Land at cost" } } }, "localname": "RealEstateAndAccumulatedDepreciationCarryingAmountOfLand", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements": { "auth_ref": [ "r720" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Initial cost of buildings and improvements for entities with a substantial portion of business acquiring and holding investment real estate. Excludes real estate not held as an investment or interest.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Initial Cost of Building and Improvements", "terseLabel": "Initial costs, buildings" } } }, "localname": "RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand": { "auth_ref": [ "r720" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Initial cost of land for entities with a substantial portion of business acquiring and holding investment real estate. Excludes real estate not held as an investment or interest.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Initial Cost of Land", "terseLabel": "Initial costs, land" } } }, "localname": "RealEstateAndAccumulatedDepreciationInitialCostOfLand", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateAndAccumulatedDepreciationLifeUsedForDepreciation1": { "auth_ref": [ "r726" ], "lang": { "en-us": { "role": { "documentation": "Useful life on which depreciation was computed for entities with a substantial portion of business acquiring and holding investment real estate, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Life Used for Depreciation", "terseLabel": "Life on which depreciation in latest income statements is computed (Years)" } } }, "localname": "RealEstateAndAccumulatedDepreciationLifeUsedForDepreciation1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_RealEstateCostOfRealEstateSold": { "auth_ref": [ "r728" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of real estate investments sold for entities with a substantial portion of business acquiring and holding investment real estate.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Cost of Investment in Real Estate Sold", "negatedLabel": "Dispositions" } } }, "localname": "RealEstateCostOfRealEstateSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIChangesInTotalRealEstateAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateDisclosureTextBlock": { "auth_ref": [ "r212", "r213", "r214", "r215", "r216" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for certain real estate investment financial statements, real estate investment trust operating support agreements, real estate owned, retail land sales, time share transactions, as well as other real estate related disclosures.", "label": "Real Estate Disclosure [Text Block]", "terseLabel": "Real Estate and Other Activities" } } }, "localname": "RealEstateDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities" ], "xbrltype": "textBlockItemType" }, "us-gaap_RealEstateGrossAtCarryingValue": { "auth_ref": [ "r722" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated depreciation, of real estate investment by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate. Excludes real estate not held as investment or interest.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Gross", "periodEndLabel": "Balance at end of period", "periodStartLabel": "Balance at beginning of period", "totalLabel": "Total at cost" } } }, "localname": "RealEstateGrossAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIChangesInTotalRealEstateAssetsDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIRealEstateInvestmentsAndAccumulatedDepreciationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateHeldforsale": { "auth_ref": [ "r917" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "mpw_GrossInvestmentInRealEstateAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in land and building held for sale. Excludes real estate considered inventory.", "label": "Real Estate, Held-for-Sale", "terseLabel": "Real estate held for sale" } } }, "localname": "RealEstateHeldforsale", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateInvestmentPropertyNet": { "auth_ref": [ "r201" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of real estate investment property, net of accumulated depreciation, which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments.", "label": "Real Estate Investment Property, Net", "terseLabel": "Net investment in lease", "totalLabel": "Real Estate Investment Property, Net, Total" } } }, "localname": "RealEstateInvestmentPropertyNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures": { "auth_ref": [ "r201" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of investments in unconsolidated real estate and other joint ventures not separately presented. This includes direct and indirect investments.", "label": "Real Estate Investments, Unconsolidated Real Estate and Other Joint Ventures", "terseLabel": "Investments in unconsolidated real estate joint ventures" } } }, "localname": "RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateOtherDeductions": { "auth_ref": [ "r728" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other deductions to real estate investments, excluding sales, for entities with a substantial portion of business acquiring and holding investment real estate.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Other Deduction", "negatedLabel": "Other" } } }, "localname": "RealEstateOtherDeductions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIChangesInTotalRealEstateAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstatePropertiesAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by ownership of the property.", "label": "Real Estate Property Ownership [Axis]", "terseLabel": "Real Estate Property Ownership" } } }, "localname": "RealEstatePropertiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RealEstatePropertiesDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents categories of ownership of real estate properties.", "label": "Real Estate Properties [Domain]", "terseLabel": "Real Estate Properties" } } }, "localname": "RealEstatePropertiesDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ReceivablesFairValueDisclosure": { "auth_ref": [ "r178", "r198", "r898" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of receivables, including, but not limited to, trade account receivables, note receivables, and loan receivables.", "label": "Receivables, Fair Value Disclosure", "terseLabel": "Interest and rent receivables, Fair value", "totalLabel": "Receivables, Fair Value Disclosure, Total" } } }, "localname": "ReceivablesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r436", "r607", "r608" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r436", "r607", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r905" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]", "terseLabel": "Related Party" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r47" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments of Long-Term Debt", "negatedLabel": "Payments of term debt", "totalLabel": "Repayments of Long-Term Debt, Total" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfOtherLongTermDebt": { "auth_ref": [ "r47" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for the payment of debt classified as other, maturing after one year or the operating cycle, if longer.", "label": "Repayments of Other Long-Term Debt", "terseLabel": "Repayments of other loan" } } }, "localname": "RepaymentsOfOtherLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLoansAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResidualValueOfLeasedAsset": { "auth_ref": [ "r600" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of residual asset covered by residual value guarantee. Excludes guarantee considered to be lease payments for lessor.", "label": "Residual Value of Leased Asset", "terseLabel": "Carrying value of lease requiring residual value guarantee", "totalLabel": "Residual Value of Leased Asset, Total" } } }, "localname": "ResidualValueOfLeasedAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndCashEquivalents": { "auth_ref": [ "r55", "r57", "r169", "r194", "r229" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted Cash and Cash Equivalents", "periodEndLabel": "Restricted cash, included in Other assets at end of period", "periodStartLabel": "Restricted cash, included in Other assets at beginning of period", "totalLabel": "Restricted Cash and Cash Equivalents, Total" } } }, "localname": "RestrictedCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes cash and cash equivalents restricted to withdrawal or usage.", "label": "Restricted Cash and Cash Equivalents, Statement of Financial Position [Extensible Enumeration]", "periodEndLabel": "Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]", "periodStartLabel": "Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]" } } }, "localname": "RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r10", "r104", "r195", "r684", "r689", "r791" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Distributions in excess of net income", "totalLabel": "Retained Earnings (Accumulated Deficit), Total", "verboseLabel": "Retained earnings (deficit)" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r223", "r277", "r278", "r279", "r283", "r291", "r293", "r359", "r473", "r474", "r475", "r496", "r497", "r532", "r680", "r682" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings (Deficit) [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapitalParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r767", "r768" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue [Policy Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r250", "r260", "r319", "r320", "r331", "r336", "r337", "r341", "r342", "r344", "r351", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r543", "r666", "r855" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails": { "order": 2.0, "parentTag": "mpw_GainLossOnDispositionOfRealEstate", "weight": 1.0 }, "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome": { "order": 0.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Revenues", "totalLabel": "Total revenues" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "terseLabel": "Revenues" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility [Member]" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r588", "r790" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Operating leases", "verboseLabel": "Changes in right-of-use asset" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalCashFlowInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIChangesInAccumulatedDepreciationParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense": { "auth_ref": [ "r728" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of depreciation expense of real estate investments for entities with a substantial portion of business acquiring and holding investment real estate.", "label": "SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation, Depreciation Expense", "terseLabel": "Depreciation" } } }, "localname": "SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIIChangesInAccumulatedDepreciationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]", "terseLabel": "Sale of Stock" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r344", "r840" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]", "terseLabel": "Revenue [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r124", "r125", "r509" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule Of Business Acquisitions By Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectMedicalHoldingsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesSoldParentheticalDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesWatsonvilleCommunityHospitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2021ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDisposalsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherDisposalTransactionsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesRentDeferralsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": { "auth_ref": [ "r124", "r125" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.", "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]", "terseLabel": "Net Assets Acquired" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r121" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "terseLabel": "Schedule of Income Tax Benefit (Expense)" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r19", "r98", "r101", "r102", "r103", "r162", "r163", "r165", "r187", "r776", "r778", "r825" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table Text Block]", "terseLabel": "Basic Terms of Senior Unsecured Notes" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "Schedule of Debt [Table Text Block]", "terseLabel": "Summary of Debt" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r117" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "terseLabel": "Schedule of Deferred Tax Assets and Liabilities" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r839" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Calculation of Earnings Per Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureEarningsPerShareUnitTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable": { "auth_ref": [ "r59", "r62", "r297", "r301", "r303" ], "lang": { "en-us": { "role": { "documentation": "The table contains disclosure pertaining to an entity's basic earnings per share.", "label": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]", "terseLabel": "Schedule Of Earnings Per Share Basic By Common Class [Table]" } } }, "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r114" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Summary of Reconciliation of Income Tax Benefit (Expense) from the Statutory Income Tax Rate to the Effective Tax Rate Based on Income before Income Taxes" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Equity Method Investments [Line Items]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsTable": { "auth_ref": [ "r83", "r228", "r260", "r351", "r543" ], "lang": { "en-us": { "role": { "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.", "label": "Schedule of Equity Method Investments [Table]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r536", "r537" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Equity Interest in Related Party and Related Loans Measured at Fair Value on Recurring Basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": { "auth_ref": [ "r111" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested shares.", "label": "Schedule of Nonvested Share Activity [Table Text Block]", "terseLabel": "Stock-based Award Activity" } } }, "localname": "ScheduleOfNonvestedShareActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.", "label": "Schedule of Other Assets [Table Text Block]", "terseLabel": "Summary of Other Assets" } } }, "localname": "ScheduleOfOtherAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureOtherAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r89" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Schedule Of Property Plant And Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfRelatedRealEstateAndOtherAssetsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSensitivityAnalysisOfFairValueOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrServicingLiabilitiesTextBlock": { "auth_ref": [ "r914" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of a sensitivity analysis or stress test showing the hypothetical effect on the fair value of the transferor's interests in transferred financial assets (including any servicing assets or servicing liabilities) of two or more unfavorable variations from the expected levels for each key assumption that is reported, independently determined from any change in another key assumption, and a description of the objectives, methodology, and limitations of the sensitivity analysis or stress test.", "label": "Schedule of Sensitivity Analysis of Fair Value, Transferor's Interests in Transferred Financial Assets [Table Text Block]", "terseLabel": "Schedule of Effects of Movement in DLOM by Sensitivity Analysis by Using Basis Point Variations" } } }, "localname": "ScheduleOfSensitivityAnalysisOfFairValueOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrServicingLiabilitiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r439", "r440", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r94", "r95", "r96", "r98", "r99", "r100", "r101", "r102", "r103", "r104", "r233", "r234", "r235", "r313", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r780", "r805", "r821" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]", "terseLabel": "Schedule Of Stock By Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r85" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Amortization Expense from Existing Lease Intangible Assets" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecuredDebt": { "auth_ref": [ "r3", "r175", "r193" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.", "label": "Secured Debt", "terseLabel": "Secured loan", "totalLabel": "Secured Debt, Total" } } }, "localname": "SecuredDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities2020ActivityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r344", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r387", "r388", "r774", "r919" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r52" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "terseLabel": "Stock / (Unit)-based compensation expense", "totalLabel": "Share-Based Payment Arrangement, Noncash Expense, Total" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": { "auth_ref": [ "r786" ], "lang": { "en-us": { "role": { "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period", "terseLabel": "Share-based compensation arrangement by share based payment award, expected service period (in years)", "verboseLabel": "Stock award service period in years" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r786" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "terseLabel": "Stock awards vesting period in years" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee": { "auth_ref": [ "r112" ], "lang": { "en-us": { "role": { "documentation": "The highest quantity of shares an employee can purchase under the plan per period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee", "terseLabel": "Maximum number of shares of common stock that may be awarded" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized", "terseLabel": "Reserved an additional shares of common stock for awards under the Equity Incentive Plan" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r787" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized", "terseLabel": "Reserved shares of new common stock for awards under the Equity Incentive Plan" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r112" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant", "terseLabel": "Common stock remaining for future stock awards transferred to the equity incentive plan" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r450" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Awarded, Shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsStockBasedAwardActivityDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r460" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Awarded, Weighted Average Value at Award Date" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsStockBasedAwardActivityDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsStockBasedAwardActivityDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-vested options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares", "periodEndLabel": "Nonvested awards at end of year, Shares", "periodStartLabel": "Nonvested awards at beginning of the year, Shares" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsStockBasedAwardActivityDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-vested options forfeited.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares", "negatedLabel": "Forfeited, Shares" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsStockBasedAwardActivityDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options forfeited.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value", "terseLabel": "Forfeited, Weighted Average Value at Award Date" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsStockBasedAwardActivityDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price", "periodEndLabel": "Nonvested awards at end of year, Weighted Average Value at Award Date", "periodStartLabel": "Nonvested awards at beginning of the year, Weighted Average Value at Award Date" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsStockBasedAwardActivityDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": { "auth_ref": [ "r461" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value", "terseLabel": "Stock-based awards, fair value" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options vested.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares", "negatedLabel": "Vested, Shares" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsStockBasedAwardActivityDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of options vested.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value", "terseLabel": "Vested, Weighted Average Value at Award Date" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureStockAwardsStockBasedAwardActivityDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares Issued, Price Per Share", "terseLabel": "Shares issued price per share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r58", "r259" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r226", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r344", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r385", "r387", "r388", "r774", "r919" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfSupplementalBalanceSheetInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r22", "r97", "r223", "r246", "r247", "r248", "r277", "r278", "r279", "r283", "r291", "r293", "r312", "r359", "r431", "r473", "r474", "r475", "r496", "r497", "r532", "r557", "r558", "r559", "r560", "r561", "r562", "r606", "r680", "r681", "r682" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapitalParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlowsParenthetical", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveIncome", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapitalParenthetical", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r277", "r278", "r279", "r312", "r645" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlowsParenthetical", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveIncome", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapitalParenthetical", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": { "auth_ref": [ "r7", "r8", "r97", "r98", "r104" ], "lang": { "en-us": { "role": { "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).", "label": "Stock Issued During Period, Shares, Conversion of Units", "terseLabel": "Conversion of LTIP units to common units (shares)", "verboseLabel": "Conversion of LTIP units to common units" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfUnits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r7", "r8", "r97", "r104" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Proceeds from offering (net of offering costs) (shares)", "verboseLabel": "Number of share sold" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfUnits": { "auth_ref": [ "r22", "r97", "r104" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).", "label": "Stock Issued During Period, Value, Conversion of Units", "terseLabel": "Conversion of LTIP units to common units" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfUnits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r7", "r8", "r97", "r104" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Proceeds from offering (net of offering costs)" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "Stock Repurchase Program, Authorized Amount", "terseLabel": "Stock repurchase program, authorized amount" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramExpirationDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expiration date for the purchase of an entity's own shares under a stock repurchase plan, in the YYYY-MM-DD format.", "label": "Stock Repurchase Program Expiration Date", "terseLabel": "Stock repurchase program expiration date" } } }, "localname": "StockRepurchaseProgramExpirationDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "xbrltype": "dateItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r7", "r8", "r97", "r104" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Shares", "negatedLabel": "Repurchase of units (shares)", "terseLabel": "Stock repurchase, Shares" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r7", "r8", "r97", "r104" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Value", "negatedLabel": "Repurchase of units", "terseLabel": "Stock repurchase, Value" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r8", "r11", "r12", "r77", "r791", "r823", "r847", "r899" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 0.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Stockholders' Equity Attributable to Parent, Ending Balance", "periodStartLabel": "Stockholders' Equity Attributable to Parent, Beginning Balance", "totalLabel": "Total Medical Properties Trust, Inc. Stockholders' Equity (MPT Operating Partnership, L.P. capital)" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r132", "r133", "r142", "r223", "r224", "r247", "r277", "r278", "r279", "r283", "r291", "r359", "r431", "r473", "r474", "r475", "r496", "r497", "r532", "r557", "r558", "r562", "r606", "r681", "r682", "r823", "r847", "r899" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total Equity / Capital" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]", "terseLabel": "Equity / Capital" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_SubleaseIncome": { "auth_ref": [ "r586", "r790" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail": { "order": 3.0, "parentTag": "us-gaap_LeaseCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of sublease income excluding finance and operating lease expense.", "label": "Sublease Income", "negatedLabel": "Sublease income" } } }, "localname": "SubleaseIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureLeasesLesseeSummaryOfLeaseExpenseDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r563", "r611" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r563", "r611" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r563", "r611" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r563", "r611" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r610", "r612" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureSubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]", "terseLabel": "Sale of Stock" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock": { "auth_ref": [ "r119" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.", "label": "Summary of Operating Loss Carryforwards [Table Text Block]", "terseLabel": "Schedule of Net NOL and Other Tax Attribute Carryforwards" } } }, "localname": "SummaryOfOperatingLossCarryforwardsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r348", "r349", "r420", "r429", "r523", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r621", "r622", "r623", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r843", "r844", "r845", "r930", "r931", "r932", "r933", "r934", "r935", "r936" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivities2022ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r21", "r108" ], "lang": { "en-us": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]", "terseLabel": "Treasury Shares [Member]" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [ "r221", "r222", "r223", "r224", "r225", "r282", "r283", "r284", "r285", "r294", "r346", "r347", "r356", "r357", "r358", "r359", "r360", "r361", "r473", "r474", "r475", "r494", "r495", "r496", "r497", "r510", "r511", "r512", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r544", "r545", "r547", "r548", "r549", "r550", "r551", "r552", "r565", "r566", "r572", "r573", "r574", "r575", "r601", "r602", "r603", "r604", "r605", "r606", "r646", "r647", "r648", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689" ], "lang": { "en-us": { "role": { "documentation": "Amendment to accounting standards.", "label": "Accounting Standards Update [Domain]", "terseLabel": "Accounting Standards Update" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfEquityCapital" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r895" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums": { "auth_ref": [ "r79" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred fees paid by borrowers and unamortized costs incurred to originate loans and leases, unamortized loan commitments and loan syndication fees, and premiums over or discounts from face amounts of loans that are being amortized into income as an adjustment to yield. Excludes amounts for loans and leases covered under loss sharing agreements.", "label": "Unamortized Loan Commitment and Origination Fees and Unamortized Discounts or Premiums", "terseLabel": "Unamortized loan issue costs" } } }, "localname": "UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIVScheduleOfMortgageLoansOnRealEstateParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r483" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "terseLabel": "Uncertain tax position liabilities and related interest or penalties", "totalLabel": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnsecuredDebt": { "auth_ref": [ "r3", "r175", "r193" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer).", "label": "Unsecured Debt", "terseLabel": "Amount of senior unsecured debt", "totalLabel": "Unsecured Debt, Total" } } }, "localname": "UnsecuredDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtCreditFacilityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnsecuredDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets.", "label": "Unsecured Debt [Member]", "terseLabel": "Senior Unsecured Notes [Member]" } } }, "localname": "UnsecuredDebtMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtSeniorUnsecuredNotesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_UnusualRiskOrUncertaintyByNatureAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by nature of risk and uncertainty, for example, but not limited to, threat of expropriation of its assets by a foreign government, rapid technological obsolescence in the industry, risk of natural disaster from earthquake or weather events, and availability of or continuation of a labor force at a reasonable cost.", "label": "Unusual Risk or Uncertainty, Nature [Axis]", "terseLabel": "Unusual Risk or Uncertainty, Nature" } } }, "localname": "UnusualRiskOrUncertaintyByNatureAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesRentDeferralsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_UnusualRiskOrUncertaintyNatureDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Describes the nature of the unusual risk or uncertainty, such as the threat of expropriation of its assets by a foreign government, rapid technological obsolescence in the industry, risk of natural disaster from earthquake or weather events, and availability of or continuation of a labor force at a reasonable cost.", "label": "Unusual Risk or Uncertainty, Nature [Domain]", "terseLabel": "Unusual Risk or Uncertainty, Nature" } } }, "localname": "UnusualRiskOrUncertaintyNatureDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesRentDeferralsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r69", "r70", "r71", "r314", "r315", "r316", "r317" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember": { "auth_ref": [ "r826", "r827", "r828", "r830", "r831" ], "lang": { "en-us": { "role": { "documentation": "Valuation allowance of deferred tax asset attributable to deductible temporary difference and carryforward.", "label": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]", "terseLabel": "Valuation Allowance, Deferred Tax Asset [Member]" } } }, "localname": "ValuationAllowanceOfDeferredTaxAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationAllowancesAndReservesBalance": { "auth_ref": [ "r269", "r275" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount", "periodEndLabel": "Balance at End of Year", "periodStartLabel": "Balance at Beginning of Year" } } }, "localname": "ValuationAllowancesAndReservesBalance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": { "auth_ref": [ "r272" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense", "terseLabel": "Additions, Charged Against Operations" } } }, "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts": { "auth_ref": [ "r273" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account", "terseLabel": "Addition, Charged to Other Accounts", "verboseLabel": "Tax valuation allowances recorded as part of purchase price allocation" } } }, "localname": "ValuationAllowancesAndReservesChargedToOtherAccounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesDeductions": { "auth_ref": [ "r274" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction", "negatedLabel": "Deductions, Net Recoveries/Write-offs" } } }, "localname": "ValuationAllowancesAndReservesDeductions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesDomain": { "auth_ref": [ "r269", "r270", "r271", "r274", "r275" ], "lang": { "en-us": { "role": { "documentation": "Valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]", "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves" } } }, "localname": "ValuationAllowancesAndReservesDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease": { "auth_ref": [ "r832" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease)", "terseLabel": "Increase (decrease) in valuation allowances", "totalLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease), Total" } } }, "localname": "ValuationAllowancesAndReservesPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesRecoveries": { "auth_ref": [ "r829" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in valuation and qualifying accounts and reserves from recovery of amount previously written off or reestablishment of reserve previously utilized.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Addition, Recovery", "terseLabel": "Credit loss recovery related to loan paydowns" } } }, "localname": "ValuationAllowancesAndReservesRecoveries", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesReservesOfBusinessesAcquired": { "auth_ref": [ "r829" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in valuation and qualifying accounts and reserves from business combination.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Business Acquired", "terseLabel": "Valuation allowances recorded as part of the purchase price allocation of the Circle Transaction" } } }, "localname": "ValuationAllowancesAndReservesReservesOfBusinessesAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesTypeAxis": { "auth_ref": [ "r269", "r270", "r271", "r274", "r275" ], "lang": { "en-us": { "role": { "documentation": "Information by valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]", "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type" } } }, "localname": "ValuationAllowancesAndReservesTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureScheduleIIScheduleOfValuationAndQualifyingAccountsParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDLOMBySensitivityAnalysisByUsingBasisPointVariationsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/DisclosureDebtAustralianTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDLOMBySensitivityAnalysisByUsingBasisPointVariationsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r296", "r305" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted average shares (units) outstanding diluted", "totalLabel": "Diluted weighted-average common shares" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r295", "r305" ], "calculation": { "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail": { "order": 0.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted average shares (units) outstanding basic", "totalLabel": "Weighted Average Number of Shares Outstanding, Basic, Total", "verboseLabel": "Basic weighted-average common shares" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail", "http://medicalpropertiestrust.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfNetIncome" ], "xbrltype": "sharesItemType" } }, "unitCount": 17 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 4.F)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187171-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.F)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187171-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f(1))", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(2)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569655-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.DD)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=116879480&loc=d3e417888-122833", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=116879480&loc=d3e417888-122833", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(7))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(1),(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.11)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(c)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(5))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(5))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(c))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(d))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.3)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=66023616&loc=d3e9079-115832", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262037&loc=d3e9915-115836", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(16))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14.1(b))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611322-123010", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r212": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "970", "URI": "https://asc.fasb.org/topic&trid=2156125", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r213": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "972", "URI": "https://asc.fasb.org/topic&trid=2134617", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r214": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "974", "URI": "https://asc.fasb.org/topic&trid=2156429", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r215": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "976", "URI": "https://asc.fasb.org/topic&trid=2134846", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r216": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "978", "URI": "https://asc.fasb.org/topic&trid=2134977", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123415192&loc=d3e39896-112707", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123415192&loc=d3e39927-112707", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123394697&loc=d3e40879-112712", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123405975&loc=d3e41551-112718", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a-c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(22))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(23))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "21D", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=SL94080555-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column B))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C(1)))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C(2)))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column D))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column E))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900988&loc=SL77927221-108306", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL82887624-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL120254519-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL120320025-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL120320025-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(a))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32059-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3461-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=121483254&loc=SL120254523-199619", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28129-110885", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r564": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "https://asc.fasb.org/topic&trid=2175825", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL77916155-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL120154346-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r58": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123420820&loc=SL77919306-209978", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919396-209981", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919359-209981", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919359-209981", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919379-209981", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919381-209981", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r612": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e639-108305", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(24))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(25))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(20))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(21))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(d))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "360", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123605564&loc=d3e23415-158514", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "360", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123605564&loc=d3e23439-158514", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123605587&loc=d3e23528-158515", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Column B))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Column D))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Column E))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Column F))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Column G))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 6))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 8))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29)", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 5))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 6))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28)", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r733": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r734": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1405", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r735": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1405", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r736": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1405", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r737": { "Footnote": "2", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r738": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r739": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r740": { "Footnote": "5", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r741": { "Footnote": "6", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r742": { "Footnote": "6", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r743": { "Footnote": "8", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r744": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column B", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r745": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column B", "Publisher": "SEC", "Section": "12", "Subsection": "29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r746": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column C", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r747": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column D", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r748": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column D", "Publisher": "SEC", "Section": "12", "Subsection": "29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r749": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column E", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r750": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column E", "Publisher": "SEC", "Section": "12", "Subsection": "29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r751": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column F", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r752": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column F", "Publisher": "SEC", "Section": "12", "Subsection": "29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r753": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column G", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r754": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column H", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r755": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column I", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r756": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "09", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r757": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r758": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r759": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(m)", "Publisher": "SEC", "Section": "4", "Subparagraph": "(1)(iii)", "Subsection": "08", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r760": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "c", "Publisher": "SEC", "Section": "5", "Subparagraph": "Schedule III", "Subsection": "04", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r761": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r762": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r763": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r764": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r765": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r766": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r767": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r768": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r769": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r770": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r771": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r772": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r773": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r774": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r775": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r776": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r777": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r778": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r779": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r78": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/subtopic&trid=2196772", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r780": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r781": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r782": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r783": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r784": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r785": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r786": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r787": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r788": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r789": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=6378536&loc=d3e10092-111533", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r790": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r791": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r792": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r793": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r794": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r795": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r796": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r797": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r798": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r799": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)(ii)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=121614798&loc=d3e15032-111544", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r800": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r801": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r802": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r803": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r804": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r805": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r806": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r807": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r808": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r809": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r810": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r811": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r812": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r813": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(7)(c))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r814": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(9)(a))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r815": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r816": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r817": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r818": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r819": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r820": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r821": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r822": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r823": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r824": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r825": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r826": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column B))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r827": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C(1)))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r828": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C(2)))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r829": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(b)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r830": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column D))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r831": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column E))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r832": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r833": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r834": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r835": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r836": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r837": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r838": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r839": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r840": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r841": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r842": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.L.1)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74567-122707", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r843": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r844": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r845": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r846": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117546-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r847": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r848": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r849": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r850": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r851": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r852": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r853": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=28183603&loc=d3e692-112598", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r854": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r855": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r856": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r857": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r858": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r859": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r860": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r861": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r862": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r863": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r864": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r865": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r866": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r867": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r868": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r869": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r870": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r871": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r872": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r873": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r874": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r875": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r876": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r877": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r878": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r879": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r880": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r881": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r882": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r883": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r884": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r885": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r886": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r887": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r888": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r889": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r890": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r891": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r892": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r893": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r894": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r895": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r896": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r897": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r898": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r899": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r900": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r901": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r902": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123408481&loc=SL77919140-209958", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r903": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919396-209981", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r904": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919359-209981", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r905": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r906": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r907": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r908": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r909": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r910": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r911": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r912": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r913": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r914": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r915": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(7)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r916": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(14)(d))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r917": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1)(d))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r918": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r919": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r920": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r921": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r922": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r923": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r924": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r925": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r926": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r927": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r928": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r929": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r93": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r930": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r931": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r932": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r933": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r934": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r935": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r936": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r937": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "303", "Subparagraph": "(5)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r938": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "11", "Subsection": "03", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r939": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column B", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r940": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column C", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r941": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column D", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r942": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column E", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r943": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column F", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r944": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column G", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r945": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column H", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r946": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column I", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r947": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(i)", "Subsection": "01", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r948": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iv)", "Subsection": "01", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r949": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iv)", "Subsection": "02", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" }